Studies on the structure of aldolase bound to F-actin and its role in endocytosis by Ho, Nhu Quynh
Boston University
OpenBU http://open.bu.edu
Theses & Dissertations Boston University Theses & Dissertations
2019
Studies on the structure of aldolase
bound to F-actin and its role in
endocytosis
https://hdl.handle.net/2144/39562
Boston University
 BOSTON UNIVERSITY 
 
GRADUATE SCHOOL OF ARTS AND SCIENCES 
 
 
 
 
 
Dissertation 
 
 
 
 
 
STUDIES ON THE STRUCTURE OF ALDOLASE BOUND TO F-ACTIN  
AND ITS ROLE IN ENDOCYTOSIS 
 
by 
 
QUINN HO 
B.S., University of California, Los Angeles (UCLA), 2008 
 
 
 
 
 
 
 
 
Submitted in partial fulfillment of the 
requirements for the degree of 
Doctor of Philosophy 
2019 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2019 by 
Quinn Ho 
All rights reserved 
 Approved by 
 
 
 
 
 
 
First Reader  ______________________________________________________ 
   Dean R. Tolan, Ph.D. 
   Professor of Biology 
 
 
 
Second Reader ______________________________________________________ 
   Karen N. Allen, Ph.D. 
   Professor of Chemistry 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 iv 
DEDICATION 
 
To my mom and dad for always wanting the best for me, 
and instilling in me the greatest tool I’ll ever need: 
 survival 
  
 v 
ACKNOWLEDGEMENTS 
 
 Seeing as my thesis is the last book I’ll be writing for the foreseeable future, I 
want to take this opportunity to express my gratitude to every person who has contributed 
in some way to helping me achieve this milestone.  First and foremost, most people have 
no idea what it took to even bring me into existence so that I could live to get a Ph.D.  
For this, I must credit my amazing parents, Nammot Thi Ly and Ngon Van Ho, who 
survived the Vietnam War and beat unbelievable odds to make it here and do everything 
in their power to give me the best life possible.  Thank you, mom and dad. 
Next, it goes without saying that the person who should receive almost all of the 
credit for getting me across the finish line is my mentor, Dr. Dean Tolan.  Thank you for 
seeing something in me and believing in me, even when I had a hard time believing in 
myself.  You have been a rock throughout this whole experience, and it has truly been an 
honor.  I am the best scientist I could possibly be because of you, and I will always be a 
biochemist at heart now.  Once again, thanks for ruining all future bosses for me.  Thanks 
for introducing me to Kim, Victoria, and Pepper, too.  Sorry about all the computer 
hardware failures and liquid nitrogen dewars… 
To my committee members—Dr. Karen Allen, Dr. Chip Celenza, Dr. Hengye 
Man, and Dr. Bill Lehman, I respect and admire all of you more than I was able to 
express in our interactions.  Thank you for always leaving me with much to think about 
after our meetings and giving me that extra push.  Your genuine interest and feedback 
truly made my thesis better and my overall experience much more rewarding.   
 vi 
To Karen Allen, especially – much of this work would not have come to fruition 
without your help.  I am so lucky to have had you as my second reader.  Thank you so 
much for going out of your way for me, believing in this actin-aldolase project, and 
making me feel like an honorary member of your lab.   
To the Densmore group in the Department of Biomedical Engineering – I am ever 
so grateful for your collaboration with us and letting us be the first to try out your MoClo 
kit.  You guys played a major role in helping us get over a critical hurdle for this work. 
To the Allen, Whitty, and Elliot groups in the Department of Chemistry – many 
thanks for all of the technical biochemistry support, which helped produce a lot of the 
data for this thesis work. 
To Jose Medrano – you have been my bestie in this program since day one.  
Thank you for your unending charisma, uniqueness, nerve, and talent.  There are no 
words to express how grateful I am to have you in my life!  You are such an incredible 
person and have helped me with so much along the way.  I truly wouldn’t have made it 
through without the support, laughter, and many Anna’s burritos.   
To all of my Tolan Lab peers, especially the “OGs”—Carolyn Ritterson Lew, 
Jack Stopa, and Sarah Oppelt, thank you guys for welcoming me into the lab when I 
started and for teaching me so much.  Carolyn, you have no idea how much you paved 
the way and really set the bar.  Your thesis came to be the all-important "aldolase 
moonlighting bible” that I constantly referred to during my time in the lab.  I try not to 
ever have heroes, but you certainly are one.   
 
 vii 
Sarah Oppelt, you’ve been like the big sister I never had since the very beginning!   
Thank you for being there for me through all this time, listening to all of my “freak-outs,” 
and having conversations with me about everything under the sun from science to Project 
Runway.  You went well out of your way for me on countless occasions, and for that, I 
can’t thank you enough.  You have been every bit a part of this thesis work, and I’ve 
really appreciated your enthusiasm, artistry, and intellect.  Thanks for all of the laughs in 
lab, too.  You are part of the reason my experience in Dean’s lab has been so great. 
To Clarke Gasper – I’ve immensely enjoyed your company in the lab and will 
sorely miss having our desks right across from each other.  Our friendship has been a 
special one, and I am so grateful for all of the fun and interesting experiences together.   
Thanks for your appreciation of food, wine, art, and fashion.  You’re a great scientist to 
boot, and I appreciate all of the immense support you lent when I needed it.  Here’s to 
lots of travel and wine together in the future! 
 There were many wonderful former undergraduates that were part of the Tolan 
Lab during my time at BU who supported and helped me out in various ways.  I 
especially want to give thanks to Jie Sun, Tom McTigue, Athena Cavounidis, Stone 
Chen, Paige Coles, Sarah Gardner, Meagan Olive, Katie Satko, Grace Call, and Cindy 
Abuyaghi.  All of you guys have been there for me in some way.  I am so grateful for 
your continued support and friendship.  It’s been a pleasure watching your brilliant minds 
grow.  A special shout-out also goes to Adam Ross, who was a member of our lab for a 
time as well.  Adam, thank you for all of the deep conversations about life and for 
following my work even after moving on from the lab. 
 viii 
 To Jinny Pham – there is so much to credit you for.  Without you, this thesis 
could not have been anywhere near as polished as it ended up.  You were like a hidden 
fairy godmother and worked some serious magic.  I am eternally grateful for your support 
and sticking with me through every last page.  Thank you for being my secret weapon in 
graphic design, growing up with me over the past couple of decades, fueling my passion 
for fashion all the livelong day, and picking me up every time I've fallen.  It’s been 
amazing watching you blossom into the most wonderful human being.  I can’t wait for 
our jewelry line! 
 To Pollock and Chau Quach – I could never forget where I came from.  You guys 
believed in me back when I was a young pup before anyone else did and helped make me 
the person (and writer) I am today.  Thank you for all the love and support throughout the 
years.  I wouldn’t have made it here without your friendship. 
 To my college and childhood friends, Lindy Lay and Linh Vu – wow, has it been 
a long time.  Neither college nor grad school would have been the same without you guys 
in my life.  Thanks for being my friends throughout my entire career so far, even after I 
moved across the country.  Lindy, I’m so grateful for all of the support, pizza, and you 
being the best listener in the world.  You have been a grounding force and enriched my 
life in a lot of ways.  Linh, I’m so glad you’ve been there for me all this time and are 
always just a phone call away.   
To all of my former UCLA mentors and colleagues – thank you for fostering a 
love of discovery, nurturing me into a real scientist, and getting me to grad school.  I 
must especially credit Margo Myers, Eric Gschweng, Dorian Gunning, Ohtan Wang, 
 ix 
Ken-ichiro Kamei, John Flanagan, Sean Millard, Minori Ohashi, Jun Nakano, and Todd 
Lorenz.  You are the best people, and the knowledge you imparted on me has been 
invaluable.  I was so lucky to get to work with you all as a mere fledgling, and your 
support made all the difference.  To all of my former PIs—Larry Zipursky, Kelsey 
Martin, Greg Payne, and Hsian-Rong Tseng, thank you for giving me the opportunity to 
learn and grow in your laboratories.   
 To all of my cohort, colleagues, and friends at BU in the Biology and Chemistry 
departments – thanks for showing me kindness and joy throughout the many years, even 
during rough times.  I’ll never forget it.  It’s been a pleasure being surrounded by a lot of 
truly great people.  In particular, to Kate Mansfield – I’m so glad we became friends and 
made it out alive together!  Thanks for being such a wonderful buddy to me, personally 
and professionally.  I can’t wait to see what the future holds.   
 My last, but not least, professional acknowledgement, is reserved for Maggie 
O’Connor.  Thank you for collaborating with me in the eleventh hour and giving me a 
small project to add to my thesis.  I learned a lot actually!  I wish you all the best of luck 
and know that there is a bright future ahead for you. 
Finally, to Mikey, Mickey & Sophie – through all the odd hours and late nights, 
you three were (literally) there for it all and are the loves of my life.  Mike Jones, I don't 
know what I would've done without you during my thesis-writing (or in general!).  
Outside of my doctoral committee, you are probably going to be the only other person 
who has read my dissertation cover-to-cover.  Thanks for putting a smile on my face 
every day and making me feel like the luckiest girl in the world.   
 x 
STUDIES ON THE STRUCTURE OF ALDOLASE BOUND TO F-ACTIN  
AND ITS ROLE IN ENDOCYTOSIS 
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Major Professor: Dean R. Tolan, Professor of Biology 
ABSTRACT 
 
Fructose 1,6-bisphosphate aldolase, or simply aldolase, is a key enzyme involved 
in the glucose and fructose metabolic pathways.  Vertebrate aldolases exists in nature as 
extremely stable tetramers.  While essential for energy metabolism, aldolase is involved 
in numerous “moonlighting functions,” many of which involve the ability to bind F-actin.  
Evidence suggests that the quaternary structure of aldolase may have evolved for such 
moonlighting activities in the cell.  Though aldolase was one of the first actin-binding 
proteins discovered, the exact structure and biological functions of this interaction have 
remained elusive.  Electron microscopy studies demonstrate that a minimum of a dimer is 
required to bind and decorate actin filaments, but only tetrameric aldolase is capable of 
binding and crosslinking F-actin into bundles.  Experiments are described that will lead to 
a high-definition structure of the aldolase-F-actin complex and resolution of the binding 
interface used by aldolase.  These include efforts to create chimeric aldolase tetramers 
using in vitro protein hybridization and modular cloning approaches.  Understanding this 
critical interaction is necessary for mechanistic models explaining aldolase moonlighting 
functions.  The significance of aldolase’s association with F-actin in vivo has only more 
recently been explored.  Studies with two other aldolase binding partners—Wiskott-
 xi 
Aldrich Syndrome protein (WASP) and Sorting Nexin 9 (SNX9), suggest that aldolase 
may be moonlighting as a scaffold protein during late stage endocytic events in the cell.  
The hypothesis that aldolase has a regulatory role in endocytosis is tested.  Precise 
coordination and efficiency of recruited proteins are hallmarks of clathrin-mediated 
endocytosis, and a scaffolding role for aldolase could serve at least two functions: 1) to 
sequester the active domains of WASP and SNX9 prior to vesicle scission, and 2), enable 
sufficient concentration of WASP and SNX9 at sites of endocytosis via association with 
F-actin.  This type of regulation would sequester each protein until the exact function is 
needed, allowing release at the appropriate time points as well as in the proper sequence.  
Uptake assays performed using two different markers and cell lines show upregulation of 
endocytosis after knockdown of aldolase.  A model is proposed for participation by 
aldolase in the dynamics of this process. 
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CHAPTER 1: INTRODUCTION 
 
BACKGROUND ON FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE 
 
Canonical Function in Metabolism 
Fructose-1,6-bisphosphate aldolase, more often referred to as simply aldolase, is a 
key enzyme involved in the glucose and fructose metabolic pathways.  Fru 1,6-P2 (FBP) 
is a hexose intermediate formed at the third step of glycolysis (Figure 1.1).  Aldolase is 
responsible for catalyzing the reversible aldol cleavage of FBP to form the two triose 
phosphates glyceraldehyde 3-phosphate (G3P) and dihydroxyacetone phosphate (DHAP) 
(Figure 1.2A).  During gluconeogenesis, aldolase catalyzes the reverse reaction, in which 
G3P and DHAP are condensed into FBP.  In fructose metabolism, aldolase cleaves 
fructose-1-phosphate (F1P) into glyceraldehyde and DHAP (Figure 1.2B).  There are two 
classes of aldolases, each utilizing distinct catalytic mechanisms (Marsh and Lebherz, 
1992).  Class I aldolases, found in higher plants and animals, form a Schiff-base 
intermediate between a highly conserved active-site lysine residue and a substrate 
carbonyl group.  Class II aldolases are considered to be more primitive, and are present in 
lower eukaryotes and prokaryotes; these aldolases require a divalent metal cofactor in the 
active site, typically Zn2+ or Fe2+.  Three aldolase isozymes are known to exist in 
vertebrates, which share in overall structural similarity and high degree of sequence 
identity with the highest variation in the C-terminal sequences.  The tissue specificities 
(Figure 1.3) appear related to catalytic properties of each isozyme (Gamblin et al., 1991; 
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Figure 1.1 The glycolytic pathway.  Entry of glucose into glycolysis for cellular metabolism in 
eukaryotic organisms is illustrated as a cross-section of the cell and mitochondria.  Ten enzyme-
catalyzed steps (black arrows) break down glucose to pyruvate in the cytosol to extract energy.  
The aldolase-catalyzed reaction is highlighted, which is responsible for the lytic step, cleaving 
FBP into two three-carbon isomers, DHAP and G3P.  The products of the remaining steps in the 
pathway are composed of three-carbon fragments rather than six-carbon molecules.  Although the 
fate of pyruvate is variable, entry into the oxidative pathway, the tricarboxylic acid cycle, is 
depicted due to glycolysis being the major energy-yielding metabolic pathway (Voet and Voet, 
2010).  Abbreviations: 1,3-BPG, 1,3-bisphosphoglycerate; 2-PG, 2-phosphoglycerate; 3-PG, 3-
phosphoglycerate; DHAP, dihydroxyacetone phosphate; F6P, fructose 6-phosphate; FBP, 
fructose 1,6-P2; G3P, glyceraldehyde 3-phosphate; G6P, glucose 6-phosphate; GLUT, glucose 
transporter; PEP, phosphoenolpyruvate; TCA, tricarboxylic acid cycle.   
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Figure 1.2 Reactions catalyzed by aldolase in glucose and fructose metabolic pathways.   
A. In glycolysis, two three-carbon fragments, G3P and DHAP, are produced from one six-carbon 
sugar, FBP.  In gluconeogenesis, the reverse reaction is catalyzed, where G3P and DHAP are 
condensed into FBP.  B. In fructose metabolism, F1P is cleaved by aldolase into glyceraldehyde 
and DHAP.  Chemical structures were generated by Sarah M. Gardner using ChemDraw 
(PerkinElmer Informatics, Waltham, MA).   
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Figure 1.3 Aldolase tissue distribution.  General expression of vertebrate aldolase isozymes is 
depicted.  Aldolase A is ubiquitously expressed and is the primary isozyme found in muscle.  
Aldolase B is primarily in the liver and kidney cortex, with a small fraction found in the small 
intestine.  Aldolase C is expressed in the brain, other nervous tissue (shown in yellow), and 
smooth muscle (stomach and other internal organs not under voluntary control). 
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Penhoet et al., 1969) as Aldolase A and C isozymes show higher substrate specificity for 
FBP than F1P, whereas aldolase B does not differ in specificity towards either substrate 
(Eagles and Iqbal, 1973; Dalby et al., 2001).  Aldolase A, primarily involved in 
glycolysis, is ubiquitously expressed and is the the major isozymic form in muscle 
(Lebherz and Rutter, 1969).  The aldolase B isozyme is most abundant in the liver and 
kidney cortex, with a smaller fraction in the small intestine.  Aldolase B plays a critical 
role in F1P metabolism and gluceoneogenesis, which largely occur in the liver (McGrane, 
2000; Rui, 2014).  Lastly, aldolase C is found in the brain, other nervous tissue, and 
smooth muscle (Lebherz and Rutter, 1969).  Although aldolase C has been suggested to 
have a neurodevelopmental role (Ahn et al., 1994) and participation in fructose 
metabolism in the brain (Funari, 2005; Oppelt et al., 2017), little is known about the 
exact function of this isozyme.  Mutations in aldolase A and B function are associated 
with nonspherocytic hemolytic anemia (Jaffé, 1970; Kishi et al., 1987; Kreuder et al., 
1996; Esposito et al., 2004) and hereditary fructose intolerance (HFI) (Tolan, 1995; 
Malay et al., 2005; Coffee and Tolan, 2010), respectively, whereas physiological 
disorders related to defects in aldolase C remain unknown at this time (Arakaki et al., 
2004).  
 
Participation in Moonlighting Interactions and Associated Pathways 
The Aldolase-F-actin Complex and Relevance of the Aldolase Quaternary Structure 
In addition to the presence in nearly all living cells as a critical enzyme necessary 
for energy metabolism, aldolase has been discovered to participate in interactions outside 
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of the canonical catalytic role (Arnold and Pette, 1968; Clarke and Morton, 1976; 
Strapazon and Steck, 1976; Pontremoli et al., 1979; Salerno and Ovádi, 1982; Koppitz et 
al., 1986; Stephan et al., 1986; Zimmer and Van Eldik, 1986; Orosz et al., 1987; Orosz et 
al., 1988; Walsh et al., 1989; Kao et al., 1999; Ta et al., 1999; Lu et al., 2001; Kim et al., 
2002; Jewett and Sibley, 2003; Dziewulska-Szwajkowska et al., 2005; Ishida et al., 2005; 
Lundmark and Carlsson, 2004; Russell et al., 2004; Singh et al., 2004; Cañete-Soler et 
al., 2005; Yañez et al., 2005; Buscaglia et al., 2006; Benziane et al., 2007; Chiquete-
Felix et al., 2009; Starnes et al., 2009; Tochio et al., 2010; Merkulova et al., 2011; 
Ritterson Lew, 2012; Ritterson Lew and Tolan, 2012; Goo et al., 2013; Ritterson Lew 
and Tolan, 2013; Du et al., 2014; Hu et al., 2016; Boucher et al., 2018), otherwise known 
as moonlighting functions (Jeffery, 1999).  Known moonlighting interactions are depicted 
in Figure 1.4.  The vast majority of these interactions were discovered using co-
precipitation techniques where aldolase was consistently isolated in a complex with other 
proteins and identified by mass spectrometric analysis.  Direct binding was often verified 
and further characterized by various means such as pulldown, immunocytochemistry 
(ICC), site-directed mutagenesis (SDM), fluorescence anisotropy, and surface plasmon 
resonance studies. 
Of particular interest among the moonlighting interactions identified is the 
relationship with F-actin.  Aldolase was discovered to be a direct actin-binding protein 
half a century ago (Arnold and Pette, 1968), yet few details have been uncovered about 
the exact structure and biological functions of this complex.  In vitro studies have long 
demonstrated the ability of aldolase to crosslink actin filaments into a gel or two-  
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Figure 1.4 The aldolase web of interactions.  Aldolase has been found to interact with 
numerous binding partners, most of which are proteins in various pathways.  Each connecting line 
depicts a reported moonlighting interaction.  Colored circles represent canonical functions as 
indicated by the corresponding pathway categories underneath the web.  Abbreviations: ARNO, 
adenosine diphosphate-ribosylation factor nucleotide-binding site opener; Arp2/3, actin-related 
protein-2/3 complex; CaMK, Ca2+/calmodulin-dependent protein kinase; CaMK IIβM, skeletal 
muscle Ca2+/calmodulin-dependent kinase IIβ; CCS, clathrin-coated structures; Dyn2, dynamin 2; 
GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GLUT4, glucose transporter 4; IP3, 
inositol 1,4,5-triphosphate; NKCC2, Na-K-2Cl cotransporter; NF-L, neurofilament light chain; 
PFK, phosphofructokinase; SNX9, sorting nexin 9; TIM, triose phosphate isomerase; TRAP, 
thrombospondin-related anonymous protein; V-ATPase, vacuolar H+-ATPase; WASP, Wiskott-
Aldrich syndrome protein.  Schematic adapted and updated from Ritterson Lew, 2012.   
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dimensional rafts (Walsh et al., 1980; Clarke et al., 1985; Pagliaro and Taylor, 1988; 
Wang et al., 1996; Sukow and DeRosier, 1998; Sukow and DeRosier, 2003, Hu et al., 
2018).  Furthermore, it has been shown that only tetrameric aldolase can crosslink F-actin 
(Pirani, 2008).  Dimer variants created through SDM (Beernink and Tolan, 1994) still 
possess full actin-binding capability (Ritterson Lew, 2012) and can decorate the F-actin 
helix but are no longer able to crosslink actin filaments (Pirani, 2008).  Monomeric 
aldolase (Beernink and Tolan, 1996), however, cannot bind to F-actin (Ritterson Lew, 
2012), indicating that a minimum of a dimer is required to bind and decorate filaments 
and the full tetramer for crosslinking (Pirani, 2008).  Despite efforts to identify the actual 
actin-aldolase binding site (Méjean et al., 1989; O'Reilly and Clarke, 1993; Wang et al., 
1996; Kusakabe et al., 1997), a structural model of the interface between aldolase and F-
actin has remained elusive (Pirani, 2008; Hu et al., 2018). 
Although the quaternary structure of aldolase seems to be relevant for actin-
binding, it appears to have no impact on catalytic function.  Dimers and monomers of 
aldolase generated via SDM retain full enzymatic activity indistinguishable from wild-
type (WT) aldolase (Beernink and Tolan, 1994; Beernink and Tolan, 1996).  Notably, 
aldolase exists in nature as an unusually stable tetramer (Penhoet et al., 1967; Deng and 
Smith, 1999; Tolan et al., 2003), as depicted in Figure 1.5.  Aldolase has one of the 
strongest interface associations known for any protein, and this feature is not shared 
among other glycolytic enzymes (Lakatos et al., 1972; Hermann et al., 1981).  
Additionally, studies on the effect of monomer and dimer variants on actin 
polymerization and actin-mediated processes suggest the quaternary structure of aldolase  
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Figure 1.5 Aldolase quaternary structure is unusually stable.  A. Aldolase is found 
exclusively as a tetramer in higher eukaryotes, with subunits that can only be dissociated under 
harsh conditions (Deng and Smith, 1999).  B. Subunit interface mutations can be generated by 
site-directed mutagenesis (SDM) to create quaternary structure variants of aldolase, such as 
dimers or monomers (shown), without loss of enzyme activity (Beernink and Tolan, 1994; 
Beernink and Tolan, 1996; Tolan et al., 2003). 
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is more relevant for moonlighting than the canonical function (Ritterson Lew, 2012), and 
clearly may be the evolutionary driving force for this stable structure.  Though the exact 
purpose of the quaternary structure has not been fully established, it is possible that the 
stability of the subunit interfaces is necessary for additional functions beyond simple 
catalysis and thermostability (Beernink and Tolan, 1994; Tolan et al., 2003).  Interactions 
with other proteins in the cell, such as F-actin, and involvement in the formation of 
higher-order complexes may require stable association by multiple subunits of aldolase.   
 
Relationship with Actin-Driven Cell Processes 
As described above, numerous binding partners of aldolase have been identified 
(Figure 1.4).  The known functions of these interaction partners can be roughly divided 
into four categories: metabolism (Stephan et al., 1986; Orosz et al., 1988; Dziewulksa-
Szwajkowska et al., 2005), signal transduction (Koppitz et al., 1986; Orosz et al., 1988; 
Kim et al., 2002; Singh et al., 2004; Ishida et al., 2005), cell motility (Jewett and Sibley, 
2003; Buscaglia et al., 2006), and vesicle trafficking (Kao et al., 1999; Lu et al., 2001; 
Lundmark and Carlsson, 2004; Benziane et al., 2007; Merkulova et al., 2011).  All of the 
non-metabolic pathways indicated involve actin dynamics.  Although aldolase was one of 
the first actin-binding proteins discovered (Sigel and Pette, 1969) and has been shown to 
co-localize with actin in cells (Kusakabe et al., 1997; Wang et al., 1997; Chiquete-Felix 
et al., 2009), the structure and functions of this interaction remain largely undefined and 
the significance in vivo has only more recently been explored (Ritterson Lew and Tolan, 
2012; Ritterson Lew and Tolan, 2013; Hu et al., 2018).   
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Knockdown of aldolase has been shown to produce defects in F-actin dependent 
processes such as morphology, proliferation, motility, and cell spreading (Ritterson Lew 
and Tolan, 2012; Ritterson Lew and Tolan, 2013).  In early experiments using mouse 
fibroblasts performed by Dr. Carolyn Ritterson Lew, aldolase knockdown produced 
defects in cell morphological and actin cytoskeletal organization (Ritterson Lew, 2012).  
These effects were shown to be specific to aldolase and were not observed after 
knockdown of other glycolytic enzymes.  In NIH-3T3 fibroblasts, decreases were seen in 
cell motility and cell spreading, processes which affect lamellipodia and filopodia 
formation (Yamazaki et al., 2005; Takenawa and Suetsugu, 2007).  Both defects could be 
rescued with WT aldolase (Ritterson Lew and Tolan, 2013). 
Proliferation (growth rate) was found to be significantly decreased upon aldolase 
knockdown with no impact on cell viability in Ras-transformed NIH-3T3 (Ras-3T3) cells 
and three other transformed rat cell lines (Ritterson Lew and Tolan, 2012).  As previously 
observed, these effects were not seen with other glycolytic enzymes such as triose 
phosphate isomerase (TIM), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and 
enolase.  In Ras-3T3 and 9L rat gliosarcoma cell lines, knockdown of aldolase resulted in 
decreased soft agar colony formation, a correlative of lowered tumor formation.  Nuclear 
staining of Ras-3T3 knockdown cells with 4′,6-diamidino-2-phenylindole (DAPI) 
showed an increase in multinucleation, likely pointing to an actin cytoskeletal defect as 
F-actin is required for proper cytokinesis (Miller, 2011).   
For many of the processes mentioned, rescue phenotypes using either 
catalytically-dead or actin-binding deficient aldolase variants have established that the 
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role of aldolase in actin-driven cell processes is both non-metabolic and related to the 
ability to bind F-actin (Ritterson Lew and Tolan, 2012; Ritterson Lew and Tolan, 2013).  
This finding is further supported by in vitro studies examining the effect of purified 
protein components on pyrene-labeled actin assembly.  WT, dimer variant, and 
catalytically-dead aldolases have been shown to inhibit actin-related protein-2/3 (Arp2/3) 
complex and Wiskott-Aldrich Syndrome protein (WASP)-stimulated actin 
polymerization, whereas actin-binding deficient and monomeric aldolase variants do not 
(Ritterson Lew and Tolan, 2013).  This inhibitory effect may be relevant to aldolase’s 
putative role in vesicle trafficking pathways such as endocytosis, as discussed below. 
 
Regulation of Endocytosis 
Overview of Endocytic Pathways 
Endocytosis is classically defined as the process by which cells uptake nutrients 
or other extracellular material and regulate the composition of the plasma membrane 
(PM) (Sigismund et al., 2012).  Although small molecules such as ions and sugars can 
enter cells through specialized channels and integral membrane proteins, macromolecules 
must be packaged into membrane bound vesicles derived from the PM (Conner and 
Schmid, 2003).  The phenomenon of endocytosis was first described in the 1850s, but a 
model proposed in 1979 by Anderson, Brown, and Goldstein that was based on studies of 
the low-density lipoprotein (LDL) receptor, later established the concept of receptor-
mediated endocytosis (Roth, 2006).  Major advances in our understanding of a receptor-
mediated pathway have come from characterization of the clathrin-mediated endocytosis 
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(CME) pathway in budding yeast, a unicellular eukaryote selected for ease of genetic 
manipulation (Schekman, 2013).  With the advent of live-cell imaging technology and 
studies of clathrin coat movement using green fluorescent protein (GFP) in 1999, 
spatiotemporal analyses enabled the defining of distinct pathway modules, setting the 
groundwork for studies in mammalian systems.  Although “receptor-mediated 
endocytosis” was used interchangeably with CME in the past, this term has become 
outdated as additional alternative routes for endocytic uptake have since been identified 
(Conner and Schmid, 2003).  Pathways outside of CME are termed clathrin-independent 
endocytosis (CIE) (Mayor and Pagano, 2007).  CME and CIE pathways each differ with 
regard to the vesicle size formed, types of cargo, mechanism of internalization, and the 
PM microdomains where these modes of internalization each take place (Doherty and 
McMahon, 2009; Hansen and Nichols, 2009).  These distinct modes of cell entry can be 
broadly divided into two categories: phagocytosis and pinocytosis (Figure 1.6).   
Phagocytosis refers to the engulfment of large particles, such as pathogens, cell 
debris, and apoptotic cells (Conner and Schmid, 2003).  It is usually only found in 
specialized mammalian cells and involves the formation of phagosomes achieved by 
generating cup-shaped pseudopod extensions that fuse around particulate material (Allen 
and Aderem, 1996; Flannagan et al., 2012).  This machinery is generally triggered by 
particles being ingested and cell-surface receptors that recognize these materials and 
activate signaling cascades involving Rho-family GTPases (Conner and Schmid, 2003).  
Phagocytosis is largely connected with physiological responses to inflammation and 
tissue damage (Chen et al., 2018).  Unlike other endocytic methods, new membrane may  
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Figure 1.6 Endocytic pathways.  The known pathways of cargo entry into eukaryotic cells can 
be broadly categorized under phagocytosis and pinocytosis.  Engulfment of large particles occurs 
via phagocytosis.  Bulk fluid uptake occurs by macropinocytosis.  The two known pathways that 
involve a membrane coat are clathrin-mediated endocytosis and caveolae-mediated endocytosis.  
Three additional pathways exist that are clathrin- and caveolae-independent pathways, some of 
which may be dynamin-independent.  The majority of cargoes are trafficked directly to the early 
endosome.  Plasma membrane remodeling is facilitated by actin polymerization in all of these 
processes.  Abbreviations: CLIC, clathrin-independent tubulovesicular carrier; GEEC, 
glycosylphosphatidylinositol-anchored protein enriched early endosomal compartment.  
Schematic adapted from Mayor and Pagano, 2007. 
 
 
be delivered to the PM at sites of engulfment in this process due to the sizable nature of 
phagocytosed cargo (Masters et al., 2013).  
 Pinocytosis, on the other hand, encompasses four additional subcategories of 
endocytosis: macropinocytosis, the coat protein-mediated pathways (clathrin- or 
caveolae-mediated endocytosis), and clathrin- and caveolae-independent pathways 
(Kumari et al., 2010).  Macropinocytosis describes a form of endocytosis used to 
 15 
internalize bulk extracellular fluid (Kerr and Teasdale, 2009).  This process has been 
linked to membrane ruffling that is induced in many cell types upon growth factor 
stimulation (Phillip and Harrison, 2018).  Similar to phagocytosis, the signaling cascades 
that trigger macropinocytosis appear to involve Rho-family GTPases (Conner and 
Schmid, 2003).  However, unlike phagocytosis, macropinocytic extensions fuse back into 
the PM to trap fluid between ruffled regions rather than producing protrusions that 
enclose cargo, though this fusion process is not well-understood.  Although regulatory 
components and other mechanistic aspects have remained elusive, the kinase p21-
activated kinase 1 (PAK1) has been shown to be necessary and sufficient for inducing 
micropinocytosis (Dharmawardhane et al., 2000).  Once presumed to operate non-
selectively, macropinocytosis is now understood to have diverse functions and may play 
a critical role in downregulating signaling molecules during processes such as cell 
migration and immune surveillance (Conner and Schmid, 2003). 
The most well-studied pathway to date is clathrin-mediated endocytosis 
(McMahon and Boucrot, 2011).  In CME, clathrin self-assembles into spherical cages on 
the cytosolic side of pits, adding stability as the pits become gradually invaginated from 
the PM (Edeling et al., 2006; Cocucci et al., 2012).  The clathrin coat consists of a highly 
dynamic network of constantly exchanging and interacting proteins that drive 
internalization (Traub, 2009; McMahon and Boucrot, 2011).  The full cycle of clathrin-
coated vesicle (CCV) formation involves a remarkably intricate and precise coordination 
of events through five stages: nucleation, cargo selection, coat assembly, vesicle scission, 
and uncoating (Figure 1.7).  Pit formation begins with the nucleation module, where  
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Figure 1.7 The five stages of clathrin-mediated endocytosis.  The proposed steps of clathrin-
coated vesicle formation proceed through five stages: I. Upon nucleation, membrane curvature 
where budding will take place is initiated.  II. During cargo selection, adaptor protein complex 2 
(AP-2) and other cargo-specific adaptors are recruited.  III. Clathrin is recruited, which triggers 
coat assembly.  IV. Vesicle scission is triggered by narrowing of the bud neck and actin 
cytoskeletal dynamics.  V. Dynamin GTPase activity severs the bud and releases the vesicle.   
VI. During uncoating, the coat proteins detach and are freed for additional rounds of endocytosis.  
Schematic adapted from Traub, 2009.   
 
 
Fer/Cip4 homology domain-only (FCHo) proteins, Epidermal Growth Factor Receptor 
Pathway Substrate 15 (EPS15), and intersectin generate membrane curvature where 
budding will take place (Henne et al., 2010).  Adaptor protein complex 2 (AP-2) and 
other cargo-specific adaptors are then recruited and are responsible for cargo selection 
(Boucrot et al., 2010).  The β2-subunit of AP-2 recruits clathrin triskelia to nascent pits, 
triggering coat assembly (Traub, 2009).  The final stages of CCV production involve 
pinching off the coated pit to form a cargo-filled vesicle.  The scission module is 
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orchestrated by Bin-Amphiphysin-Rvs (BAR) domain proteins and the GTPase dynamin 
(Rao et al., 2012).  BAR domain proteins sense and further induce membrane curvature 
(Zimmerberg and Kozlov, 2006).  Dynamin is recruited to the neck of forming vesicles 
and oligomerizes to form a helical collar that upon Sorting Nexin 9 (SNX9)-stimulated 
GTPase activity, severs the bud from the PM (Lundmark and Carlsson, 2005; Soulet et 
al., 2005).  Depending on the cell type and specific membrane properties, F-actin 
dynamics may be required at this step to drive vesicle release (Kaksonen et al., 2006).  
Once detached, clathrin and other coat proteins are freed and reused in subsequent rounds 
of CME (McMahon and Boucrot, 2011).  Following release from the PM, the newly 
formed vesicle is propelled into the cytoplasm and subsequently docks and fuses at the 
early endosome (Hsu et al., 2012).  Endocytosed cargoes can undergo three major fates: 
transport to the late endosome/multivesicular body (MVB) then to the lysosome for 
degradation, retrograde transport toward the trans-Golgi network for entry into the 
secretory pathway, and direct or indirect recycling back to the PM.   
 In addition to clathrin-mediated endocytosis, caveolae-mediated endocytosis 
(CavME) is the only other known endocytic pathway involving a membrane coat and the 
most well-studied of the clathrin-independent pathways identified (Hansen and Nichols, 
2009; Kumari et al., 2010).  CavME is characterized by the formation of flask-shaped 
pits enriched in cholesterol and sphingolipids known as caveolae, which are marked by 
the coat proteins caveolin-1 and Cavin1 (Rothberg et al., 1992; Kovtun et al., 2015).  
With the exception of neurons (Shikanai et al., 2018), caveolae are present in most 
mammalian cell types, but are particularly abundant in adipocytes and endothelial cells 
 18 
(Andersson, 2012; Parton and Del Pozo, 2013).  CavME has been proposed to be 
important for lipid transport (Thomas and Smart, 2008) and cell signaling events 
(Andersson, 2012).  In various cell types, CavME is responsible for the uptake of a wide 
array of cargoes that include proteins, lipids, lipid-anchored proteins, and pathogens 
(Parton and Simons, 2007).  Caveolar pits are known to be smaller (Conner and Schmid, 
2003) and uptake is much slower (Fittipaldi et al., 2003), but events that dictate the 
occurrence of CavME need to be further elucidated. 
Clathrin- and caveolae-independent pathways can further be distinguished from 
CME and CavME by whether these routes are dynamin-dependent or independent 
(Mayor and Pagano, 2007; Hansen and Nichols, 2009).  Those identified thus far include: 
Ras homolog gene family, member A (RhoA)-regulated, adenosine diphosphate-
ribosylation factor (Arf) 6-regulated, flotillin-dependent, and the clathrin-independent 
tubulovesicular carrier (CLIC)/ glycosylphosphatidylinositol (GPI)-anchored protein 
enriched early endosomal compartment (GEEC) pathway.  RhoA-regulated is dynamin-
dependent, whereas the other pathways are dynamin-independent.  The RhoA-regulated 
pathway has been shown to internalize the β-chain of the interleukin-2 receptor (IL-2R-
β), γc-cytokine receptor, and IgE receptor in immune cells and fibroblasts.  The Arf6-
regulated pathway has been implicated in endocytosis of major histocompatibility 
complex (MHC) class I proteins, β-integrins, E-cadherin, carboxypeptidase E, the GPI-
anchored protein CD59, and Tac.  Flotillin-dependent endocytosis appears to overlap 
morphologically or functionally in certain cases with other clathrin-independent routes, 
and a specific role for budding from the PM by this process has not been established.  
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The CLIC/GEEC pathway represents the major route by which bulk fluid and GPI-
anchored proteins are internalized into CLICs and subsequently found in GEECs.  
CLIC/GEEC carriers are marked by GTPase regulator associated with focal adhesion 
kinase-1 (GRAF1) (Lundmark et al., 2008) and regulated by cell division cycle 42 
(Cdc42) (Sabharanjak et al., 2002; Chadda et al., 2007) and Arf1 (Kumari and Mayor, 
2008).  Although it has become clear that multiple means of clathrin-independent 
endocytosis operate with pathway-specific molecules and mechanisms far beyond those 
of CME, much is still unknown.  The membrane components concentrated at different 
types of pits, crosstalk between clathrin- and caveolae-independent pathways, and the 
extent to which each one contributes to PM remodeling are still under active investigation 
and debate (Donaldson et al., 2009). 
 
Putative Role of Aldolase in Late-Stage Clathrin-Mediated Endocytosis 
Studies with two other aldolase binding partners—WASP and SNX9, further 
suggest that aldolase may be moonlighting as a scaffold protein during late-stage 
endocytic events in the cell, possibly via interactions with WASP and SNX9 via 
individual subunits within the tetramer while simultaneously bound to cortical actin.  
Supporting this model, aldolase has been observed to have an inhibitory effect on WASP-
mediated actin polymerization (Ritterson Lew and Tolan, 2013) and SNX9 membrane 
association (Lundmark and Carlsson, 2004), both of which facilitate the final scission 
step of endocytosis (Ferguson and De Camilli, 2012; Bendris and Schmid, 2017).  SNX9, 
WASP, and actin are known to be enriched at sites of endocytosis; aldolase interacts with 
each of these proteins and may link them during scission (Figure 1.8).  The domain  
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Figure 1.8 Domain architecture and binding partners of SNX9 and N-WASP.  Domain 
structures of SNX9 and N-WASP are depicted.  The assigned domain functions and overlapping 
binding partners of SNX9 and N-WASP link these proteins to clathrin and actin machinery.  
Dashed lines highlight aldolase binding regions on each protein and suggest a potential 
scaffolding role in endocytosis.  Note: N-WASP is the ubiquitous isoform of the WASP family.  
Abbreviations: A, acidic domain; AP-2, adaptor protein complex 2; Arp2/3, actin-related 
protein-2/3 complex; B, basic region; BAR, Bin-Amphiphysin-Rvs; C, cofilin-homology; CRIB, 
cell division cycle 42 (Cdc42)/Rac-interactive region; PX, phox (phagocyte oxidase) homology 
domain; SH3, Src Homology 3; SNX9, sorting nexin 9; V, verprolin-homology; WASP, Wiskott-
Aldrich syndrome protein; WH1/EVH1, WASP homology 1/Ena-VASP-homology-1; YC, C-
terminal yoke; YN, N-terminal yoke.  Schematic adapted from Lundmark and Carlsson, 2009; 
Takenawa and Suetsugu, 2007.   
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functions that have been assigned for SNX9 and WASP based on collective evidence 
suggest crosstalk between actin nucleation and scission machinery in coordinating vesicle 
release (Shin et al., 2007; Takenawa and Suetsugu, 2007; Yarar et al., 2007; Lundmark 
and Carlsson, 2009).  Aldolase has been shown to bind SNX9 and WASP in vitro and in 
vivo (Lundmark and Carlsson, 2004; Buscaglia et al., 2006).  Moreover, WASP and 
SNX9 have each been co-crystallized with aldolase and shown to bind in the same 
hydrophobic pocket near the enzyme active site (Figure 1.9), making aldolase a strong 
candidate for linking dynamin-mediated scission to actin cytoskeletal dynamics (St-Jean 
et al., 2007; Rangarajan et al., 2010).  Although the binding sites have been 
characterized, the purpose of these interactions in the context of CME has not been 
explored. 
 
AIMS OF THIS THESIS 
 
The major aim of this dissertation is to further explore and characterize non-
catalytic or “moonlighting” interactions of aldolase that are directly linked to the 
association with F-actin.  As many of the putative non-canonical roles of aldolase involve 
actin-mediated processes, a high-resolution structure of the aldolase-F-actin complex and 
definition of the binding interface used by aldolase are critical for further deciphering the 
precise structural mechanisms employed by aldolase in these various non-metabolic 
interactions.  The aims for achieving this goal are further subdivided as follows: 1) to 
engineer and isolate a chimeric tetramer variant of aldolase that is ideal for producing a  
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Figure 1.9 WASP and SNX9 bind to aldolase in a hydrophobic pocket near the enzyme 
active site.  The crystal structure of the aldolase homotetramer is shown (PDB: 1ADO).  Subunits 
are colored accordingly to demonstrate expected binding units with interacting proteins.  Aldolase 
has a known association with cortical actin (Arnold and Pette, 1968), and expected bidentate 
binding (Pirani, 2008) as indicated by the blue-colored subunits in the black dashed-line box.  
However, a structure of the binding interface has not been resolved yet.  Each subunit of aldolase 
contains a hydrophobic pocket near the active site thought to be capable of simultaneous 
interactions with different binding partners (blue solid-lined boxes).  Close-up of the green-
colored subunit shows the structure of aldolase co-crystallized with the LC4 domain of SNX9 
(navy blue sticks) with interacting residues highlighted in magenta (PDB: 3LGE).  The purple 
subunit shows the interaction with the C-terminal region of WASP (orange sticks) with 
interacting residues of aldolase highlighted in cyan (PDB: 2OT0).  Abbreviations: F-actin, 
filamentous actin; LC4, low complexity domain 4; PDB: Protein Data Bank; SNX9, sorting nexin 
9; WASP, Wiskott-Aldrich syndrome protein. 
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three-dimensional structure of the aldolase-F-actin complex by cryogenic electron 
microscopy (cryo-EM); 2) to determine whether the produced variant can decorate F-
actin without crosslinking and be utilized for identification of the actin-aldolase binding 
interface by helical or single-particle reconstruction; 3) to probe uncharacterized roles of 
aldolase in F-actin-mediated processes such as endocytosis. 
In Chapter 3 of this dissertation, efforts to produce chimeric/heterotetrameric 
variants of aldolase A are described.  Conventional methods of co-expression were 
initially explored.  Upon discovery of consistently unequal/biased expression of two 
variant aldolases by traditional means, a newly developed modular cloning method called 
MoClo was tested.  This system enabled tunable co-expression of a His-tagged WT 
variant and actin-binding deficient variant of aldolase to produce a mixed tetramer set of 
homo- and hetero-tetrameric aldolases with modulated actin-binding capability.  A 50:50 
heterotetramer of aldolase was successfully produced for further EM studies. 
Chapter 4 describes the analysis of several different aldolase variants by negative 
staining and cryo-EM, including those produced in Chapter 3.  In vitro F-actin co-
sedimentation and actin bundling assays were performed to test the binding of the 
heterotetrameric aldolases created.  Concentrations of purified proteins were optimized in 
preparation for structural determination by cryo-EM reconstruction.  Experiments 
inducing the partial depolymerization of aldolase-decorated F-actin were analyzed for 
potential use in single-particle analysis.  A partially-complete preliminary model of the 
aldolase-F-actin complex is described. 
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In Chapter 5, the effect of aldolase knockdown was tested in various cell lines, 
including those commonly used to model endocytosis.  CME and clathrin-independent 
pathways were probed with fluorescent uptake markers.  The hypothesis that aldolase 
potentially has a regulatory role in the coordination to actin dynamics and scission 
machinery is explored.  Overall upregulation of endocytosis was observed in knockdown 
cells compared to mock-transfected or scrambled control cells.   
 
  
 25 
CHAPTER 2: MATERIALS AND METHODS 
 
MATERIALS 
 
Plasmids, Chemicals, and Reagents 
Plasmids listed in Tables 2.1-2.3 were provided by the references indicated unless 
stated otherwise.  Primers in Table 2.4 were synthesized by Eurofins Genomics or 
Integrated DNA Technologies.  Custom siRNAs were synthesized by Dharmacon, Inc.  
BD Bacto™ tryptone was from BD Biosciences.  Agar was from Acros Organics.  
Paraformaldehyde was from Alfa Aesar.  Fetal bovine serum, horse serum, and normal 
goat serum were from Atlanta Biologicals.  Hi-Lo DNA Marker was from Minnesota 
Molecular Inc.  Actin (C-2), aldolase-A (C-10), and synaptophysin (D-4) antibodies were 
from Santa Cruz Biotechnology.  Restriction endonucleases, T4 DNA ligase, and NEB 
Broad Range Prestained Protein Marker were from New England BioLabs Inc.  
Unstained broad range SDS-PAGE marker, Kaleidoscope Prestained Standards, and goat 
anti-mouse IgG (H + L)-HRP conjugate were from Bio-Rad Laboratories Inc.  
AcquaStain and BlueEasy Prestained Protein Marker were from Bulldog Bio.  Penicillin-
streptomycin solution and DMEM with L-glutamine, 4.5g/L glucose and sodium 
pyruvate were from Corning.  CM Sepharose Fast Flow resin and IMAC Sepharose 6 
Fast Flow resin were from GE Healthcare Bio-Sciences.  Antibiotics (ampicillin and 
kanamycin), bovine serum albumin, 6× Gel Loading Solution, fluorescein isothiocyanate 
(FITC)–dextran, 5-(iodoacetamido)fluorescein, L-amino acids, human transferrin, and  
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Table 2.1 Single expression plasmids  
Namea Source Plasmid(s) Protein Encodedd Reference 
pHRA pPB14 HRA  Beernink and Tolan, 
1992 
pR42A pPB3 R42A S. Oppelt (unpublished) 
pJ06B12X_AE(K) pJ23106_AB, 
pBCD12_BC, etc.b 
HRA or R42A Iverson, 2016 
pJ07B2X_AE(K) pJ23107_AB, 
pBCD12_BC, etc.b 
HRA or R42A Iverson, 2016 
pJ07B12X_AE(K) pJ23106_AB, 
pBCD12_BC, etc.b 
HRA or R42A Iverson, 2016 
pJ02B2X_EF(K) pJ23102_EB, 
pBCD12_BC, etc.c 
HRA or R42A Iverson, 2016 
pJ02B12X_EF(K) pJ23102_EB, 
pBCD12_BC, etc.c 
HRA or R42A Iverson, 2016 
 
a Letter X indicates HRA or R42A. 
b Additional source plasmids include pB0015_DE and pDVK_AE. 
c Additional source plasmids include pB0015_DE and pDVK_EF. 
d Abbreviations: HRA, His6-tagged rabbit aldolase A; R42A, rabbit R42A aldolase A. 
 
  
 27 
 
 
 
 
 
 
 
Table 2.2 Dual-expression plasmids  
Name Source Plasmid(s) Proteins Encodeda,b Reference 
p1-9 pJ06B12HRA_AE(K), 
pJ02B2R42A_EF(K) 
HRA, R42A Iverson, 2016 
p1-10 pJ06B12HRA_AE(K), 
pJ02B12R42A_EF(K) 
HRA, R42A Iverson, 2016 
p2-9 pJ07B2HRA_AE(K), 
pJ02B2R42A_EF(K) 
HRA, R42A Iverson, 2016 
p2-10 pJ07B2HRA_AE(K), 
pJ02B12R42A_EF(K) 
HRA, R42A Iverson, 2016 
p3-9 pJ07B12HRA_AE(K), 
pJ02B2R42A_EF(K) 
HRA, R42A Iverson, 2016 
p3-10 pJ07B12HRA_AE(K), 
pJ02B12R42A_EF(K) 
HRA, R42A Iverson, 2016 
p6-4 pJ06B12R42A_AE(K), 
pJ02B2HRA_EF(K) 
R42A, HRA  Iverson, 2016 
p6-5 pJ06B12R42A_AE(K), 
pJ02B12HRA_EF(K) 
R42A, HRA Iverson, 2016 
p7-4 pJ07B2R42A_AE(K), 
pJ02B2HRA_EF(K) 
R42A, HRA Iverson, 2016 
p7-5 pJ07B2R42A_AE(K), 
pJ02B12HRA_EF(K) 
R42A, HRA Iverson, 2016 
p8-4 pJ07B12R42A_AE(K), 
pJ02B2HRA_EF(K) 
R42A, HRA Iverson, 2016 
p8-5 pJ07B12R42A_AE(K), 
pJ02B12HRA_EF(K) 
R42A, HRA Iverson, 2016 
 
a Abbreviations: HRA, His6-tagged rabbit aldolase A; R42A, rabbit R42A aldolase A. 
b The order of proteins as listed reflects the coding sequence order for transcription. 
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Table 2.3 Fluorescent reporter constructs  
Bacterial-expression constructs 
Namea Source plasmid(s) Protein encodedd,e Reference 
pJ06B12X_AE(A) pJ23106_AB, 
pBCD12_BC, etc.b 
GFP, RFP, X:GFP,  
or X:RFP 
Iverson, 2016 
pJ07B2X_AE(A) pJ23107_AB, 
pBCD12_BC, etc.b 
GFP, RFP, X:GFP,  
or X:RFP 
Iverson, 2016 
pJ07B12X_AE(A) pJ23106_AB, 
pBCD12_BC, etc.b 
GFP, RFP, X:GFP,  
or X:RFP 
Iverson, 2016 
pJ02B2X_EF(A) pJ23102_EB, 
pBCD12_BC, etc.c 
GFP, RFP, X:GFP,  
or X:RFP 
Iverson, 2016 
pJ02B12X_EF(A) pJ23102_EB, 
pBCD12_BC, etc.c 
GFP, RFP, X:GFP,  
or X:RFP 
Iverson, 2016 
Mammalian expression constructs 
Name Source plasmid(s) Protein encodedg Reference 
pDsRed-D33Sf pDsRed-Monomer-C1 DsRed-D33S Goulding et al., 2008 
pDsRed-R42Af pDsRed-Monomer-C1 DsRed-R42A Goulding et al., 2008 
pEGFP pEGFP-C1 EGFP Cormack et al., 1997 
pEGFP-WA pEGFP-C1 EGFP-WA Cormack et al., 1997 
pGST-WA pGEX-4T-1 GST-WA Smith and Johnson, 
1988 
 
a Bold letter X indicates the protein encoded (GFP, HRA, R42A, or RFP). 
b Additional source plasmids include pB0015_DE and pDVA_AE. 
c Additional source plasmids include pB0015_DE and pDVA_EF. 
d Abbreviations: GFP, green fluorescent protein; RFP, red fluorescent protein. 
e Letter X indicates N-terminal fusion of the first 36 bases of the HRA or R42A coding sequence. 
f Parent plasmid was provided by Dr. Christopher V. Carman (Harvard Medical School). 
g Abbreviations: D33S, human D33S aldolase A; DsRed, monomeric red fluorescent protein 
derived from Discosoma; EGFP, enhanced green fluorescent protein; GST, glutathione S-
transferase; R42A, rabbit R42A aldolase A. 
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Table 2.4 Oligonucleotides  
Name of oligo Typea Sequence (5’-3’)b Purposec 
ALDO_A_REV_SEQ DNA  TACCTTGATGCCCACA 
ACAC 
Sequencing 
SI-198 AldoHRA_For_Ca DNA ATGAAGACGTaatgGGG 
CATCACCATCATCACC 
ACAGCCAGGA 
Cloning 
SI-199 AldoR42A_For_Ca DNA ATGAAGACGTaatgCCTC 
ACTCCCATCCAGCGTTA 
Cloning 
SI-200 Aldo_Rev_D DNA ACGAAGACGTacctTTAG 
TAGGCGTGGTTAGAGA 
TGAAGAG 
Cloning 
SI-201 Aldo_Mut_A DNA ATGAAGACGTgacgCTCT 
ACCAGAAGGCGGACGA 
TG 
Cloning 
SI-202 Aldo_Mut_B DNA ACGAAGACGTcgtcTCGT 
GGAAGAGGATGACGCC 
Cloning 
SI-203 Aldo_Mut_C DNA ATGAAGACGTactaCCAC 
CCAAGGGTTGGATGGG 
CTG 
Cloning 
SI-204 Aldo_Mut_D DNA ACGAAGACGTtagtCTCG 
CCATTAGTTCCTGCCAG 
Cloning 
siAldolase 287 (monkey) siRNA  AGGCUGCAGUCCAUUG 
GCA 
RNAi  
siAldolase A 287 
(mouse/rat) 
siRNA  CGCCUGCAGUCCAUUG 
GCA 
RNAi 
Vector Forward (VF2) DNA TGCCACCTGACGTCTA 
AGAA 
Sequencing 
Vector Reverse (VR) DNA ATTACCGCCTTTGAGTG 
AGC 
Sequencing 
 
a Abbreviations: DNA, deoxyribonucleic acid; siRNA, short interfering RNA. 
b Nucleotides denoted as lowercase letters indicate modular cloning (MoClo) fusion sites. 
c Abbreviation: RNAi, RNA interference. 
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ovomucoid were from Sigma-Aldrich.  Agarose, yeast extract, HisProbe™-HRP 
Conjugate, SuperSignal West Dura Extended Duration Substrate kit, Lipofectamine 
2000/3000/RNAiMAX, trypan blue stain, Alexa Fluor 546 phalloidin, 4′,6-diamidino-2-
phenylindole (DAPI), Dulbecco’s Modified Eagle Medium (DMEM), Opti-MEM™, 
Silencer™ Negative Control No. 1 siRNA, goat anti-mouse IgG (H+L), Superclonal™ 
Recombinant Secondary Antibody (Alexa Fluor 488 or Alexa Fluor 555), Hanks’ 
balanced salt solution, 5′-fluoro-2′-deoxyuridine, B-27 supplement, Neurobasal Medium, 
and ProLong Gold or Diamond Antifade Mountant were from Thermo Fisher Scientific.  
All other chemicals and reagents were from Sigma-Aldrich, Thermo Fisher Scientific, or 
provided as a gift.   
 
MOLECULAR BIOLOGY TECHNIQUES 
 
Purification of Nucleic Acids 
Amplification and Isolation of Plasmid DNA 
 
Preparation of Chemically-Competent Cells  
A yeast tryptone (YT) agar plate was streaked with E. coli DH5α or BL21(DE3) 
cells (Table 2.5) and grown overnight at 37 °C.  A single colony was used to inoculate a 
100 mL YT broth starter culture.  The starter culture was grown to saturation at 37 °C in 
a shaker.  One L of YT media was inoculated with 10-50 mL of the starter culture.  An 
initial optical density at 600 nm (O.D.600) reading was taken before returning the cells to 
the 37 °C shaker to double a minimum of two times.  Once the O.D. reached 0.5, cells  
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Table 2.5 Bacterial strains  
Strain Bacteria Genotype Purpose Reference 
α-
Select 
Escherichia 
coli  
F– φ80lacZΔM15 Δ(lacZYA-
argF)U169 recA1 endA1  
hsdR17(rK–, mK+) phoA supE44 
λ– thi-1 gyrA96 relA1 
Cloning Bioline 
BL21 
(DE3) 
Escherichia 
coli 
F– ompT hsdSB (rB–, mB–) gal 
dcm (DE3) 
Protein 
expression 
Wood, 
1966 
DH5α Escherichia 
coli 
F- deoR endA1 recA1 relA1  
gyrA96 hsdR17(rk -, 
mk +) supE44 thi-1 phoA 
Δ(lacZYA argF)U169 
Φ80lacZΔM15 λ- 
Cloning Hanahan, 
1983 
 
 
were pelleted by centrifugation at 5000 × g for 10 min at 4 °C.  The supernatant fraction 
was discarded by decanting.  Pelleted cell fractions were resuspended in 400 mL of ice-
cold Tsf I solution (30 mM potassium acetate, pH 5.8, 50 mM MnCl2 or MgCl2, 100 mM 
KCl, 10 mM CaCl2, 15% (w/v) glycerol) and incubated on ice for 30 min.  Centrifugation 
was repeated and the supernatant fraction discarded as before.  The cells were 
resuspended in 40 mL of ice-cold Tsf II solution (10 mM 3-(N-
morpholino)propanesulfonic acid (MOPS)-Na, pH 7.0, 75 mM CaCl2, 10 mM KCl, 15% 
(w/v) glycerol), aliquoted into microcentrifuge tubes, and flash frozen in liquid nitrogen 
(N2(l)) prior to storage at -80 °C.   
 
Introduction of Plasmid DNA into E. coli 
Competent cells were thawed on ice for 20-30 min.  Bacterial transformation of 
plasmid DNA from purified preparations or ligation reactions were carried out using 20-
50 µL of cells placed in a glass culture tube on ice.  A volume of 1-5 µL of purified 
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plasmid (containing 0.01-100 ng of DNA) or 20 µL of a DNA ligation reaction was 
mixed with the cells and incubated on ice for up to 30 min.  Cells were subjected to heat 
shock at 42 °C for 45-60 s and then placed on ice for 2 min.  One mL of pre-warmed YT 
media was added to the mixture and placed in a shaking incubator for outgrowth at 37 °C 
for 20-45 min.  Some or all of the transformation was plated onto double yeast tryptone 
(DYT) agar containing the appropriate antibiotic and grown in a 37 °C incubator 
overnight.  For plasmid transformations, up to 100 µL of each mixture was plated.  
Ligation transformations were centrifuged at 25 °C for 1 min at 14,000 × g, the majority 
of the supernatant fraction decanted, and the cells resuspended in the remaining volume 
before plating the entire sample. 
 
Antibiotic Selection of Transformants Containing Recombinant Plasmids 
YT or DYT agar plates containing 100 µg/mL of the appropriate antibiotic were 
streaked from a frozen stab or freshly-transformed competent cells.  For each plasmid to 
be purified, 3 mL of YT broth with the same concentration of antibiotic was inoculated 
with a single bacterial colony.   
 
Growth of Bacterial Cultures 
All E. coli cultures were incubated at 37 °C for growth.  Broth cultures were 
grown overnight with vigorous shaking.  Plated cultures were grown for 16-18 h.   
 
Harvesting and Lysis 
Liquid cultures were divided into 1.5 mL microcentrifuge tubes and centrifuged at 
14,000 × g for 1 min at 25 °C.  The supernatant fraction was removed by aspiration.  
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Each pellet fraction was resuspended by vortexing in 100 µL of Solution I (25 mM 
tris(hydroxymethyl)aminomethane (Tris)·Cl, pH 8.0, 50 mM glucose, 10 mM 
ethylenediaminetetraacetic acid (EDTA)).  Samples were consolidated and allowed to sit 
at room temperature for 5 min until viscous.  For each consolidated sample, 400 µL of 
Solution II (0.2 N NaOH, 1% (w/v) sodium dodecyl sulfate (SDS)) was added and mixed 
by inversion.  Samples were incubated on ice for about 5 min until clear.  Ice-cold 
Solution III (3 M potassium acetate, pH 9.0, 2 M acetic acid) was added at 300 µL per 
reaction and vortexed thoroughly.  Tubes were stored on ice for 3-5 min before 
centrifuging at 14,000 × g for 5 min at 4 °C.  The supernatant fraction of each sample 
was split evenly into two fresh 1.5 mL microcentrifuge tubes.  Samples were then 
subjected to ethanol (EtOH) or isopropanol precipitation. 
 
Precipitation of Nucleic Acids 
Double-stranded (ds) DNA was precipitated by adding two volumes of ice-cold 
100% EtOH (or one volume of isopropanol) and 3 M sodium acetate to a final 
concentration of 0.3 M in 1.5-mL microcentrifuge tubes.  Samples were vortexed and 
incubated on ice for 15 min.  Tubes were centrifuged at 14,000 × g for 30-60 min at 4 °C.  
The supernatant fraction was discarded.  Each pellet fraction was washed with 0.5 mL of 
70% EtOH and briefly inverted.  Samples were centrifuged at 14,000 × g for 10 min.  
The supernatant fraction was aspirated and tubes were centrifuged at maximum speed in 
a microfuge for 10 s.  Remaining traces of liquid were gently aspirated.  Tubes were 
placed in a vacuum desiccator with the caps open until the pellet fractions were 
completely dry.  Each DNA pellet fraction was dissolved by adding 50 µL of TE buffer 
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(10 mM Tris·Cl, pH 8.0, 1 mM EDTA) containing 50 µg/mL of DNase-free RNase A, 
incubated at room temperature for 5 min, followed by vortexing before another 
incubation at 50 °C for 45 min for RNase treatment.  Tubes were consolidated and an 
additional 100 µL of TE buffer with RNase was added to a final volume of 200 µL.   
 
Extraction with Phenol:Chloroform 
Following EtOH precipitation and RNase treatment as described above, 100 µL of 
phenol and 100 µL of chloroform were added to each sample in a 1.5-mL 
microcentrifuge tube and vortexed.  Tubes were centrifuged at 14,000 × g for 5 min.  The 
upper (aqueous) phase was collected and transferred to a fresh tube, and the organic layer 
discarded.  An equal volume of chloroform was added to each aqueous phase and 
vortexed.  Samples were centrifuged at 14,000 × g for 5 min.  The aqueous phase was 
collected once again into a fresh tube and the organic layer discarded.  EtOH 
precipitation was repeated as described above without the 45 min RNase treatment step. 
 
Degradation of RNA in Plasmid DNA Preparations 
If concentrations of RNA were high enough to interfere with DNA analysis, 
purified plasmid preparations were incubated at 4 °C overnight to degrade excess RNA 
present, analyzed by agarose gel electrophoresis (as described below), and stored at  
-20 °C.   
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Quantitation of DNA Yield 
Spectrophotometric Determination of the Amount of DNA 
The absorbance of purified plasmid samples was measured at 260 and 280 nm.  
The O.D.260/O.D.280 ratio was used to estimate the purity of each sample.  A ratio of ~1.8 
for DNA preparations was generally deemed to be of sufficient purity (Sambrook et al., 
1989; Gallagher and Desjardins, 2008).  The A260 reading was used to calculate the 
concentration of DNA in the sample (1 O.D. = 50 µg/mL of dsDNA).  Estimates using 
this method were further validated as described below. 
 
Agarose Gel Electrophoresis 
Individual agarose gels were prepared by sealing the edges of a plastic gel-casting 
tray with masking tape and placing flat on a bench.  Alternatively, an unsealed 2” × 3” 
glass slide was used for casting surface-tension agarose minigels.  A well comb was 
positioned at a 1-2 mm height above the bottom of the tray or slide.  Powdered agarose 
was melted in TAE buffer (40 mM Tris-acetate, pH 8.0, 1 mM EDTA) to a final 
concentration of 1% (w/v) by intermittently microwaving and swirling to mix until the 
agarose was fully dissolved.  The solution was cooled to 50-60 °C and poured into the 
mold or glass-slide surface.  Once the gel solidified, the comb and masking tape were 
removed.  The gel was then mounted into an electrophoresis tank and TAE buffer added 
until fully immersed at a height of 2-3 mm above the surface of the gel.  Samples of DNA 
were mixed with 6× Gel Loading Solution (Cat No. G7654; Sigma-Aldrich, St. Louis, 
MO) and loaded into the wells of the submerged gel using a micropipette.  Each gel was 
subjected to electrophoresis at 50-130 V until the bromophenol blue and xylene cyanol 
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dyes were equidistant from the top of the gel or had migrated close to the bottom of the 
gel (Wieslander, 1979; Parker and Seed, 1980). 
 
Ethidium Bromide Estimation of Double-Stranded DNA 
After electrophoresis, gels were stained in ethidium bromide (EtBr) solution (0.5 
µg/mL) for 10-30 min depending on the size of the gel, and then destained in distilled 
water (dH2O) for 1 min.  DNA-EtBr complexes were detected by ultraviolet (UV) 
illumination using a Bio-Rad Gel Doc XR+ Gel Documentation System (Bio-Rad 
Laboratories Inc., Hercules, CA).  Plasmid DNA bands were compared to standards of 
known size and concentration from Hi-Lo DNA Marker (Minnesota Molecular Inc., 
Minneapolis, MN) loaded.  Approximate sample DNA sizes were estimated according to 
migration relative to the marker standards (Sharp et al., 1973).  DNA concentration was 
estimated by comparing the intensity of UV-induced fluorescence emitted by EtBr in the 
sample band to a marker band with similar brightness.  The amount of DNA in the 
sample was estimated from the fluorescent yield relative to the most closely matching 
marker band and used to back calculate concentration of the stock. 
 
In Vitro Amplification of DNA Fragments by Polymerase Chain Reaction (PCR) 
PCR Primer Design and Synthesis 
Primers for DNA amplification were designed using Primer3web version 4.1.0 
(http://bioinfo.ut.ee/primer3/) (Kõressaar and Remm, 2007; Untergasser et al., 2012; 
Kõressaar et al., 2018).  Prior to synthesis, primer sequences were checked against target 
sequences using Benchling (https://benchling.com/).  Oligonucleotides were synthesized 
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by Eurofins Genomics (Eurofins Genomics LLC, Louisville, KY) or Integrated DNA 
Technologies (Integrated DNA Technologies, Inc., Coralville, Iowa) and dissolved to 100 
µM with TE buffer prior to use.  Dissolved oligonucleotides were stored at -20 °C.   
 
PCR Using Taq DNA Polymerase 
 Reactions were assembled on ice prior to transferring to an Eppendorf 
Mastercycler thermocycler (Eppendorf, Hamburg, Germany) preheated to the 
denaturation temperature.  Each reaction contained 1-10 ng of template DNA, 5 pmol of 
each forward and reverse primer, 1 pmol of deoxyribonucleotide triphosphates (dNTPs), 
1× Standard Taq Reaction Buffer (10 mM Tris·Cl, pH 8.3, 50 mM KCl, 1.5 mM MgCl2), 
2-4 mM of MgCl2, 1.25 U of Taq DNA Polymerase, and dH2O to 50 µL.  Thermocycling 
conditions used were as follows: denaturation at 95 °C for 30 s, annealing for 30 cycles 
(95 °C for 30 s, 45-68 °C for 60 s, 68 °C for 1 min/kilobase (kb)), elongation at 68 °C for 
5 min, followed by holding at 4 °C.  PCRs were stored at -20 °C or immediately purified 
as described below.   
 
Purification of PCR Products 
 
Cetyltrimethylammonium Bromide (CTAB) Extraction 
Each 50-µL PCR was brought to a final volume of 80 µL with TE buffer.  CTAB 
solution (5% CTAB (w/v), 0.5M NaCl) was added to a final concentration of 0.3%.  The 
sample was centrifuged at 14,000 × g for 5 min.  The supernatant fraction was discarded.  
The pellet fraction was dissolved in 100 µL of 1.2 M NaCl, followed by 200 µL of 100% 
EtOH, and the centrifugation step repeated.  The pellet fraction was washed with 500 µL 
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of 70-80% EtOH.  The sample was centrifuged at maximum speed in a microfuge for 10 
s, and the supernatant fraction discarded.  The 10 s centrifugation was repeated, and 
remaining traces of EtOH were gently aspirated.  The pellet fraction was air dried at 25 
°C for 5 min by leaving the cap open.  Dried samples were stored at -20 °C or 
resuspended in 10-30 µL of TE buffer for immediate use. 
 
Spin Column Purification of Amplification Fragments 
As an alternative to CTAB extraction, the QIAquick PCR Purification Kit 
(QIAGEN, Hilden, Germany) or NucleoSpin Gel and PCR Clean-up kit (MACHEREY- 
NAGEL, Bethlehem, PA) were used according to the manufacturers’ instructions. 
 
Restriction Mapping Analysis of DNA 
Restriction Endonuclease Digestion 
A 10-50 µL reaction was set up for DNA digestion according to the 
manufacturer’s protocol (New England BioLabs Inc., Ipswich, MA).  Briefly, each 
reaction was set up to contain 0.1-1 µg of DNA, 1-10 units (U) of restriction enzyme, a 
volume of the appropriate 10× NEBuffer to a final 1× concentration, bovine serum 
albumin (BSA) to a final concentration of 100 µg/mL (if required to stabilize the enzyme 
and/or prevent adhesion to instruments or reaction tubes), and dH2O up to the desired 
final volume.  Reactions were incubated at 37 °C for 1-3 h.  Samples were then diluted 
with 6× Gel Loading Solution (Sigma-Aldrich, St. Louis, MO) and subjected to 
electrophoresis in a 1% (w/v) agarose gel for analysis or further DNA manipulation. 
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Mapping by Single Digestions and Multiple Digestions 
Restriction digest fragments of plasmid DNA were analyzed by agarose gel 
electrophoresis as described above (see Agarose Gel Electrophoresis).  Gels were stained, 
imaged, and analyzed as described above (see Ethidium Bromide Estimation of Double-
Stranded DNA).  Linear DNA fragment sizes were compared to predicted sizes of insert 
sequences and plasmid vector maps.  Based on the fragment pattern analysis, confirmed 
plasmid stocks were selected for additional sequence verification. 
 
Gel Extraction of Digested DNA 
The QIAquick Gel Extraction Kit (QIAGEN, Hilden, Germany) or NucleoSpin 
Gel and PCR Clean-up kit (MACHEREY-NAGEL, Bethlehem, PA) were used according 
to the manufacturers’ instructions. 
 
Subcloning of DNA Fragments into Plasmid Vectors 
Ligation with T4 DNA Ligase 
 Ligation reactions were set up in a microcentrifuge tube to contain the following 
components: T4 DNA Ligase Buffer (50 mM Tris·Cl, pH 7.5, 10 mM MgCl2, 1 mM 
ATP, 10 mM dithiothreitol (DTT)), 0.020 pmol of vector DNA, 0.060 pmol of insert 
fragment DNA, 400 U of T4 DNA Ligase, and dH2O to a final volume of 20 µL.  The 
reaction was incubated at 16 °C overnight, followed by transformation into competent 
cells (see Introduction of Plasmid DNA into E. coli).   
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DNA Sequence Determination 
Sequencing Primer Design 
Custom sequencing primers were designed using Primer3web version 4.1.0 
(http://bioinfo.ut.ee/primer3/) (Kõressaar and Remm, 2007; Untergasser et al., 2012; 
Kõressaar et al., 2018).  Oligonucleotide sequences were submitted to Eurofins Genomics 
LLC (https://www.eurofinsgenomics.com/en/products/dnarna-synthesis/customoligos/) 
for “Custom DNA Oligo” synthesis.  Lyophilized primers were dissolved to 10-100 µM 
in TE buffer and stored at -20°C.   
 
Sequence Verification 
Plasmid DNA template samples and sequencing primers were submitted to 
Eurofins Genomics LLC (https://www.eurofinsgenomics.com/en/products/dna-
sequencing/tube-sequencing/) for processing of sequencing reactions.  Samples were 
prepared as “Premixed” or “Templates Only” according to Eurofins Genomics’ sample 
preparation guidelines.   Sequenced portions were checked for accuracy by consensus 
alignment to the gene sequence using Benchling (https://benchling.com/). 
 
Storage of Plasmid Clones 
Preparation of Glycerol Stocks 
For long-term storage of E. coli transformants, glycerol stocks were prepared in 1 
mL Cryo.s Freezing Tubes (Greiner Bio-One, Monroe, NC).  Briefly, 2-5 mL of YT 
medium containing the appropriate antibiotic was inoculated with a single colony and 
grown overnight in a 37 °C shaker.  Using aseptic technique, the glycerinated suspension 
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was prepared by adding 800 µL of the overnight culture to a freezing tube containing 200 
µL of 75% (w/w) sterile glycerol in dH2O and vortexed for 10 s.  Cultures were 
immediately placed in storage at -80 °C.   
 
Modular Cloning (MoClo) Library Propagation 
 MoClo experiments were performed in collaboration with Dr. Sonya V. Iverson 
and Dr. Douglas M. Densmore. 
 
Preparation of Insert Fragments 
PCR amplification of each aldolase coding sequence was performed using 
thermocycling conditions previously reported (Iverson et al., 2016).  The two rabbit 
aldolase A variants were attained from expression plasmids previously described 
(Beernink and Tolan, 1992; Wang et al., 1996), one with an N-terminal His6-tag (HRA) 
in the pPB14 vector, and the other a R42A variant in the pPB3 vector (Beernink and 
Tolan, 1992). 
 
Construction of Initial Combinatorial Library of Single Gene Expression Vectors 
Expression cassette libraries were engineered by combinatorial assembly using 
the CIDAR MoClo Parts Kit (Addgene, Watertown, MA).  Additional details of 
individual kit components listed below are described in Iverson et al., 2016.  MoClo 
Type IIS enzyme one-pot digestion ligation reactions (10-20 L) contained 10 fmol of 
PCR product (coding sequence (CDS)) engineered with flanking _CD fusion sites (Table 
2.4), equimolar amounts of a constitutive promoter (J23102, J23106, or J23107 in a 
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DVA_AB or DVA_EB backbone), RBS (BiCistronic Design element (BCD)-2 or BCD-
12 in a DVA_BC backbone), B0015 double terminator (in a DVA_DE or DVA_DF 
backbone), destination vector (DVK_AE or DVK_EF), 10 U of Bsa I, 20 U of T4 DNA 
Ligase in 50 mM Tris·Cl, pH 7.5, 10 mM MgCl2, 1 mM adenosine triphosphate (ATP), 
and 10 mM DTT.  Reactions were carried out on a thermocycler with the following 
parameters: 15 cycles alternating between 37 C for 1.5 min and 16 C for 3 min, 
followed by a 50 C step for 5 min, an 80 C step for 10 min, and a final hold at 4 C.  
Bacterial transformations were performed using 2-5 L of each MoClo reaction with 6-
15 L of -Select Gold Competent Cells (Bioline, London, UK) (Table 2.5) according to 
the manufacturer’s protocol.  Cells were plated on lysogeny broth (LB) agar containing 
the appropriate antibiotic, supplemented with 80 L of 20 mg/mL X-Gal and 100 L of 
0.1 M isopropyl β-D-1-thiogalactopyranoside, and grown overnight at 37 C.  Blue-white 
screening was used to select colonies.  Positive (white) colonies were used to inoculate 3-
5 mL of LB media (Sigma-Aldrich, St. Louis, MO) containing the appropriate antibiotic 
and grown overnight in a 37 C incubator with shaking.  Plasmids were purified using the 
QIAGEN Plasmid Mini Kit (QIAGEN, Hilden, Germany) and sequence verified using 
standard BioBrick vector primers, Vector Forward (VF2) and Vector Reverse (VR) 
(BioBricks Foundation, San Francisco, CA).   
 
Assembly of Dual Expression Plasmid Library 
Single expression plasmids were combined into dual-expression cassettes using 
the single assembly-step Multiplex MoClo cloning reaction as previously described 
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(Iverson et al., 2016).  Briefly, each reaction containing 10 fmol of the destination vector 
DVA_AF and each pairwise combination of single expression plasmids.  Transformation, 
selection, purification, and sequence validation were performed as described above. 
 
Construction of Green and Red Fluorescent Protein (GFP and RFP) Fusion Expression 
Plasmids 
The effect of the amino-terminal sequences on expression was tested using 
constructs linking the first 36 nucleotides of each aldolase variant coding sequence to the 
coding sequences of E0040m (GFP) or E1010m (RFP).  These GFP and RFP plasmid 
maps are annotated online at https://benchling.com/siverson/.  Transformation, selection, 
purification, and sequence validation were performed as described above (see 
Construction of Initial Combinatorial Library of Single Gene Expression Vectors).   
 
Flow Cytometry Analysis of Fluorescent Reporter Constructs 
Flow cytometry experiments with the provided collection of GFP and RFP 
reporters were conducted using methods as previously reported (Iverson et al., 2016).  
The flow cytometry data were converted from arbitrary units to compensated molecules 
of equivalent fluorescein (MEFL).  
 
Fluorescence Measurement of Fusion Protein (FP) Expression 
A Tecan SPECTRAFluor Plus Microplate Reader with Magellan v6.6 software 
was used to measure O.D.600 and fluorescence expression of aldolase:FP fusion 
expression plasmids in culture.  Measurements were performed in 96-well plates on 200 
μL of culture.  To measure the O.D., default settings were used along with blank wells to 
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provide background subtracted data.  For fluorescence, top and bottom read options were 
used as noted with manual gain and filter settings as follows: for RFP, the excitation 
wavelength was 580 nm, the emission wavelength was 635 nm, with a gain of 87.  For 
GFP, the excitation wavelength was 485 nm, the emission wavelength was 535 nm, with 
a gain of 89.  Fluorescence of each clone was measured in triplicate.   
 
Protein Expression in E. coli.   
Dual expression plasmids were transformed into competent BL21(DE3) cells.  
Cells were plated on DYT agar containing 100 g/mL of ampicillin (Amp) and incubated 
overnight.  Single colonies from each plate were inoculated into 3-5 mL of DYT-Amp 
media and grown overnight in a 37 °C shaker.  Cultures were usually from 2-3 O.D./mL 
and were diluted to 1 O.D./mL using 1× SDS-polyacrylamide gel electrophoresis (SDS-
PAGE) sample buffer (60 mM Tris·Cl, pH 6.8, 4% (v/v) glycerol, 4% (w/v) SDS, 1% 
(v/v) -mercaptoethanol (β-me), 0.001% (w/v) bromophenol blue), and heated for 10 min 
at 95 C.  Either 0.02 O.D. of each sample or 1 g of purified aldolase controls was 
applied to the wells of a 15% SDS-PAGE gel and subjected to electrophoresis at 80-100 
V for separation (see SDS-Polyacrylamide Gel Electrophoresis of Proteins below).   
 
Site-Directed Mutagenesis of Cloned DNA  
Design of Mutagenic Oligonucleotides 
Forward and reverse mutagenic oligonucleotides were designed using 
NEBaseChanger version 1.2.9 (http://nebasechanger.neb.com/) by entering the template 
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coding sequence and following the “Quick-Start Steps” instructions.  Mutagenic primers 
were synthesized by Eurofins Genomics and prepared as described above (see PCR 
Primer Design and Synthesis). 
 
Q5 Site-Directed Mutagenesis 
The following reagents were assembled in a PCR tube: 0.1-25 ng/μL of template 
DNA, 0.5 μM of each forward and reverse primer, 0.2 mM dNTPs, 3 mM MgCl2, 2% 
dimethylsulfoxide (DMSO), 1× Q5 Reaction Buffer, 0.4 U Q5 High Fidelity Polymerase, 
and dH2O to a final volume of 50 µL.  The reaction was transferred to a PTC-100 
thermocycler (MJ Research, Inc., Watertown, MA) and the following conditions used: 
initial denaturation at 98°C for 30 s, annealing for 25 cycles (98°C for 10 s, 60-68°C for 
30 s, 72°C for 60 s/kb), final extension at 72°C for 2 min, followed by holding at 4°C.  
PCRs were stored at -20°C or immediately transformed into NEB 5-alpha competent  
E. coli cells (New England BioLabs Inc., Ipswich, MA) following the manufacturer’s 
instructions.  Transformed cells were screened and the plasmid DNA was purified as 
described above.  Sequence accuracy and incorporation of the desired mutation(s) were 
verified as described above (see DNA Sequence Determination). 
 
Expression of Cloned Genes in E. coli 
Preparation and Denaturation of Protein Samples 
Protein samples were diluted to a 1× concentration using 5× SDS-PAGE sample 
buffer and heated for 5-10 min at 95 C.   
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Sample Preparation of Cell Extracts 
A volume of bacterial culture was diluted to the desired concentration (O.D./mL) 
with 5× SDS-PAGE sample buffer and dH2O, and heated prior to electrophoresis as 
described above (see SDS-Polyacrylamide Gel Electrophoresis of Proteins). 
 
Sample Preparation of Purified Proteins 
For column chromatography-purified proteins, 10-50 µL aliquots were collected 
at each purification step.  Samples were prepared for loading onto an SDS-PAGE gel 
using an equal percentage (0.01-0.04%) of each fraction.  Purified protein controls were 
desalted if necessary (see Removal of Salts for Protein Sample Analysis) and diluted to 
the desired concentration (µg/µL).  All samples were denatured in 5× SDS-PAGE sample 
buffer and dH2O, heated, and subjected to electrophoresis (see Preparation and 
Denaturation of Protein Samples and SDS-Polyacrylamide Gel Electrophoresis of 
Proteins). 
 
SDS-PAGE 
A discontinuous electrophoresis method was used to resolve loaded protein 
samples by size (Laemmli, 1970).  The resolving gel was cast at 25 °C using 10-15% 
(w/v) 29:1 acrylamide: N,N'-methylenebisacrylamide (bis), 375 mM Tris·Cl, pH 8.8, 
0.1% (w/v) SDS, 0.07% (w/v) ammonium persulfate (APS), and 0.07% (v/v) N,N,N′,N′-
tetramethylethylenediamine (TEMED).  Similarly, a 4% stacking gel was cast containing 
4% (w/v) 29:1 acrylamide:bis, 126 mM Tris·Cl, pH 8.8, 0.1% (w/v) SDS, 0.08% (w/v) 
APS, and 0.13% (v/v) TEMED.  Gels were cast at 0.75-1.5 mm thickness and subjected 
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to electrophoresis using the Bio-Rad Mini-PROTEAN 3 system (Bio-Rad Laboratories 
Inc., Hercules, CA).  Protein samples were prepared as described above.  The samples 
were loaded and separated using 50-80 V for stacking and 100-200 V for resolving.   
 
Molecular Weight Standards 
Protein samples were subjected to co-electrophoresis with a commercial protein 
ladder consisting of molecular weight standards for size estimation.  An unstained broad 
range SDS-PAGE marker (Bio-Rad Laboratories Inc., Hercules, CA) was used for gels 
that would be stained for total protein.  For western blotting, one of the following 
prestained markers was used: NEB Broad Range Prestained Protein Marker (New 
England BioLabs Inc., Ipswich, MA), Kaleidoscope Prestained Standards (Bio-Rad 
Laboratories Inc., Hercules, CA), or BlueEasy Prestained Protein Marker (Bulldog Bio, 
Portsmouth, NH). 
 
Staining of SDS-Polyacrylamide Gels 
Total-protein staining was achieved by immersing acrylamide gels in AcquaStain 
(Bulldog Bio, Portsmouth, NH) for ≥ 1 h at 25 °C and destaining in dH2O for 10-30 min 
with gentle agitation.  Alternatively, gels were stained in Coomassie Brilliant Blue Stain 
(0.25% (w/v) Coomassie Brilliant Blue R-250 dye in 5:5:1 (v/v) 
dH2O:methanol(MeOH):acetic acid) for ≥ 2 h and destained (in 5:5:1 (v/v) dH2O: 
MeOH:acetic acid solution) for ≥ 60 min at 25 °C with gentle agitation.  Gels were 
scanned in a HP OfficeJet 6210 All-in-One printer (Hewlett-Packard Company, Palo 
Alto, CA) for imaging. 
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Western Blot Analysis of Proteins 
 
Electrophoretic Transfer of Proteins from Polyacrylamide Gels to Polyvinylidene 
difluoride (PVDF) Membrane 
Following electrophoresis, each acrylamide gel was transferred onto a PVDF 
membrane using a Trans-Blot SD Semi-Dry Electrophoretic Transfer Cell (Bio-Rad 
Laboratories Inc., Hercules, CA) for western blot analysis (Kaufmann et al., 1987; 
Bjerrum and Heegaard, 1988).  Transfer sandwiches were assembled and buffer-soaked 
with Towbin transfer buffer (25 mM Tris, 192 mM glycine, 20% MeOH) according to the 
manufacturer’s instructions.  Gels were transferred at 25 mA for 45 min.   
 
Blocking Non-specific Binding Sites for Immunoglobulins 
Blots were removed from the transfer apparatus and placed in blocking solution 
(20 mM Tris·Cl, pH 7.6, 150 mM sodium chloride (NaCl), 0.1% polyethylene glycol 
sorbitan monolaurate (TWEEN 20), 5% milk, 0.02% sodium azide) for 1 h at 25 °C or 4 
°C overnight with gentle agitation.  Following blocking, each membrane was briefly 
rinsed with low salt TBST (20 mM Tris·Cl, pH 7.6, 150 mM NaCl, 0.1% TWEEN 20). 
 
Binding of Probe to Target Protein  
Blots were incubated with either HisProbe-HRP Conjugate (Thermo Fisher 
Scientific, Rockford, IL) diluted at 1:5000 or an aldolase-A antibody (C-10) (Santa Cruz 
Biotechnology, Santa Cruz, CA) diluted at 1:10,000.  Primary probe binding to the target 
protein was performed for 1-3 h at 25 °C or overnight at 4 °C with gentle agitation.  Each 
blot was washed three times in high salt TBST (20 mM Tris·Cl, pH 7.6, 0.5 M NaCl, 
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0.5% TWEEN 20) for 10 min total.  Blots requiring a secondary antibody for detection 
were washed and probed with goat anti-mouse IgG (H + L)-HRP Conjugate (Bio-Rad 
Laboratories Inc., Hercules, CA) diluted at 1:3000 for 45 min at 25 °C with gentle 
agitation.  Each membrane was subsequently washed three times in high salt TBST for 30 
min total, then briefly rinsed 1-2 in 1× phosphate buffered saline (PBS) prior to 
development.   
 
Detection with Chemiluminescent Substrate  
All blots were developed with the SuperSignal West Dura Extended Duration 
Substrate kit (Thermo Fisher Scientific, Rockford, IL) following the manufacturer’s 
protocol (Walker et al., 1995; Mattson and Bellehumeur, 1996).  Blots were gently 
pressed with Whatman paper to remove excess PBS and placed inside of a plastic sheet 
protector.  For each membrane, 1.4 mL of working solution was prepared by mixing 
Stable Peroxide Buffer and Luminol/Enhancer Solution at a 1:1 ratio.  Blots were 
incubated in working solution for 5 min, after which excess liquid was blotted with a 
paper towel.  Any bubbles over the membrane(s) were pressed out of the sheet protector.  
The sheet was placed in a film cassette with the protein side of the blot(s) facing up for 
film exposure. 
 
Exposure and Development of Autoradiographic Film 
Blot exposure was performed using CL-XPosure Film (Thermo Fisher Scientific, 
Rockford, IL) at various exposure times on the order of seconds to minutes.  Films were 
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developed using a Kodak M35A X-OMAT Processor (Eastman Kodak Company, 
Rochester, NY).   
 
BIOCHEMICAL METHODS 
 
Large-Scale Protein Purification of Aldolases 
Preparation of Crude Protein Extract 
 
Cell Growth and Harvesting 
Individual clones from transformed E. coli were used to inoculate 1-5 mL of DYT 
media containing 50 µg/mL Amp and grown overnight (see Growth of Bacterial 
Cultures).  The clone with the highest expression levels was selected for protein 
purification.  Clones were screened via SDS-PAGE (see Sample Preparation of Cell 
Extract).  DYT-Amp media (1 L) was inoculated with 1 mL of the starter culture and 
grown for 18-24 h.  Cells were collected and pelleted in a Sorvall GS-3 rotor (Thermo 
Fisher Scientific, Rockford, IL) at 13000 × g for 10 min at 4 °C.  The cell pellet fraction 
was washed with 1× PBS and centrifuged as before.  The supernatant fraction was 
discarded prior to cell lysis.  For purification at a later time, bacterial pellet fractions at 
this stage were stored at -80 °C and thawed on ice for 30-40 min prior to lysis.   
 
Lysis of Cells and Extract Clarification 
All lysis steps were performed at 0-4 C.  The bacterial pellet fraction was 
resuspended in the appropriate lysis buffer for the chromatography technique to be 
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employed.  The E. coli cell suspension was lysed in a French pressure cell press 
(American Instrument Co., Inc., Silver Spring, MD) at 18,000-20,000 psi.  The lysate was 
collected in Nalgene Oak Ridge High-Speed PPCO Centrifuge Tubes (Thermo Fisher 
Scientific, Rockford, IL), each containing 150 µL of 250 mM phenylmethylsulfonyl 
fluoride (PMSF) added prior to lysis.  The lysate was cleared by centrifugation at 35,000 
× g in a Sorvall SS-34 rotor (Thermo Fisher Scientific, Rockford, IL) for 30 min.  The 
supernatant fraction was collected and the cell debris pellet fraction discarded. 
 
Equilibration and Storage of Gravity Columns 
A 1.5 × 30 cm Econo-Column Chromatography Column (Bio-Rad Laboratories 
Inc., Hercules, CA) was packed with 10 mL of the appropriate resin.  The column was 
equilibrated with 3-5 column volumes (CV) of the appropriate equilibration buffer based 
on the chromatography to be performed and drained to the surface of the bead layer 
before use.  Packed columns were sealed and stored at 4 °C in equilibration buffer 
containing 20% EtOH when not in use.  Beads were stripped and equilibrated between 
uses as needed according to the manufacturer’s instructions (GE Healthcare Bio-
Sciences, Marlborough, MA). 
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Ion Exchange Chromatography 
 
Carboxymethyl (CM) Cation Exchange Chromatography  
Sample Preparation 
 
Crude extract samples were prepared as described in “Preparation of Protein 
Enzyme Extract” using 20 mL of freshly prepared MOPS lysis buffer (250 mM MOPS, 
10 mM EDTA, 2 mM DTT, 1% glycerol, 100 ng/mL pepstatin A, 0.1 mg/mL DNase, 0.1 
mg/mL RNase, 2.5 mM PMSF).   
 
Ultracentrifugation 
 
The supernatant fraction was collected and centrifuged in an ultracentrifuge Type 
70 Ti rotor (Beckman Coulter Inc., Brea, CA) at 260,000 × g for 30 min for 4 °C.  This 
step was repeated once to completely remove ribosomes from the extract.   
 
Ammonium Sulfate Fractionation 
 
Salt fractionation steps were performed at 4 °C.  Briefly, crystallized ammonium 
sulfate was added gradually to centrifugal extracts with gentle stirring to 30% saturation 
(0.164 g/mL) over 30 min, followed by a 15 min equilibration.  The sample was 
centrifuged at 18,000 × g for 10 min, afterwards recollecting the supernatant fraction and 
discarding the pellet fraction.  Solid ammonium sulfate was added to 70% saturation 
(0.249 g/mL), equilibrated, and centrifuged as above.   
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Protein Dialysis and Desalting 
 
The pellet was resuspended in 5 mL of freshly prepared MOPS/glycine/KOH 
(MGK) buffer (28.8 mM MOPS, pH 7.0, 10.6 mM potassium hydroxide (KOH), 10.6 
mM glycine, 1 mM DTT).  For each buffer change the resuspended sample was dialyzed 
against 1 L MGK buffer (generally ≥ 100× sample volume) for  3 h and the process 
repeated three times.  The dialysate was centrifuged at 12,000 × g for 10 min to remove 
aggregates.  The clarified dialysate was collected and used as the loading fraction for 
chromatography.   
 
Chromatography 
 
Purification using CM Sepharose Fast Flow resin (GE Healthcare Bio-Sciences, 
Marlborough, MA) was performed according to Morris and Tolan, 1993.  All purification 
steps were performed at 0-4 C.  Briefly, columns were packed and equilibrated (see 
Equilibration and Storage of Gravity Columns).  MGK buffer was used for equilibration.  
The clarified dialysate sample was loaded onto the column and drained to the surface of 
the resin.  The flow-through fraction was collected and the column was washed with 
MGK buffer until the A280 reading was < 0.02.  Purified aldolases were eluted in MGK 
buffer containing 2.5 mM fructose 1,6-bisphosphate (Fru 1,6-P2).  Column-eluate 
fractions with A280 readings > 0.8 were pooled and concentrated to  2 mg/mL using an 
Amicon Stirred Cell (MilliporeSigma, Burlington, MA) with a Ultracel 10 kDa 
Ultrafiltration Disc (MilliporeSigma, Burlington, MA).  Aliquots collected at each 
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purification step were analyzed for protein identification and purity via SDS-PAGE 
(Laemmli, 1970), as well as for protein concentration (Bradford, 1976) and enzymatic 
activity (Morris and Tolan, 1993) as described in “SDS-Polyacrylamide Gel 
Electrophoresis of Proteins,” “Photometric and Colorimetric Assays,” and “Measurement 
of Enzyme Activity,” respectively.  The purified protein solution was stored as described 
in “Storage of Purified Aldolases.” 
 
Affinity Chromatography 
 
Glutathione Chromatography 
Glutathione Column Preparation 
 
The glutathione (GSH) column was assembled as described above (see 
Equilibration and Storage of Gravity Columns).  Briefly, the column was packed with 
Glutathione Sepharose 4 Fast Flow resin (GE Healthcare Bio-Sciences, Marlborough, 
MA) and equilibrated with 1× PBS.  The column was incubated with freshly prepared 
GSH solution (50 mM Tris·Cl, pH 8.0, 10 mM reduced GSH) for 30 min at 4 °C.  The 
GSH solution was drained to the surface and the column subsequently re-equilibrated 
with ≥ 50 mL of Binding Buffer (1× PBS pH 7.3 with 0.5 mM DTT).  All remaining 
steps were performed at 4 C.   
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GSH Column Purification of GST-tagged Proteins 
 
Cell lysates were prepared as described in “Preparation of Protein Enzyme 
Extract.”  The protein load fraction was applied to the beads.  The flow-through fraction 
was collected and the beads were washed with Binding Buffer until the A280 reading was 
< 0.1.  The GST-tagged protein was eluted with 0.5-1 mL of GSH solution per mL of 
resin bed volume, and 1-mL eluate fractions were collected.  Peak fractions with A280  
> 0.8 were pooled.  Aliquots collected at each purification were step analyzed for protein 
identity and purity via SDS-PAGE (Laemmli, 1970) and protein concentration (Bradford, 
1976) (see SDS-Polyacrylamide Gel Electrophoresis of Proteins and Photometric and 
Colorimetric Assays).  Assay of enzyme activity or adjustment to the protein 
concentration were performed as necessary for the specific protein purified.  The purified 
preparation was stored as a precipitate at 4 °C or aliquots at -80 °C as specified for each 
protein.   
 Following purification, the column was drained and washed with 1-2 CV of 
Buffer A (100 mM Tris, pH 8.5, 500 mM NaCl) followed by 1-2 CV of Buffer B (100 
mM NaOAc, pH 4.5, 500 mM NaCl).  These steps were repeated three times.  The 
column was washed with 1 CV of 1× PBS followed by 1-2 CV of 6 M guanidine 
chloride.  The PBS wash was repeated followed by 1-2 CV of 70% EtOH.  The column 
was subsequently washed with 5-10 CV of 1× PBS prior to storage as described above.   
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Nickel Chelate Chromatography 
Sample Preparation 
 
Cells were harvested as described above.  Prior to lysis, the mass of each pellet 
fraction was obtained in grams.  The sample was resuspended in freshly prepared Lysis 
Buffer (20 mM sodium phosphate, pH 7.0, 500 mM NaCl, 5 mM imidazole, 2.5 mM 
PMSF, 100 ng/mL pepstatin A, 0.1 mg/mL DNase, 0.1 mg/mL RNase) at 5 mL/g cell 
paste.   
 
Ni2+ (nickel) Column Purification 
 
The Ni2+ column was prepared as described above (see Equilibration and Storage 
of Gravity Columns).  The column was packed with ≥ 10 mL of IMAC Sepharose 6 Fast 
Flow resin (GE Healthcare Bio-Sciences, Marlborough, MA).  Beads were charged with 
100 mM nickel(II) sulfate hexahydrate (Sigma-Aldrich, St. Louis, MO) according to the 
manufacturer’s instructions and equilibrated with ≥ 2 CV of Equilibration Buffer (20 mM 
sodium phosphate, pH 7.0, 500 mM NaCl).  All remaining steps were performed at 4 C.  
The aldolase load fraction was applied to the Ni2+ beads.  The column was capped and 
sealed before placement on a LABQUAKE Rotator (Barnstead|Thermolyne Corporation, 
Dubuque, IA) for ≥ 3-4 h.  The column was drained to the surface of the resin and the 
flow-through fraction collected.  The beads were washed with Binding Buffer (20 mM 
sodium phosphate, pH 7.0, 500 mM NaCl, 5 mM imidazole) until A280 < 0.02-0.08.  
Purified aldolase was eluted using a linear imidazole gradient made from Elution Buffers 
A and B (20 mM sodium phosphate, pH 7.0, 500 mM NaCl, 40 or 500 mM imidazole, 
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respectively).  Eluate fractions (1-3 mL) were collected and assayed for absorbance at 
280 nm.  All peak fractions with A280 > 0.8 were pooled.  DTT was added to a final 
concentration of 2 mM.  Aliquots taken at each purification were step analyzed via SDS-
PAGE (Laemmli, 1970), protein concentration (Bradford, 1976), and enzymatic activity 
(Morris and Tolan, 1993) (see SDS-Polyacrylamide Gel Electrophoresis of Proteins, 
Photometric and Colorimetric Assays, and Measurement of Enzyme Activity).  The 
remaining protein solution was stored as described in “Storage of Purified Aldolases.” 
 
Size-Exclusion Chromatography (SEC) 
To remove oligomers of aldolase tetramers that occasionally formed (Minton, 
1997) and other contaminating proteins, purified aldolase samples (2-15 mg/mL and ≤ 13 
mL) were loaded onto a HiPrep 16/60 Sephacryl S-300 HR column (GE Healthcare Bio-
Sciences, Marlborough, MA) and eluted with MGK buffer at a flow rate of 1 mL/min on 
an ÄKTA-pure system (GE Healthcare Bio-Sciences, Marlborough, MA).  The 
appropriate peak fraction was collected, concentrated, and stored as described below. 
 
Manipulation of Purified Protein Solutions 
 
Ultrafiltration 
Column-eluate fractions (1-2 mL each) with A280 readings > 0.8 were pooled and 
concentrated to  1 mg/mL using an Amicon Stirred Cell (MilliporeSigma, Burlington, 
MA) with a Ultracel 10 kDa Ultrafiltration Disc (MilliporeSigma, Burlington, MA).   
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Storage of Purified Aldolases 
Ammonium Sulfate Precipitation  
 
Concentrated purified protein solutions (≥ 1 mg/mL) were stored as a 70% 
saturated ammonium sulfate suspension.  Briefly, 0.436 g/mL of solid (NH4)2SO4 was 
added and mixed with gentle inversion until fully dissolved before storing at 4 C. 
 
Removal of Salts for Protein Sample Analysis 
 
Aldolase ammonium sulfate suspensions were centrifuged at 14,000 × g for 30 
min at 4 °C and the pellet fraction dissolved in the appropriate buffer for further 
manipulation.  The protein was dialyzed and precipitates removed as described above 
(see Protein Dialysis and Desalting). 
 
Analytical Chromatography 
ÄKTA FPLC Analysis 
 
Degassing and Sterilizing Buffer Solutions 
Buffer solutions were placed in a vacuum flask and degassed overnight at 4 °C 
with stirring.  The degassed solution was vacuum filter sterilized prior to usage in the 
ÄKTA FPLC system.   
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Gradient Elution  
 
Purified aldolases were loaded onto a HiTrap SP FF column (GE Healthcare Bio-
Sciences, Marlborough, MA) using a ÄKTA-pure system for analytical ion-exchange 
chromatography.  Proteins were fractionated using a linear salt gradient (0-0.5M NaCl in 
MGK buffer) while monitoring absorbance at 280 nm at a flow rate of 0.5-2 mL/min. 
 
Sample Collection 
 
Eluate fractions were collected using a Frac-920 fraction collector (GE Healthcare 
Bio-Sciences, Marlborough, MA). 
 
In vitro Hybridization of Aldolases 
Purified HRA and R42A aldolase slurries were desalted as described above (see 
Removal of Salts for Protein Sample Analysis).  Each aldolase variant was dissolved to a 
final concentration of 1 mg/mL in 10 mM Tris·Cl, pH 7.5 with 1 mM EDTA and placed 
on ice.  The variants were acidified separately to pH 1.0 at 4 °C by slow addition of 1 N 
phosphoric acid with stirring.  The acidified solutions were mixed together and allowed 
to stand for 10-30 min at 0 °C.  The mixture was diluted into 10 volumes of buffer 
containing 10 mM Tris·Cl, pH 8.0, 1 mM EDTA, 5 mM β-me, and 20% sucrose.  The 
solution was re-neutralized to pH 7.0 by dropwise addition of 1 M Tris base with slow 
stirring at 0 °C.  The HRA-R42A hybrid solution was concentrated to 1-5 mg/mL using 
an Amicon Stirred Cell (MilliporeSigma, Burlington, MA) with a Ultracel 10 kDa 
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Ultrafiltration Disc (MilliporeSigma, Burlington, MA).  The 5-membered mixed tetramer 
set was further analyzed and resolved using various separation techniques.   
 
Protein Analysis 
Quantitative Determination of Protein Concentration 
 
Photometric and Colorimetric Assays  
Dye-Binding (Bradford) Assay 
 
A Coomassie dye-binding assay was used for determination of protein 
concentration (Bradford, 1976).  Briefly, the protein sample was mixed with 20 µL of 
triethanolamine (TEA)·Cl, pH 7.4 and 980 µL of Bradford reagent (0.1% (w/v) 
Coomassie Brilliant Blue G-250, 4.75% (w/v) EtOH, 8.5% (w/v) phosphoric acid) in a 1 
mL plastic cuvette.  The reaction was incubated at 25 °C for 2 min.  The absorbance at 
595 nm was measured against a reagent blank on a Beckman Coulter DU 800 
spectrophotometer (Beckman Coulter Inc., Brea, CA).  The mass (µg) of the protein 
sample was calculated from a standard curve equation that was determined for the stock 
of Bradford reagent using various amounts (0-50 µg) of BSA of known concentration.  
The mass was then divided by the volume of the protein sample input to obtain the 
concentration. 
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Protein Concentration via UV Absorbance 
 
The molar concentration of purified protein solutions was determined from UV 
absorbance readings using Beer’s Law (𝐴 = 𝜀𝑐𝑙) with the molar extinction coefficient, ε, 
at A280 for the particular protein (Leach and Scheraga, 1960; Pace et al., 1995; Noble and 
Bailey, 2009; Noble, 2014).  An ε value of 0.91 cm2/mg was used for aldolase (Sine and 
Hass, 1969); ε = 48,988 M-1 cm-1 was used for actin (Rosenblatt et al., 1995). 
 
Measurement of Enzyme Activity 
 
Aldolase Specific Activity Assay (Coupled Assay)  
For purified preparations of aldolase, serial dilutions of aldolase mixed with 
reaction cocktail were prepared in a 96-well plate.  An initial 10 L of each aldolase 
sample (generally 2-15 mg/mL) was added to the first row of the plate.  The next four 
rows contained 200 L of activity cocktail (50 mM TEACl, pH 7.4, 10 mM EDTA, 0.16 
mM β-nicotinamide adenine dinucleotide, reduced (NADH), 2 mM Fru 1,6-P2, 10 U/mL 
glycerol-3-phosphate dehydrogenase/TIM).  Reactions were initiated by adding 90 L of 
activity cocktail to the first row using a multi-channel pipette.  Samples were further 
diluted by taking 50 L from the previous row and adding to the next, resulting in an 
additional five-fold dilution with each row of cocktail.  The absorbance at 340 nm was 
measured over 5 min on a SpectraMax 190 Absorbance Microplate Reader with SoftMax 
Pro Software v5.4 (Molecular Devices, LLC., San Jose, CA).  Dilutions yielding initial 
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A340/min rates between 0.05-0.25 were used for calculation of substrate cleavage rates.  
Initial rates within the linear range of the curves generated were used for analysis. 
For measurements of aldolase activity in mammalian cell lysates, no serial 
dilutions were performed (to conserve limited sample volumes).  Instead, a volume of the 
lysate sample (generally 40-50 µL) was brought to 200 µL with activity assay cocktail.  
The assay was performed in a 96-well plate and A340 measured as above.  The sample 
volume was adjusted to obtain a ΔA340/min rate within the 0.05-0.25 range if needed. 
 
Separation of Isozymes by Native Zone Electrophoresis (Zymography) 
 
Zymogram Sample and Cellulose Acetate Membrane Preparation 
Aldolase samples (50-100 µL) were dialyzed 2-3 times for 3 h each against 500 
mL of barbital buffer (60 mM sodium barbital, pH 8.6, 10 mM β-me).  A cellulose 
acetate strip was soaked in barbital buffer for ≥ 20 min at 25 °C.  Dialyzed aldolase 
samples were assayed for enzymatic activity (see Measurement of Enzyme Activity).  
Each sample was adjusted to an activity concentration of 50-100 U/mL as necessary.  The 
membrane was gently blotted on Whatman filter paper to remove excess buffer. 
 
Native Zone Electrophoresis 
The pre-soaked membrane was mounted onto a zymogram bridge, and samples 
were applied to the membrane as fine bands using a Sepratek 4 Applicator (DiaSys 
Europe Ltd, Wokingham, UK).  The bridge and mounted membrane were placed into a 
cellulose acetate electrophoresis chamber (Gelman Sciences Inc., Ann Arbor, MI) with 
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the ends of the strip in contact with barbital buffer, which was then used for 
electrophoresis.  The strip was subjected to electrophoresis at 200 V for 45-60 min at 4 
°C. 
 
Colorimetric Assay for Visualization of Isozymes (Activity Staining) 
Solid noble agar was dissolved to a final concentration of 0.7% w/v in 50 mM 
Tris·Cl, pH 8.0 and 10 mM sodium arsenate.  The slurry was intermittently microwaved 
and swirled to mix until the agar was fully dissolved.  The solution was cooled to 50-60 
°C before adding the following mixture as a colorimetric assay: 10 mM Fru 1,6-P2, 612 
µM nitroblue tetrazolium, 2.3 mM nicotinamide adenine dinucleotide, oxidized (NAD+), 
98 µM phenazine methosulfate, and 1.4 mM GAPDH (previously dissolved from 
lyophilized powder in 10 mM Tris·Cl, pH 8.0 containing 2 mM DTT).  The molten agar 
solution was poured into a 15 cm petri dish and allowed to solidify at 4 °C.  Following 
electrophoresis, the membrane was placed in the assay plate with the sample side facing 
down on the agar.  The assay plate was incubated at 37 °C for 10-15 min or until band 
development was observed. 
 
In Vitro F-actin Binding Assay 
 
Purification of Globular Actin (G-actin) from Rabbit Muscle 
Rabbit muscle acetone powder was provided as a gift from Dr. C. James 
McKnight (Boston University School of Medicine).  All steps were performed at 4 C 
unless stated otherwise.  One gram of rabbit muscle acetone powder was added to 30 mL 
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of freshly prepared G-buffer (2 mM Tris·Cl, pH 8.0, 0.2 mM CaCl2, 0.2 mM Na2ATP, 
0.2 mM DTT) and stirred in an ice water bath for 30 min with an overhead stirrer.  The 
mixture was gently filtered through sterile cheesecloth.  The remaining pulp was re-
extracted with 20 mL of G-buffer, stirred as before for 10 min, filtered, and combined 
with the previous extract.  The extract was centrifuged at 20,000 × g for 1 h and the 
supernatant fraction recovered.  KCl was added dropwise with gentle stirring to a final 
concentration of 50 mM, followed by similar addition of MgCl2 and ATP to final 
concentrations of 2 mM and 1 mM, respectively.  Filamentous actin (F-actin) was 
allowed to polymerize for  2 h up to a maximum of 12-18 h.  Solid KCl was added to a 
concentration of 0.6 M and gently stirred for 30 min.  The solution was centrifuged at 
80,000 × g for 3 h in a Type 70 Ti Rotor (Beckman Coulter Life Sciences, Indianapolis, 
IN).  The F-actin pellet fractions were resuspended in 150 mL of F-buffer (2 mM Tris·Cl, 
pH 8.0, 0.2 mM CaCl2, 1 mM Na2ATP, 2 mM MgCl2, 0.6 M KCl, 0.2 mM DTT) and the 
centrifugation step repeated.  Pellet fractions were soaked in 5 mL of G-buffer for 1 h 
without resuspension.  Softened pellet fractions were consolidated and transferred to a 
homogenizer for gentle resuspension.  The sample was dialyzed against 1 L of G-buffer 
for  3 d with daily buffer exchanges.  The dialysate was collected and centrifuged at 
140,000 × g for 1 hour.  The G-actin supernatant fraction was collected and stored as 
aliquots at -80 C.  The concentration of actin was determined from UV absorption using 
the following equation: [(A290 – A320)/0.603] × (volume in cuvette/volume of G-actin).  
Purity was assessed via SDS-PAGE and total protein staining with AcquaStain (Bulldog 
Bio, Portsmouth, NH).  A sample gel is shown below (Figure 2.1). 
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Figure 2.1 Purification of G-actin from rabbit muscle.  Purified actin (2-6 mg/mL) was 
analyzed via SDS-PAGE for qualitative assessment of purity.  A Bio-Rad Broad Range SDS-
PAGE marker (lane 1) was used for size verification.  The ladder and actin (lane 2) samples were 
loaded onto a 12.5% SDS-PAGE gel and stained with AcquaStain. 
 
 
Actin Recycling 
Purified G-actin was diluted to 0.5 mg/mL in freshly prepared buffers to final 
concentrations of 0.1 M KCl, 1 mM MgCl2, and 1 mM ATP.  All steps were performed at 
4 °C.  The solution was incubated with gentle stirring for 2 h.  Next, the sample was 
centrifuged at 150,000 × g for 1.5 h and supernatant fraction discarded.  The tube and 
pellet fraction were then rinsed with Buffer A (2 mM Tris·Cl, pH 8.0, 0.2 mM Na2ATP, 
0.5 mM β-me, 0.2 mM CaCl2).  The pellet fraction was placed on ice for 1 h before being 
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gently homogenized in Buffer A.  The solution was dialyzed against 1 L of Buffer A for  
6 h with rapid stirring.  The sample was centrifuged at 150,000 × g for 1.5 h.  The 
supernatant fraction was collected and the pellet fraction discarded.  The concentration of 
actin was determined as described above. 
 
Co-sedimentation (Actin Pulldown) Assay 
Purified G-actin was centrifuged at 150,000 × g in a TLA-100 rotor (Beckman 
Coulter Life Sciences, Indianapolis, IN) for 1.5 h at 4 C to remove residual F-actin.  
Aldolase ammonium sulfate suspensions (0.3-0.5 mL) were subjected to dialysis and 
precipitate removal (see Removal of Salts for Protein Sample Analysis).  Precipitated 
protein was re-dissolved in and dialyzed against IKMD buffer (10 mM imidazole, pH 6.8, 
40 mM KCl, 1 mM MgCl2, 0.1 mM DTT).  Samples were concentrated to 1 mg/mL using 
Amicon Ultra-0.5 Centrifugal Filter Units (MilliporeSigma, Burlington, MA).  Pulldown 
assays (50 µL) were carried out in 7 × 20 mm polycarbonate centrifuge tubes (Beckman 
Coulter Life Sciences, Indianapolis, IN) containing G-actin [2 mg/mL] diluted 1:1 into F-
buffer (5 mM MOPS, pH 8.0, 0.1 mM CaCl2, 0.1 mM ATP, 0.5 mM DTT, 30 mM 
MgCl2, 100 mM KCl).  F-actin was polymerized for 1 h at 25 °C.  The binding 
interaction was initiated by a subsequent 1:1 dilution of F-actin in the same buffer and 
addition of a 1/5 volume of aldolase (1 mg/mL), followed by incubation for 1 h at 25 °C.  
Reactions were centrifuged at 150,000 × g for 1 h at 4 C.  The supernatant fractions 
were collected into fresh microcentrifuge tubes.  Pellet fractions were dissolved in 50 µL 
of SDS-PAGE sample buffer.  Supernatant fractions were diluted with a 5× SDS-PAGE 
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sample buffer to 62.5 µL.  Both fractions were incubated for 12-18 h at 4 C and then 
heated to 95 C for 10 min prior to loading (5-10 L) on a 12.5% acrylamide gel.  
Discontinuous electrophoresis was performed at 50-80 V for stacking followed by 100-
150 V.  Samples from each fraction were analyzed by SDS-PAGE.  Gels were stained 
with AcquaStain (Bulldog Bio, Portsmouth, NH) (see Staining of SDS-Polyacrylamide 
Gels). 
 
Densitometry Analysis 
Densitometry analysis was performed using ImageJ software (NIH v1.52a) 
(Rasband, 1997-2018; Abramoff et al., 2004; Schneider et al., 2012). 
 
Fluorescent Labeling of Purified Protein  
Fluorescein-Conjugation of Transferrin 
 
Preparation of Solid-State Transferrin 
A protocol was adapted from Kim et al. (2008).  First, a 200 µM protein slurry 
was prepared by dissolving 16 mg/mL of human transferrin (Tf) (Sigma-Aldrich, St. 
Louis, MO) in TGED buffer (20 mM Tris·Cl, pH 7.9, 100 µM EDTA, 1 mM DTT, 5% 
glycerol).  The solution was reduced by adding DTT to a 10 mM concentration and 
allowing to stir for ≥ 2 h at 4 °C.  The sample was then precipitated to 70% saturation by 
adding 0.436 g/mL of (NH4)2SO4(s) and stored ≥ 24 h at 4 °C prior to labeling.   
 
  
 68 
Fluorescein Conjugation Reaction 
An aliquot of 50 µL was taken from the stored Tf slurry and centrifuged at 14,000 
× g for 30 min at 4 °C.  The supernatant fraction was discarded.  The pellet fraction was 
resuspended in 50 µL of TE buffer.  A Bradford dye-binding assay was performed to 
estimate the amount of protein in the solid state (see Dye-Binding (Bradford) Assay).  
Based on the protein concentration determined, 40 nmol of the (NH4)2SO4 slurry was 
reduced with DTT as described above (see Preparation of Solid-State Transferrin).  The 
sample was pelleted at 14,000 × g for 5 min at 4 °C.  Two nmol of powdered 5-
(iodoacetamido)-fluorescein was dissolved in 100 µL of DMSO before addition into 
Buffer A (100 mM sodium phosphate, pH 7.3, 200 mM NaCl, 1 mM EDTA) to a final 
concentration of 2 mM.  The pellet fraction was then dissolved in 1 mL of Buffer A (plus 
fluorescein).  The conjugation reaction was incubated with stirring at 25 °C for 30 min in 
the dark.  The reaction was quenched by adding β-me to a final concentration of 0.5% 
and incubated at 25 °C for 10 min.   
 
Size Exclusion Chromatography of Fluorescently Labeled Protein 
Unreacted excess dye was removed by running the labeled Tf sample through a 
1.0 × 20 cm Econo-Column Chromatography Column (Bio-Rad Laboratories Inc., 
Hercules, CA) that was pre-packed with 5 mL of Toyopearl HW-40F resin (Tosoh 
Bioscience LLC, Montgomeryville, PA) and equilibrated with 1× PBS.  A FC 203B 
fraction collector (Gilson Incorporated, Middleton, WI) was used to collect 100 µL 
fractions.  Peak fractions containing the labeled protein were pooled and stored, protected 
from light, at 4 °C.   
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Protein Concentration Determination of Fluorescently Labeled Transferrin 
A correction factor (CF) was first determined by the following ratio of absorbance 
measurements: 
𝐶𝐹 =
𝐴280
𝐴491
 
The molar concentration (M) was then determined with the following equation using the 
extinction coefficient (ε) of 5-IAF: 
𝑀 =
𝐴280 − (𝐴491 − 𝐶𝐹)
ε
× 𝐷𝐹 
 
Calculation of Fluorescent Labeling Efficiency 
The following equation was used to calculate the ratio of labeled Tf: 
𝑚𝑜𝑙𝑒𝑠 𝑜𝑓 𝑑𝑦𝑒
𝑚𝑜𝑙𝑒𝑠 𝑜𝑓 𝑝𝑟𝑜𝑡𝑒𝑖𝑛
=
𝐴491
82,000 𝑀−1𝑐𝑚−1
×
80,000 𝐷𝑎
𝑚𝑔
𝑚𝑙 𝑜𝑓𝑝𝑟𝑜𝑡𝑒𝑖𝑛
 
 
CELL BIOLOGY TECHNIQUES 
 
Preparation of Tissue Culture Surfaces for Microscopy 
Poly-L-Lysine Coating of Glass Coverslips and Chemical Dishes 
 
Poly-L-Lysine Solution 
Poly-L-Lysine (PLL) solution was prepared at 0.1 mg/mL by mixing 1 L of 0.1M 
borate buffer, pH 8.5, 3.1 g of boric acid, and 4.75 g of borax.  The mixture was 
autoclaved to sterilize and allowed to cool to room temperature before adding 100 mg of 
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powder poly-L-Lys.  The solution was filter sterilized once more, aliquoted, and stored at 
-80 °C.  Aliquots were thawed for immediate use as needed. 
 
Coverslip Preparation 
Deckgläser No. 0 cover glasses (Carolina Biological Supply Company, 
Burlington, NC) were submerged in 100% nitric acid inside a sealed glass jar and 
incubated at 25 °C overnight.  The coverslips were rinsed six times under a running dH2O 
tap for acid removal.  Subsequent steps were performed under a sterile tissue culture 
hood.   
 
Coverslip and Chemical Dish Coating 
The coverslips were placed in a petri dish and washed three times in 70% EtOH 
with gentle swirling.  Each coverslip was flame sterilized and placed into a 6 cm petri 
dish (5 coverslips/dish).  Coverslips were submerged in 3 mL of PLL while 1 or 2 mL of 
PLL was added to 6-well plates or petri dishes (6 cm) to be used for culturing, 
respectively.  Coverslips and culturing vessels were incubated ≥ 4 h at 37 °C.   
 
Washing and Storage of Coverslips and Chemical Dishes 
Following incubation, the PLL was removed from each dish or plate by vacuum 
aspiration.  Coverslips and dishes were washed three times with sterile dH2O and 
arranged for plating in the appropriate vessel(s).  For immediate use, plating media was 
added and dishes/plates returned to the tissue culture incubator.  Alternatively, the 
prepared coverslips were sealed with Parafilm (Bemis Company, Inc., Neenah, WI) and 
stored at 4 oC for up to several weeks. 
 71 
Tissue Culture 
Propagation and Maintenance of Immortalized Cell Lines 
 
Thawing and Plating Cell Lines 
All mammalian cell lines were provided as gifts (Table 2.6).  Complete growth 
medium (DMEM supplemented with 10% fetal bovine serum (FBS), 50 units/mL of 
penicillin, and 50 µg/mL of streptomycin) was warmed for 10-15 min at 37 °C.  Cell 
vials were removed from N2 (l) storage and thawed in a 37 °C water bath incubator with 
rapid manual swirling.  The pre-warmed media (10 mL) was added to a 10 cm petri dish.  
Cells were added to the dish and gently swirled to distribute.  Each dish was incubated 
for 3-4 h at 37 °C to allow the cells to adhere.  The cells were checked under a light 
microscope for proper morphology and adhesion before changing the media with 10 mL 
of pre-warmed DMEM as before.   
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Table 2.6 Mammalian cell lines  
Cell line Species Tissue type Source 
BSC1 Cercopithecus aethiops African green monkey kidney 
epithelial 
D. Yarar 
COS-7 Cercopithecus aethiops African green monkey kidney 
epithelial 
F. Naya 
HeLa Homo sapiens Human cervical cancer epithelial K. Allen 
NIH-3T3 Mus musculus Mouse embryo fibroblast U. 
Hansen 
 
 
Passaging of Confluent Cells 
Cells at 95-100% confluency were passaged into new culturing vessels as 
necessary.  All media and reagents were aliquoted and warmed for 10-15 min at 37 °C 
prior to passaging.  The media was aspirated from each 10 cm dish.  Cells were washed 
twice with 5-10 mL of sterile 1× PBS.  A 0.4 mL volume of 0.05-0.25% trypsin was 
added to each plate and incubated at 37 °C for 5-10 min or until fully detached.  The cells 
were resuspended in 10 mL of complete medium to inactivate the trypsin and triturated 
until clumped cells were no longer visible.  The appropriate volume of cells was added to 
new plates or dishes containing predetermined volumes of growth media.  The cells were 
gently swirled to distribute and incubated at 37 °C.   
 
Liquid Nitrogen Storage 
Confluent cells were passaged into two 10 cm petri dishes at a 1:2 dilution.  The 
following day, cells were trypsinized and resuspended in 5-10 mL of DMEM.  The 
suspension was collected and pelleted in an IEC Clinical Centrifuge (International 
Equipment Company, Needham Heights, MA) on setting #5 (3,660 × g) for 5 min at 25 
°C.  The supernatant fraction was aspirated and the cells were resuspended in 8-10 mL of 
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complete growth media containing 10% (v/v) DMSO.  The cell suspension was added to 
Cryo.s Freezing Tubes (Greiner Bio-One, Monroe, NC) at 1 mL per tube.  The tubes 
were slow-frozen at -20 °C for 3-4 h and -80 °C overnight before being transferred to  
N2 (l) storage. 
 
Tissue Collection and Plating of Primary Neuron Cultures 
 Neuronal cultures were provided by Dr. Hengye Man and prepared for 
experiments by Margaret L. O’Connor and Zachary V. Gardner.  Experiments with 
neurons were performed in collaboration with Margaret O’Connor.   
 
Coverslip and Dish Preparation 
Coverslips (18 mm No. 0 circular; Carolina Biological Supply Company, 
Burlington, NC) and 6 cm Petri dishes were prepared (see Poly-L-Lysine Coating of 
Glass Coverslips and Chemical Dishes).  Five coverslips/dish were left in plating medium 
(DMEM with L-glutamine, 4.5g/L glucose and sodium pyruvate (Corning, Corning, NY) 
supplemented with 10% FBS, 5% horse serum (Atlanta Biologicals, Flowery Branch, 
GA), 62 µg/mL L-cysteine, 1× concentration of Penicillin-Streptomycin Solution 
(Corning, Corning, NY), and 1 mM L-glutamine) before plating cells.   
 
Primary Neuron Culture Preparation 
Cortical brain tissues were dissected out from male or female day-18 embryo 
(E18) rat fetuses.  Tissues were prepared for primary culture by digestion with papain 
(0.5 mg/ml in Hanks’ Balanced Salt solution (Sigma-Aldrich, St. Louis, MO)) at 37 °C 
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for 20 min.  The tissues were gently triturated in buffer (0.1% DNase, 1% ovomucoid, 
1% BSA in DMEM) until the neurons were fully dissociated.  Dissociated cortical 
neurons were counted and plated for ICC experiments.  Plating medium was replaced 
with feeding medium (Neurobasal Medium (Thermo Fisher Scientific, Rockford, IL) 
supplemented with 1% horse serum, 2% B-27 Supplement (Thermo Fisher Scientific, 
Rockford, IL), 1× concentration of Penicillin-Streptomycin Solution, and 2 mM L-
Glutamine) 1 d after cell plating.  Neurons were maintained in feeding medium with 10 
μm 5′-fluoro-2′-deoxyuridine (Sigma-Aldrich, St. Louis, MO) supplemented at 7 d in 
vitro (DIV7) to suppress glial growth until experimental use. 
 
RNA Interference (RNAi) 
Design of short interfering RNAs (siRNAs) 
An siRNA targeting mouse/rat Aldolase A (siAldolase A 287) was previously 
designed by Dr. Carolyn Ritterson Lew (Ritterson Lew, 2012).  The siRNA targeting 
monkey/human Aldolase A, “siAldolase A 287 (monkey),” was modified from the 
aforementioned sequence to fully match the targeted monkey sequence.  Custom dsRNA 
oligonucleotide sequences were submitted to Dharmacon for siRNA synthesis 
(Dharmacon, Inc., Lafayette, CO).   
 
Alignment Analysis 
Aldolase A (ALDO A) coding sequences were obtained from the NCBI Gene 
database (National Center for Biotechnology Information, Bethesda, MD) 
(https://www.ncbi.nlm.nih.gov/) for the following species: Homo sapiens (human), Mus 
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musculus (house mouse), Rattus norvegicus (Norway rat), and Macaca fascicularis (crab-
eating macaque).  Multiple sequence alignment was performed using Clustal Omega 
(https://www.ebi.ac.uk/Tools/msa/clustalo/) to compare siRNA sequences against select 
target species. 
 
Transfection of siRNA and plasmid DNA 
Transfection by cationic lipid-mediated delivery was performed in mammalian 
cell lines using Lipofectamine 3000/RNAiMAX (Thermo Fisher Scientific, Rockford, 
IL).  Transfections were performed in 6-well plates following the manufacturer’s 
protocol.  Following transfection, the cells were checked daily under a light microscope 
for qualitative assessment of viability and morphology.  Cells were harvested for protein 
analysis or processed for imaging 2-4 d post-transfection. 
Transfections in rat neuronal primary cultures were carried out exclusively with 
Lipofectamine 2000 (Thermo Fisher Scientific, Rockford, IL) in 12-well plates using a 
modified procedure.  Briefly, the Lipofectamine 2000 and individual samples (siRNA 
and/or plasmid DNA) were separately incubated with DMEM at 25 °C for 5 min.  Each 
sample was then mixed at a 1:1 ratio with Lipofectamine 2000 in Opti-MEM and 
incubated for 20 min prior to applying to the cells.  The cells were allowed to incubate for 
3-4 h at 37 °C before the media was changed.  Coverslips were processed and imaged  
2-4 d post-transfection. 
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Analysis of Knockdown 
Native Cell Lysate (NCL) Preparation from Cell Line Samples 
 
Cells were washed twice with sterile 1× PBS at 25 °C and trypsinized (see 
Passaging of Confluent Cells).  The cells were resuspended in 1 mL of 1× PBS and 
collected in a microcentrifuge tube.  A small aliquot (10 µL) was set aside for cell 
counting before centrifuging the remaining sample at 500-1000 × g for 5 min at 4 °C.  
The supernatant fraction was discarded by vacuum aspirating.  The cells were 
resuspended in 75 µL of ice-cold NCL buffer (20 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% v/v 
Triton-X 100, 1 mM DTT, 1 µg/mL leupeptin, 1 µg/mL pepstatin A, 1 µg/mL PMSF, and 
Protease Inhibitor Cocktail (Sigma-Aldrich, St. Louis, MO)) and triturated through a 27-
gauge needle.  The sample was incubated on ice for 30 min before centrifuging at 14,000 
× g for 30-60 min at 4 °C.  The cleared lysate was collected into a fresh microcentrifuge 
tube for further processing or storage at -80 °C.  
 
Cell Counting 
Trypan Blue Exclusion Assay 
Cells were diluted ≥ 1:2 in 0.4% trypan blue Stain (Thermo Fisher Scientific, 
Rockford, IL).  A hemocytometer (Cynmar, Yulee, FL) was used for cell counting to 
determine the number of cells/mL.   
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Endocytosis Assays 
Bulk Fluid-Phase Endocytosis 
 
Dextran Uptake Assay 
FITC-Dextran (Dx) solution was added directly to coverslip media at a final 
concentration of 0.5 mg/mL.  The cells were incubated for 30 min at 37 °C.  Each 
coverslip was rinsed with ice-cold 1× PBS to stop endocytosis and wash excess dye 
bound to the cell surface.  The samples were rinsed three more times in PBS at room 
temperature for 5 min each with gentle agitation.  Cells were fixed and the nuclei stained 
prior to mounting on glass slides as described below. 
 
Clathrin-Mediated Endocytosis 
 
Transferrin (Tf) Uptake Assay 
An adapted Tf uptake procedure was used for this work (Boucrot et al., 2010; 
Doyon et al., 2011; Benjamin et al., 2011).  Cells grown on poly-L-lysine (PLL)-coated 
coverslips were washed twice with 1× PBS at 25 °C.  To deplete residual Tf present in 
serum, the cells were serum-starved for 1 h at 37 °C in starvation medium (DMEM 
containing 20 mM HEPES, pH 7.4 and 5 mg/mL BSA).  Fluorescein-labeled Tf uptake 
marker was added to the starvation medium to a final concentration of 5-20 µg/mL.  The 
cells were incubated for 30 min at 37 °C.  Coverslips were rinsed in ice-cold 1× PBS to 
stop endocytosis and remove unbound ligand.  Cells were fixed and stained prior to 
mounting on glass slides as described below. 
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Fluorescent Staining of Cell Structures 
Fixation and Permeabilization of Cells 
Fixation steps were carried out at 25 °C.  Cells were incubated in either 4% (v/v) 
paraformaldehyde (PFA) in 1× PBS or PHEM fixative (60 mM piperazine-N,N′-bis(2-
ethanesulfonic acid) (PIPES), 20 mM HEPES, pH 7.2, 4% (v/v) PFA, 10 mM ethylene 
glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid (EGTA), 2 mM MgCl2, 3% 
sucrose) for 10-15 min.  The coverslips were washed with 1× PBS and permeabilized 
with 0.1-0.3% (v/v) Triton X-100 in PBS for 1-5 min.  The PBS wash was repeated two 
times before staining of additional cell structures. 
 
Immunocytochemistry 
For antibody staining of cellular structures, all incubation steps were performed at 
25 °C (or 4 °C overnight) and used 500 µL of each reagent applied to the coverslip.  
Wash steps were carried out by rinsing the coverslips twice with 1× PBS.  Following 
fixation, cells were incubated in blocking solution (1× PBS containing 10% goat serum) 
for 40 min.  Primary antibody was prepared at a minimum 1:100 dilution in 1× PBS 
containing 5% goat serum, applied to each coverslip, and incubated for 2 h.  The wash 
step was repeated as before.  Secondary antibody was diluted at 1:500 in 1× PBS 
containing 5% goat serum, added to the cells, and incubated for 1 h.  The wash step was 
repeated.  Coverslips were subjected to additional staining procedures as needed or 
mounted as described below. 
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F-actin and Nuclear Staining 
Fluorescent staining procedures not requiring the use of antibodies were carried 
out in a foil-covered humidity chamber to minimize evaporation and exposure to light.  
For actin staining, the fixed cells were pre-incubated in blocking solution (1× PBS 
containing 1% BSA) for 20-30 min.  Alexa Fluor 546 Phalloidin (Thermo Fisher 
Scientific, Rockford, IL) was diluted in blocking solution following the manufacturer’s 
instructions, applied to each coverslip, and stained for 20 min at 25 °C.  Coverslips were 
rinsed 2-3 times in 1× PBS.   
Staining of nuclei was performed as the last staining step with either DAPI or 
Hoechst nucleic acid stain.  Briefly, 300 nM of DAPI or 2 µg/mL of Hoechst were 
dissolved in 1× PBS.  The stain was applied and incubated for 1-5 min before repeating 
the PBS wash step a final time.  Coverslips were mounted and processed as described 
below. 
 
Fluorescence Microscopy Imaging of Fixed Cells 
Slide Preparation and Storage 
 
Mounting Coverslips 
Fully-processed cell coverslips were mounted on glass slides and cured prior to 
imaging using either ProLong Gold or Prolong Diamond Antifade Mountant (Thermo 
Fisher Scientific, Rockford, IL).  Briefly, the mountant solution was warmed to room 
temperature prior to use.  Excess moisture was removed from each coverslip by wicking 
with a Kimwipe (Kimberly-Clark Professional, Roswell, GA).  A small amount of 
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mountant (7 µL) was gradually pipetted onto a glass slide, taking care to avoid air 
bubbles.  The coverslip was lowered onto the slide with the cell-side facing down.  If 
necessary, excess mountant around the edge of the coverslip was aspirated from one spot.  
Coverslips were allowed to cure in the dark at 25 °C for ≥ 24 h before viewing. 
 
Storage of Prepared Slides 
Coverslip-mounted slides were stored at 4 °C in a slide box.  For long-term 
storage, coverslip edges were sealed with nail polish.   
 
Imaging and Data Analysis 
Images were acquired using a Nikon Eclipse Ni-E microscope (Nikon Instruments 
Inc., Melville, NY) or Zeiss Axiovert 200 M inverted fluorescence microscope with 
AxioVision Release 4.5 software (Carl Zeiss Microscopy, LLC, Thornwood, NY).  
Fluorescence labeling was analyzed and quantified with images in 8-bit grayscale using 
ImageJ software (NIH v1.52a) (Rasband, 1997-2018; Abramoff et al., 2004; Schneider et 
al., 2012) or Fiji (Schindelin et al., 2012).  For quantification of puncta, cell outlines 
were traced using the polygon or freehand selection tools.  Mean fluorescence intensity 
was measured for individual cells in arbitrary units (a.u.). 
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STRUCTURAL BIOLOGY METHODS 
 
F-actin Bundling Assay 
Preparation of Aldolase-F-actin Complex Samples for Electron Microscopy 
Actin and aldolase samples were prepared as described in “Co-Sedimentation 
(Actin Pulldown) Assay” up to the second 1 h incubation step at 25 °C.  The samples 
were processed with no additional manipulation or following dilutions in F-buffer as 
needed for electron microscopy optimization. 
 
Partial Depolymerization of F-actin 
Samples of aldolase bound to F-actin were prepared as described above.  Partial to 
complete depolymerization of actin filaments was initiated by dialyzing the samples 
against 1 L of G-buffer for ≤ 3 d with one buffer change per day. 
 
Negative Stain Electron Microscopy (EM) 
Negative stain procedures and transmission EM (TEM) image acquisition were 
performed in collaboration with Maria Ericsson (Harvard Medical School).   
 
EM grid preparation 
Prior to sample application, carbon or formvar/carbon coated grids were made 
hydrophilic using a table-top glow discharge unit.  Samples composed of purified 
aldolases, F-actin, or aldolases complexed with F-actin (5 µL) were adsorbed to each grid 
surface.  Excess liquid was removed by blotting on filter paper (Whatman #1).  Each grid 
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was floated on a 5 µL drop of 0.75% uranyl formate for up to 5 min.  Excess stain was 
blotted and each grid rinsed with dH2O and air dried before imaging.  
 
Transmission Electron Microscopy 
Electron micrographs were recorded at a voltage of 80 kilovolts (kV) and 
magnifications of 1200-68000× on a JEOL 1200EX transmission electron microscope 
equipped with an AMT 2k CCD camera (JEOL USA, Inc., Peabody, MA) or Tecnai G² 
Spirit BioTWIN Transmission Electron Microscope equipped with a Hamamatsu ORCA 
HR Camera (Thermo Fisher Scientific, Rockford, IL). 
 
Cryo-Electron Microscopy (Cryo-EM) 
Cryo-EM Grid Preparation of Aldolase-F-actin Complex Samples 
QUANTFOIL Holey Carbon grids (Quantifoil Micro Tools GmbH, Großlöbichau, 
Germany) or C-Flat holey grids (C-Flat R1.2/1.3, 400 mesh) (Electron Microscopy 
Sciences, Hatfield, PA) were glow-discharged using the PELCO easiGlow™ Glow 
Discharge Cleaning System (Ted Pella, Inc., Redding, CA) at 20 mA for 60 s.  Aldolase-
F-actin complex samples were freshly prepared using identical concentrations, buffers, 
and ionic conditions as actin pulldown assays (see Co-Sedimentation (Actin Pulldown) 
Assay).  Samples of aldolase alone or complexed with actin (3 µL) were applied to 
individual grids, blotted, and plunge-frozen in liquid ethane using an FEI Vitrobot Mark 
IV automated grid plunging system (Thermo Fisher Scientific, Rockford, IL).  Frozen 
grids were stored in N2(l) until processed. 
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Data Collection, Image Processing, and 3-D Reconstruction 
 Cryo-EM data were collected and analyzed by Dr. Chen Xu and Dr. Kyounghwan 
Lee (UMass Medical School Cryo-EM Facility).  Model-building of the aldolase-F-actin 
complex was performed by K. Lee using single-particle analysis.  Briefly, movies were 
collected at 45,000× magnification with the K3 direct electron detector on the FEI Talos 
Artica cryo-TEM (Thermo Fisher Scientific, Rockford, IL) operated at an accelerating 
voltage of 200 kV, using a total dose of 41.62 electrons/Å2 and 26 frames (calculated 
pixel size of 0.87 Å/pixel).  The defocus range was between −1.0 and −2.50 µm.  
Approximately 3000 movie images were collected.  The collected movies were imported 
into cisTEM (Grant et al., 2018) for data processing.  Particles were auto-picked and 
extracted (Figure 2.2).  All subsequent data processing steps were performed using 
cisTEM software.  The resulting particles after 2-D classification selection (Figure 2.3) 
were submitted to three-dimensional (3-D) classification. 
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Figure 2.2 Particle selection of aldolase complexed with actin from 2-D images.  
Purified F-actin decorated with the 6-5 aldolase set was depolymerized and applied to a glow-
discharged carbon grid before plunge-freezing in liquid ethane.  A micrograph from the 
subsequent cryo-EM data set collected is shown at 45000× magnification.  Raw images were 
acquired using a Talos Arctica transmission and scanning electron microscope (Thermo Fisher 
Scientific, Rockford, IL).  Particles were auto-selected (circled in white) using cisTEM software 
for single-particle analysis. 
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Figure 2.3 Two-dimensional class averages of actin-bound aldolase particles.  Class averages 
of individual aldolase molecules expected to be bound to partially-depolymerized F-actin 
fragments (circled in red) were selected for 3-D reconstruction.   
 
 
STATISTICAL ANALYSIS 
 
Experiments were conducted in biological replicates and standard deviation (σ) or 
standard error of the mean (SEM) calculated.  All values are reported as X ± σ.  A 
Student's t-test or one-way ANOVA with Tukey's post-hoc test was performed as 
appropriate using Graphpad Prism (GraphPad Software, San Diego, CA). 
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CHAPTER 3: HYBRIDIZATION OF ALDOLASE VARIANTS FOR 
MODULATION OF ACTIN-BINDING 
 
INTRODUCTION 
 
 Oligomeric structure is a common feature of most proteins (Klotz et al., 1970; 
Goodsell et al., 2000).  The significance of the particular quaternary structure of a protein 
is not always clear, and the purpose may extend beyond protein stability and regulatory 
functions (Ponstingl et al., 2005).  In the case of fructose-1,6-bisphosphate (Fru-1,6-P2) 
aldolase (aldolase; EC 4.1.2.13), a glycolytic enzyme also involved in fructose 
metabolism, the quaternary structure is important for stability, but not regulation 
(Penhoet and Rutter, 1971; Beernink and Tolan, 1996; Sygusch and Beaudry, 1997).  In 
vertebrates, three distinct aldolase subunit types are produced by separate homologous 
genes: aldolases A, B, and C.  Upon association, homo- and hetero-tetramers of aldolase 
are formed (Swain and Lebherz, 1986).  Furthermore, aldolase requires the quaternary 
structure for several non-canonical (non-catalytic) roles in the cell (Ritterson Lew and 
Tolan, 2012) (see Chapter 1). These non-canonical interactions may require a multi-
subunit binding interface not normally used for catalysis (Pirani et al., 2004).  Consistent 
with these roles, all higher eukaryotes express aldolase exclusively as a tetramer, and this 
quaternary structure is unusually stable.  Subunits can only be dissociated under harsh 
conditions, even after denaturation of the subunit itself (Deng and Smith, 1999), and 
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strong interface interactions exist with the tetramer-to-monomer dissociation constant of 
< 10-26 M3 for aldolase A (Tolan et al., 2003).  
Naturally occurring hybrids exist in tissues where more than one isozyme of 
aldolase is present, and these hybrids vary in subunit composition (Penhoet et al., 1966; 
Rutter et al., 1968).  Chimeric forms of vertebrate aldolases have been used to explore 
quaternary structure (Penhoet et al., 1967), isozyme-specific functions, and evolutionary 
relationships (Meighen and Schachman, 1970; Gibbons, 1974; Kitajima et al., 1990).  
Heterotetramers from combinations of aldolase A, B, or C isozyme subunits have been 
produced in vitro using a denaturation/renaturation procedure (Penhoet et al., 1966; 
Rutter et al., 1968; Penhoet and Rutter, 1971).  Similar methods have generated hybrids 
of aldolases originating from different species, demonstrating the high degree of 
evolutionary conservation (Heil and Lebherz, 1978; Swain and Lebherz, 1986).  In fact, 
the kinetic analyses of such mixed-isozyme hybrids have demonstrated the independence 
of catalytic activity (Penhoet and Rutter, 1971).  While heterotetrameric combinations 
between different isozymes have been produced and purified, studies with hybrid 
tetramers created from genetic variants of the same aldolase isozyme have not been 
reported.  We set out to understand the aldolase-F-actin complex using such hybrid 
tetramers of different variants of the same isozyme wherein one subunit was proficient 
and the other subunit was deficient in binding F-actin.   
Modern gene-editing methods have further enabled artificial assembly and 
isolation of such heterotetrameric combinations via expression in Escherichia coli 
(Beernink and Tolan, 1992).  Though there are a variety of in vivo co-expression systems 
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and cell-free protein synthesis methodologies for the production of multiple subunits of 
heterocomplexes, many have variable and uncontrolled expression levels (Yang et al., 
2001; Neumann et al., 2003; Alexandrov et al., 2004; Berger et al., 2004; Dzivenu et al., 
2004; Kim et al., 2004; Romier et al., 2006; Scheich et al., 2007; Stols et al., 2007; 
Wakamori et al., 2010; Zeng et al., 2010; Terada et al., 2014; Held et al., 2016).  The 
vast majority of these systems have unpredictable or mixed results necessitating a trial-
and-error approach.  Importantly, the inability to gauge or control stoichiometry is a 
common flaw.  Many elements impact co-expression, and therefore, stoichiometry.  
These elements include promoter types, ribosomal binding sites (RBS), use of single or 
multiple vectors, mRNA stability, amino-terminal extensions or sequences, expression 
cassette order, number of terminators, and other influencing factors (Kozak, 1986; Voges 
et al., 2004; Keum et al., 2006; Diebold et al., 2011; Chen et al., 2017).   
Recent methods using synthetic biology and a multiplex-selection procedure have 
led to the development and characterization of DNA modules and/or elements important 
for controlling expression levels of recombinant proteins in Escherichia coli (Bieniossek 
et al., 2009; Zeng et al., 2012; Mutalik et al., 2013).  One such approach employs 
modular cloning, or MoClo (Weber et al., 2011).  The Cross-disciplinary Integration of 
Design Automation Research (CIDAR) MoClo Library is the first of its kind created for 
use in E. coli.  MoClo is a one-pot restriction-ligation assembly standard based on the 
Golden Gate (Engler et al., 2009) method that enables rapid and flexible construct design 
(Iverson et al., 2016).  This technology enables predictive design capability and 
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streamlines the process of generating a library of expression cassettes from which those 
showing the desired expression levels can be selected. 
As stated above, we set out to understand the structure of the aldolase-F-actin 
complex using hybrids of the aldolase tetramer.  Higher-order F-actin structures exist in a 
wide array of cellular contexts and are regulated by distinct networks of proteins specific 
to each process (Lappalainen, 2016). One such higher-order F-actin structure is aldolase, 
which interacts with F-actin and other proteins involved in the regulation of cytoskeletal 
dynamics, though its exact functional role in these processes has not been established 
(Arnold and Pette, 1970; Arnold et al., 1971; Kusakabe et al., 1997; Wang et al., 1997; 
Tolan et al., 2003; Lundmark and Carlsson, 2004; Buscaglia et al., 2006; Sherawat et al., 
2008).  Negative stain electron microscopy studies have shown that aldolase bundles and 
crosslinks F-actin in vitro (Clarke and Morton, 1976; Morton et al., 1977; Stewart et al., 
1980; Wang et al., 1997; Hu et al., 2018). Though the aldolase-F-actin binding interface 
is not known, actin co-sedimentation and electron microscopy experiments performed 
using monomeric and dimeric aldolase variants have suggested that two subunits of 
aldolase are sufficient for binding to F-actin, but not for crosslinking (Pirani et al., 2004).  
An 22 tetramer of aldolase in which one dimer does not bind F-actin, is desired for 
investigation of the aldolase-actin binding without crosslinking, as crosslinking produces 
bundles that are heterogeneous and problematic for structure determination.  Identifying 
the aldolase-F-actin interface is important for understanding the role of aldolase in actin-
driven processes and its potential to form complexes with other actin-associated proteins.  
However, in order to identify this interface, a non-bundling aldolase tetramer is needed.   
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 This chapter describes efforts to construct and engineer aldolase heterotetramers 
composed of wild-type and actin-binding deficient variant aldolase A subunits (Table 
3.1).  Conventional methods for bacterial co-expression were first explored, followed by 
in vitro hybridization (IVH).  Finally, CIDAR MoClo was used for the construction of 
libraries with tunable gene expression cassettes in E. coli.  Through rational design and 
expression tuning to achieve equal expression of two unique subunits, an 22 tetramer of 
rabbit muscle aldolase was produced.   
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Table 3.1 Aldolase variants used in subunit hybridization experiments 
Name Description Quaternary 
Structure 
Purpose 
HRA His6-tagged rabbit 
aldolase A 
Tetramer Tagged aldolase (comparable to 
WT) with net charge and Mr 
differences 
R42A Rabbit aldolase A with 
R42A substitution 
Tetramer Non-actin binding variant for 
studies with F-actin  
 
 
DOMINANT EXPRESSION OF R42A ALDOLASE VARIANT 
 
His-tagged WT Rabbit Aldolase A and R42A Express in Equal and High Amounts 
When Introduced Individually into Bacteria 
Co-expression in bacteria was first tested as a means to facilitate in vivo 
intrasubunit hybridization of distinct aldolases.  Two variants of rabbit aldolase A, a His6-
tagged WT (HRA) and R42A actin-binding deficient variant (R42A), were transformed 
individually and co-transformed in E. coli (Figure 3.1).  When only one plasmid was 
introduced, a similar level of expression was observed for each aldolase variant (Figure 
3.1; lanes 2 and 4).  As the backbone vectors for each variant carried different resistance 
markers, co-transformants were selected by growth in ampicillin- and kanamycin-
containing media.  The introduction of two plasmids, however, did not result in the co-
expression of both aldolase variants as a doublet band could not be seen (Figure 3.1; lane 
6).  Rather, the expression of R42A was observed with no expression of HRA.  
Alternative avenues for generating chimeric tetramers were subsequently explored, and 
are described below. 
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Figure 3.1 Co-expression of His6-tagged wild-type and R42A rabbit aldolase A in bacteria.  
E. coli DH5α cells were singly transformed with pPB14 encoding His6-tagged rabbit aldolase A 
(HRA; lane 2) or pPB3 encoding R42A rabbit aldolase A (R42A; lane 4), or co-transformed with 
both plasmids (lane 6).  Bacterial lysate samples were prepared from log phase cultures.  A Bio-
Rad Broad Range SDS-PAGE marker (lane 1) and purified protein controls (20 µg) were 
included for size comparison (lanes 8 and 9).  Samples were subjected to electrophoresis on a 
10% SDS-PAGE gel and stained with Coomassie Blue.  Empty spaces indicate lanes where no 
sample was loaded. 
 
 
IN VITRO HYBRIDIZATION (DENATURATION/RENATURATION) OF 
ALDOLASE VARIANTS 
 
Reversible Dissociation of HRA and R42A 
An established in vitro denaturation/renaturation procedure for hybridizing 
aldolases using purified protein was employed to generate a set of mixed/chimeric 
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tetramers varying in the number of HRA and R42A subunits.  Large-scale amounts (100-
200 mg) of HRA and R42A aldolases were purified individually for the procedure.  The 
general workflow for this process is depicted in Figure 3.2.   
Dissociation and re-association of subunits from the starting homotetramers was 
monitored by specific activity and total protein assays at each stage (Figure 3.3).  The 
average specific activity observed for HRA and R42A preparations used in this method 
was 14 ± 1.1 U/mg.  After acidification, 10 ± 7.1 percent of the specific activity remained 
on average compared to the starting activity (Figure 3.3A).  Upon re-neutralization to 
facilitate reformation of tetramers, the specific activity was generally found to be 89 ± 15 
percent that of the starting material, indicating nearly full recovery of activity. 
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Figure 3.2 General workflow for in vitro hybridization of purified aldolases.  Distinct 
aldolase homotetramers are shown as magenta and blue molecules with individual subunits 
depicted as hexagons (top left).  The purified aldolases are acid denatured in solution to fully 
unfold and dissociate subunits. The subunits are mixed together and hybridized by re-neutralizing 
(center and bottom left).  Following renaturation, the mixed tetramer set is concentrated and 
separated by charge via ion exchange chromatography (right). 
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Figure 3.3 Recovery of enzyme activity and total protein following IVH procedure.  Aldolase 
activity and yield (mg) were monitored at each stage of in vitro hybridization.  A. Specific 
activity (U/mg) was measured prior to subunit dissociation, at full denaturation, and at re-
association into tetramers.  B. Total protein (mg) was assayed for the input protein and end 
product of the hybridization procedure.  Error is represented as standard deviation (σ) where n=5.  
****, P<.0001; **, P<.05; ns, not significant. 
 
  
A 
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ns 
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 In contrast, recovery of total protein mass with respect to the starting material 
appeared low, yielding on average 33 ± 25 percent of the input protein (Figure 3.3B).  
Additionally, clear separation of specific tetramer species produced by hybridization 
could not be discerned (Figure 3.4).  Cation-exchange chromatography of the 
concentrated material produced two small peaks (Figure 3.4A).  The fractions of each 
peak were further analyzed by SDS-PAGE (Figure 3.4B).  Earlier fractions in the first 
eluted peak were suggestive of species composed of a higher ratio of R42A subunits, as 
would be expected from the pI.  Based on the doublet bands observed, fractions from the 
second peak appeared to contain both HRA and R42A subunits.  However, it was 
uncertain as to whether the fractions contained differing heterotetramer species.  
Moreover, a reduction in R42A subunits is not evident in later fractions.  Due to the 
insufficient protein yield by this technique, which did not allow for more observable 
peaks, a more amenable method for in vivo production of mixed tetramers was pursued. 
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Figure 3.4 Cation exchange chromatography separation of mixed aldolase set generated by 
IVH.  A. The concentrated mixed tetramer set was applied to a HiTrap SP FF column to separate 
different species using a linear NaCl gradient (0-0.5 M; shown as a percentage of the gradient on 
the right y-axis).  Protein in each fraction (purple curve) was monitored by A280 (left y-axis).  B. 
Protein fractions from the two peaks (denoted I and II) were analyzed by SDS-PAGE at an equal 
volume across all fractions.  Gels were visualized using AcquaStain.  Migration of 41 and 40 kDa 
variants is indicated using purified protein controls in the last two lanes of each set.   
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IN VIVO HYBRIDIZATION: ENGINEERING A DUAL EXPRESSION PLASMID 
LIBRARY VIA CIDAR MoClo 
 
Fluorescent Aldolase Fusions as Proxy Measurements of Individual Variant 
Expression in the Dual Expression Context 
The predictive capability of the CIDAR MoClo system for production of plasmids 
with high levels of expression at equimolar levels was tested with the two aldolase 
variants.  Due to the high degree of similarity between HRA and R42A (varying only by 
the N-terminal His-tag of the former and single internal residue substitution of the latter), 
quantification of each variant in a dual expression system was challenging.  Previous 
work has suggested an effect of various 5’-end coding sequences on protein expression 
(Mutalik et al., 2013).  This effect was tested using fusion proteins constructed from the 
first 36 nucleotides of a gene of interest (GOI) fused to the 5’-end of GFP or RFP under 
the control of a standard promoter and series of RBS parts (Mutalik et al., 2013).  From 
this information, it was hypothesized that fusion proteins carrying the first 36 nucleotides 
of each aldolase variant in the CDS could substitute as proxy measurements for 
expression levels of HRA and R42A in non-fusion plasmid backbones.  As previous 
findings have further demonstrated the consistency of expression in a given context when 
assembled into a multigene construct, it was thought that these proxy measurements 
could add information on expression patterns of any dual expression plasmids created 
(Iverson et al., 2016).   
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To provide an option for a proxy measurement of the relative expression of each 
aldolase component in a dual expression library, fluorescent fusion proteins of 
HRA:GFP, HRA:RFP, R42A:GFP and R42A:RFP were created using promoters with the 
highest strength in the CIDAR MoClo library (pJ06, pJ07, and pJ02) along with the 
strongest RBS type parts in the library (B2 and B12) (Iverson et al., 2016).  B2 and B12 
are engineered ribosome binding elements called BiCistronic Designs (BCDs), which 
consist of an RBS, a short coding sequence, and a second RBS embedded in this coding 
sequence.  This design is intended to reduce the influence of surrounding sequences on 
protein expression levels. 
These promoter and RBS parts were selected for constructing plasmids to test 
whether they had similar expression levels in terms of promoter, RBS, and vector context 
(Figure 3.5).  Previous studies with fluorescent protein reporters have suggested that the 
expression of a given transcription unit in a single or dual expression context is 
unchanged as long as the backbone remains the same (Iverson et al., 2016).  Clones were 
grown overnight alongside the same contexts with GFP and RFP coding sequences for 
comparison.  The fluorescence was measured in triplicate for each clone using a Tecan 
plate reader. 
The fluorescence measurements for the GFP fusions indicated varied expression, 
with HRA fusions having substantially lower levels of fluorescence (an average variance 
of 12-fold observed between R42A:GFP and HRA:GFP units) (Figure 3.5A).  RFP 
comparisons appeared more closely related with an average variance of 2.5-fold between 
R42A:RFP and HRA:RFP (Figure 3.5B).  Overall, while the amino-terminal sequence  
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Figure 3.5 Fluorescent fusion proteins as a proxy measurement of HRA and R42A aldolase 
variant expression.  Expression cassettes for five combinations (pJ06B12, pJ07B2, pJ07B12, 
pJ02B2, or pJ02B12) were used for testing the effect of N-terminal fusion to either the R42A 
(dark green or maroon) or the HRA aldolase (teal or light pink) 12 N-terminal amino acids.  
Clones were grown overnight and fluorescence measured and normalized to optical density 
(O.D.).  Fluorescence yield in arbitrary units (a.u.) is plotted for each clone.  A. Fluorescence for 
clones using green fluorescent protein (GFP) for the five expression cassettes.  Inset: diagrams of 
the three constructs.  B. As in A, but using red fluorescent protein (RFP).  Error bars are from 
standard deviations at 1𝞂 for three replicates. 
A 
B 
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clearly affected the expression of these fusion proteins, the reliability of this method as a 
means of evaluating equivalent expression of the full-length protein was unclear due to 
the inconsistency between GFP and RFP expression.  As BCDs have been found to 
decrease variance by an approximate 10-fold, this information suggests the possibility of 
HRA expression being 40-fold lower than the R42A equivalent without the influence of a 
BCD (Mutalik et al., 2013).  The average variance between HRA:GFP and GFP 
transcriptional units is 4.4-fold with a BCD present, and 1.8-fold  between HRA:RFP and 
RFP transcriptional units.  As the BCD elements are specifically designed to minimize 
variation in expression due to the RBS:CDS interaction, it was expected that the 
expression would remain fairly consistent with the change in GOI between the GFP, 
HRA:GFP, and R42A:GFP contexts or RFP, HRA:RFP, and R42A:RFP contexts.  
However, it is possible the N-terminal His6-tag may have more influence on gene 
expression than can be alleviated by the BCDs.  The discovery of a proper set of BCDs 
that would yield equal expression of these two variants, and at high levels, required 
further investigation. 
 
Combinatorial Engineering of Twelve Bicistronic Design Plasmids 
Cloning Strategy and Predictive Design of Aldolase Expression Constructs 
The range of expression under the various transcriptional and translational 
elements within the MoClo collection ranged from 200 to 51,000 molecules of equivalent 
fluorescein (MEFL) (Iverson, 2016) units measured using GFP and RFP reporters 
analyzed by flow cytometry (Iverson et al., 2016).  Specific promoters:RBS were 
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selected in the MoClo collection for constructing plasmids and subsequently testing for 
similar expression levels of GFP and RFP.  Five such plasmids for each fluorescent 
protein were tested for expression by in vivo flow cytometry (Table 3.2).  Among the 
GFP constructs, the _AE vector context tended to have higher expression compared to the 
same gene in an _EF vector.  However, this expression bias (based on vector context) 
was not observed with the RFP expression set.  Moreover, as the expression in the _EF 
transcription unit was the limiting factor for _AF dual expression plasmids (Iverson, 
2016), the two _EF vectors chosen showed similar expression for each CDS, as opposed 
to the _AE vectors.  The three _AE constructs in Table 3.2 were chosen to match these 
_EF plasmids with the expectation that they would balance the expression in dual _AF 
plasmids. With this demonstration of similar and high expression levels, these constructs 
were used for assembling dual expression plasmids, substituting the fluorescent protein 
coding sequences with those of the full-length aldolase variants (Figure 3.6). 
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Table 3.2 In vivo fluorescent protein expression for selecting 
MoClo plasmids with high and similar levels of expression 
Plasmidd Fluorescence (MEFL)a 
     GFPb          RFPc 
pJ06B12X_AE 7800  420 
7400  400 
8360  160 
5660  250 
5920    55 
11200  1100 
8300  1000 
18000    840 
13400  1300 
11530      70 
pJ07B2X_AE 
pJ07B12X_AE 
pJ02B2X_EF 
pJ02B12X_EF 
 
a MEFL is molecules of equivalent fluorescein measured by in vivo flow  
cytometry.  Values are the geometric mean and standard deviation of each  
plasmid. 
b Green fluorescent protein is abbreviated as GFP. 
c Red fluorescent protein is abbreviated as RFP. 
d Letter X refers to the coding sequence (GFP or RFP).  
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Figure 3.6 Plasmid design for aldolase dual expression.  The HRA-single expression plasmids 
(yellow plasmids containing black block arrows) were numbered 1-5 (pJ06B12HRA_AE(K), 
pJ07B2HRA_AE (K), pJ07B12HRA_AE(K), pJ02B2HRA_EF(K), pJ02B12 HRA_EF(K), 
respectively).  The R42A-single expression plasmids (yellow plasmids containing white block 
arrows) were numbered 6-10 (pJ06B12R42A_AE(K), pJ07B2R42A_AE(K), pJ07B12 
R42A_AE(K), pJ02B2R42A_EF(K), pJ02B12R42A_EF(K), respectively).  The selection marker 
gene, kanamycin (Kan in yellow block) (K), and colored circles containing capital letters indicate 
the relevant 4 bp MoClo fusion sites (red-A, purple-E, green-F).  Other designations of plasmid 
components are as in Figure 3.5, including the promoters with J0xBx designations.  In the 
Multiplexing MoClo reaction, _AE(K) fragments assemble into the first transcription unit in each 
dual expression cassette.  The _EF(K) fragments fill the second position that generated the 12 
dual expression plasmids depicted in green to the right with numbering indicating the 
combination of the single expression plasmids. 
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Five promoter:RBS combinations in the CIDAR MoClo Parts Kit were chosen 
based on the data in Table 3.2 as these configurations were expected to express a GOI in 
similar molar quantities.  To test whether these five promoter:RBS combinations 
expressed both aldolase variants at similar levels, an initial library of single expression 
units for each aldolase variant was constructed (Figure 3.6).  The single expression units 
for each aldolase variant were subsequently assembled, or multiplexed, into twelve dual-
expression plasmids (Figure 3.6).  It was anticipated that one or more of these constructs 
would express the two aldolase variants at roughly equimolar amounts in high yield. 
 
Co-Expression Analysis of Dual Expression Library 
Western Blot Analyses Show High and Relatively Equal Expression Across All Twelve 
Vectors in the Library 
To analyze expression of HRA and R42A using the MoClo system, western blots 
were performed using bacterial lysates from each expression clone for comparison of 
protein levels (Figure 3.7).  Expression of either aldolase variant in the single expression 
plasmids (1-10) was similar and at high levels as determined by immunoblotting with an 
aldolase antibody (Figure 3.7A).  There was a discernable size difference between the 
two variants.  This difference allowed for the analysis of stoichiometric expression of 
HRA and R42A during co-expression by all twelve dual expression clones (Figure 3.7B).  
Purified homotetramers of either the HRA and R42A variant protein standards were 
subjected to electrophoresis alongside to show the difference in migration due to the ~1  
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Figure 3.7 Relative expression of HRA and R42A from single and dual expression plasmids. 
Bacterial lysates from equal numbers of cells measured by optical density (O.D.) were separated 
by SDS-PAGE and western blotted to test for expression from the 10 single expression plasmids 
and the 12 dual expression plasmids described in Figure 3.6, as well as for controls of purified 
HRA and R42A aldolases.  A. Expression of HRA and R42A single-expression plasmids using 
anti(α)-aldolase antibody (designated at the right).  Clones are designated above as defined in 
Figure 3.6.  B. Expression of HRA and R42A double-expression plasmids (designated above as 
described in Figure 3.6) detected using α-aldolase antibody.  The HRA and R42A aldolases 
migrated at 41 kDa and 40 kDa, respectively (left).  C. Detection of the HRA expression only in 
dual-expression plasmids using HisProbe-HRP Conjugate.   
 
 
kDa difference in subunit size due to the His6-tag on the WT variant.  For confirmation 
that the slower migrating protein was the HRA with its His6-tag, a similar blot was 
probed using HisProbe-HRP Conjugate.  The 41 kDa HRA, but not the 40 kDa R42A 
subunit, was clearly detected (Figure 3.7C).  Expression of both HRA and R42A was 
observed across the entire set of dual expression plasmids with the majority of cassettes 
having nearly equal expression of both variants.  However, slight biases were seen in 
several of the constructs.  Plasmids 1-10 and 2-10 showed lower R42A expression.  
Furthermore, 2-10, 3-10, and 8-4 in particular had noticeably higher expression of HRA 
compared to the rest of the constructs, replicating the results seen in the blot probing for 
A 
B 
C 
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only the HRA subunit (Figure 3.7C).  In contrast, a bias toward higher R42A expression 
was not apparent in any of the samples.  High levels of HRA expression were observed in 
all dual expression plasmids with nearly equal levels in 2-9, 6-4, 6-5, and 7-4. 
 
Selection of 6-5 Construct for Purification 
Class I aldolase isozymes produce mixed tetramers, both in vivo and in vitro 
(Penhoet and Rutter, 1971).  Thus, hetero- and homo-tetramers of these isozymes can 
form from random subunit combinations and produce a five-membered set (Penhoet and 
Rutter, 1971).  This observation was in fact used to establish aldolase as a tetrameric 
protein (Penhoet et al., 1967).  Based on this knowledge, the two variants of aldolase A, 
HRA and R42A, were predicted to associate in the same fashion if produced in equal 
amounts (Figure 3.8).  The dual expression plasmid 6-5 appeared to yield both high and 
equal expression of HRA and R42A subunits (Figure 3.7B), therefore, it was expected for 
the mixed tetramers to show a five-membered set, if they could be separated.   
Verification of tetramer hybridization was performed on the purified aldolase set 
expressed using the 6-5 plasmid (Figure 3.9).  The purified 6-5 aldolase set was subjected 
to analytical cation-exchange chromatography using conditions that easily separated the 
individually-purified homotetramers (Figure 3.9A).  The bound 6-5 aldolases were eluted 
with a linear salt gradient (0-0.25 M), which showed a heterogeneous population of 
species (Figure 3.9B) consistent with the predicted pattern of hybridization (Figure 3.8).  
Species eluting first were predominated by R42A subunits (Figure 3.9C), which were 
predicted to have a lower positive charge.  Species eluting last were predominated by  
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Figure 3.8 Schematic of the five-membered set of aldolase tetramers from the HRA and 
R42A variants of aldolase A.  (Left) Each subunit is depicted as a hexagon such that the two 
distinct interfaces (A (side) and B (vertex)) are depicted.  (Box) The R42A-F-actin-binding 
deficient (– below) variant (white) and the HRA-F-actin-competent (+ below) variant (lavender) 
in all possible combinations are within the box.  The predicted relative net charge due to the 
presence of the His6-tag is depicted as a gradient at the bottom.  Only the three possible subunit 
combinations resulting in 2:2 heterotetramers (dashed box), and the HRA-enriched tetramers, are 
predicted to bind F-actin, which requires two adjacent subunits for bimodal binding to F-actin.   
 
  
- 
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Figure 3.9 Analytical ion-exchange chromatography separates heterotetramers in dual 
expression plasmids.  A. Purified HRA (black) or R42A (red) were separated using a linear NaCl 
gradient (0-0.5 M depicted as a percentage of the gradient on the right) on a HiTrap SP FF 
column at 0.5 mL/min.  B. The hybrid set of aldolase heterotetramers from the 6-5 expression 
plasmid (blue) were separated as in Panel A except at 2 mL/min.  Protein in each fraction was 
monitored by absorbance at 280 nm (y-axis).  C. Protein fractions from the highest peak 
(containing 7-13 µg) across the separation depicted in Panel B were analyzed by SDS-PAGE.  
One percent of each fraction volume was loaded onto the gel.  Migration of variants at 41 and 40 
kDa is indicated (right). 
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HRA subunits (Figure 3.9C), which were predicted to have a more positive charge due to 
the added His6-tag.  Although the differences in net charge were insufficient to yield five 
distinctly observable peaks under these conditions, the elution profile indicated that a 
heterogeneous population of tetramers was produced (Figure 3.9B).   
The use of expression engineering described in this chapter was undertaken due to 
the failure of more traditional methods in producing heterotetramers composed of both 
wild-type and variant subunits of the aldolase A isozyme for structural studies with F-
actin.  The CIDAR MoClo system enabled the generation of hybrid tetramer sets of 
aldolase A variants that exhibited modulated F-actin binding.  These results demonstrate 
the first successful case study for a biological application of the CIDAR MoClo 
technique.  The heterotetramers produced were subsequently used for electron 
microscopy studies with decorated F-actin, which are described in Chapter 4. 
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CHAPTER 4: ELECTRON MICROSCOPIC STUDIES OF THE ALDOLASE-F-
ACTIN COMPLEX  
 
INTRODUCTION 
 
In the majority of eukaryotic cells, actin is the most abundant protein, existing at 
concentrations of 50-200 µM (Pollard, 2016).  The actin filament is a highly conserved 
structure, and actin dynamics play a role in a host of cellular functions (DeRosier and 
Tilney, 1984; Dominguez and Holmes, 2011). Complex cell processes from the formation 
of PM-protrusive structures such as pseudopodia, filopodia, and lamellipodia for motility 
(Alberts et al., 2002) to the control of cell shape (Chalut and Paluch, 2016), vesicular 
trafficking pathways (Pollard and Cooper, 2009), regulation of transcription (Miralles and 
Visa, 2006), and cytokinesis (Miller, 2011; Chen et al., 2017) all depend upon the 
structural dynamics of F-actin.   
Actin binds to a larger number of proteins than any other known protein (Pollard 
and Cooper, 1986; Dos Remedios et al., 2003; Dominguez and Holmes, 2011).  Proteins 
that interact with actin have been found to regulate actin assembly through nucleation 
(Goode and Eck, 2007), elongation (Ferron et al., 2007; Paul and Pollard, 2009; Hansen 
and Mullins, 2010; Edwards et al., 2014), capping of barbed (Courtemanche and Pollard, 
2013) or pointed ends (Rao et al., 2014), severing (Harris et al., 2004; Andrianantoandro 
and Pollard, 2006; Nag et al., 2013; Gurel et al., 2014), branching (Rouiller et al., 2008), 
or crosslinking filaments (Matsudaira, 1994; Xu et al., 1998).  As described in Chapter 1, 
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aldolase was identified as an actin-binding protein over fifty years ago (Arnold and Pette, 
1968), with early studies establishing the ability to crosslink F-actin in vitro (Walsh et al., 
1980; Wang et al., 1996; Sukow and DeRosier, 1998).  Although aldolase has been 
linked to non-glycolytic functions involving F-actin (Ritterson Lew, 2012), the biological 
significance of this structural interaction is unclear.    
A high-definition structure of the aldolase-F-actin complex resolving the binding 
interface has not been achieved.  Several fundamental challenges have thwarted efforts to 
solve the structures of many actin-binding proteins complexed with F-actin, including 
aldolase.  Due to the tendency of actin to spontaneously polymerize into filaments, it has 
not been possible to obtain the structure of F-actin by x-ray crystallography (Reisler and 
Egelman, 2007; Pollard, 2016).  Co-crystallization with either DNase I (Kabsch et al., 
1990) or profilin (Schutt et al., 1993) provided structures of monomeric G-actin.  
However, the highest resolution structures of F-actin to date are from electron 
micrograph reconstructions and x-ray fiber diffraction models of actin filaments (Oda et 
al., 2009; Fujii et al., 2010; von der Ecken et al., 2014).  Although plausible models have 
been proposed for F-actin (Holmes et al., 1990) and medium-resolution X-ray diffraction 
data obtained (Popp et al., 1987; Oda et al., 2001), no atomic resolution structure 
currently exists.  Additionally, the disorder in crosslinked filaments and presence of 
bundled aggregates does not lend to precisely determining the binding interface between 
F-actin and proteins that produce this effect in solution (Sukow and DeRosier, 2003).  
Thus, resolving the structure of F-actin complexed with a crosslinking protein such as 
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aldolase has necessitated the use of alternative methods that can remove or work around 
this heterogeneous bundling issue.   
The F-actin structure consists of two chains forming a right-handed helix (Hanson 
and Lowy, 1963; Holmes et al., 1990; Graceffa and Dominguez, 2003).  Initial EM 
studies aimed at solving the structure of the aldolase-F-actin complex showed that 
D128V dimer variants of aldolase can decorate the F-actin helix without crosslinking, 
and that tetramers of aldolase can crosslink and connect actin filaments together (Pirani, 
2008).  Due to the rotational symmetry of dimeric aldolase, however, the binding site 
could not previously be determined by helical reconstruction and docking of the D128V 
crystal structure.  A structural comparison of the WT aldolase tetramer and D128V dimer 
is shown in Figure 4.1A.   
We predict that an asymmetric binding unit will lend itself to resolving the 
interface using EM.  As described in the previous chapter, the native structure of aldolase 
contains two distinct subunit interfaces that can be utilized for this purpose.  The tetramer 
exhibits two distinct dimer interfaces that are observable from rotational views of the 
molecule (Figure 4.1B).  Based on previous cryo-EM studies (Pirani, 2008), it was 
hypothesized that each half-tetramer joined at the B-interface could serve as the minimal 
actin-binding unit.  An approach is presented in this chapter that entailed testing the 
chimeric aldolase tetramers produced by modular cloning (see Chapter 3) for use in cryo-
EM reconstruction methods to afford a high-resolution structure of the aldolase-F-actin 
complex.  Solving the structure will shed light on the relevance of quaternary structure 
integrity for transient cytoskeletal interactions and roles of aldolase in the cell that 
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Figure 4.1 Rabbit aldolase A crystal structures.  A. Side-by-side structures of homo-tetrameric 
and dimeric aldolases are shown (PDB: 1ADO and 3BV4, respectively).  Each half-tetramer of 
wild-type (WT) aldolase is colored differently (in red and blue) for 90° rotational viewing and to 
highlight the interface in which Asp128 substitution dissociates aldolase into stable dimers 
(Beernink and Tolan, 1994).  The crystal structure of the D128V dimer variant is shown in violet 
on the far right for comparison (Sherawat et al., 2008).  B. Three views of wild-type aldolase 
related by 45° (middle) and 90° rotations (far right) are shown.  Protein subunits are shown in 
different colors to demonstrate the overall structure of the homotetramer.  For simplicity, only the 
carbon backbone (Cα trace) is depicted.  
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involve multi-subunit binding.  Mutations that disrupt aldolase quaternary structure are 
linked to impaired red blood cell structure and muscle pathologies (Beernink and Tolan, 
1994; Kreuder et al., 1996).  Understanding this interaction is fundamental for producing 
more definitive models of moonlighting mechanisms and critical roles of aldolase.   
 
F-ACTIN CO-SEDIMENTATION ANALYSIS: ACTIN PULLDOWN ASSAYS 
 
Actin-Binding of Five-membered Mixed Tetramer Set Falls Between WT and Binding-
Deficient Aldolases 
As described above, previous unpublished studies have determined that dimeric 
aldolase can bind to and decorate F-actin (Pirani, 2008; Ritterson Lew, 2012).  Therefore, 
it was predicted that chimeric tetramers composed of two more HRA subunits would 
show similar binding.  To test for direct binding and co-sedimentation with F-actin, actin 
pulldown assays were performed as described in Figure 4.2.  The 6-5 mixed aldolase 
tetramer set produced by MoClo was tested for differences in F-actin-binding from 
purified preparations of HRA and R42A homotetramers (Figure 4.3).  As predicted in 
Chapter 3, the amount of actin-bound aldolase using the 6-5 mixed tetramer population 
was expected to fall between that of the HRA and R42A controls (see Figure 3.8). 
SDS-PAGE was used to analyze the supernatant and pellet fractions from each 
reaction and compare the amounts of aldolase bound in each sample (Figure 4.3A).  The 
control R42A and HRA variants showed most of the aldolase in either the supernatant 
fraction or pellet fraction, respectively.  These data corroborated the respective lower and  
 116 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 Actin co-sedimentation workflow.  Actin polymerization is initially induced by the 
addition of ATP and divalent cations to purified G-actin monomers.  Protein samples of interest 
such as aldolase (depicted as blue tetramers in the diagram) are added to the F-actin and allowed 
to incubate.  The filaments, along with any bound protein(s), are pelleted by ultracentrifugation.  
Unbound molecules remaining in the supernatant fraction are removed and separated from the 
sample prior to processing each fraction for analysis. 
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Figure 4.3 Modulation of aldolase-actin interaction by heterotetramer sets produced from 
dual expression plasmids.  A. In vitro F-actin co-sedimentation assays with purified R42A, 6-5, 
2-10, and HRA aldolases were performed and analyzed by SDS-PAGE by separation of equal 
fractions of protein in the pellet (P) and supernatant fractions (S).  Control reactions to account 
for any aggregated aldolase appearing in the pellet fractions without F-actin were negative (not 
shown).  The migration of actin (43 kDa) and aldolase (40-41 kDa) are indicated on the left.  B. 
Densitometry analysis of the electropherogram calculated the ratio of aldolase bound to F-actin to 
unbound.  Errors in the densitometry at 2𝞂 are indicated.  P<.0001 between 6-5 and 2-10 as 
determined by t-test. 
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higher F-actin-binding capacity of these particular aldolase variants as has been 
previously observed (Wang et al., 1996).  Chimeric aldolases produced by dual 
expression, the so-called 6-5 aldolase, showed an intermediate ratio of supernatant:pellet 
fractions (Figure 4.3B), suggesting the presence of a mixture of tetramers composed of a 
fraction of aldolase species unable to bind actin in addition to a fraction of species with 
retained actin-binding ability (see Figure 3.8).  As there is more than one way for 2:2 
heterotetramers to form through mixing of subunits, these hybrid species were expected 
to comprise the majority of tetramers in the 6-5 aldolase set.  Therefore, the extent of co-
sedimentation with F-actin observed in these results more likely represents binding by 
heterotetramer species rather than merely an average of the pool of HRA-bound and 
unbound R42A homotetramers. 
In addition to the 6-5 sample, a mixed aldolase set was purified from the 2-10 
dual expression plasmid, which has its expression skewed towards HRA over R42A (see 
Figure 3.7B).  More aldolase tetramers in this prep should bind to F-actin.  Indeed, the  
2-10 sample showed more aldolase bound in the pellet fraction compared to the 6-5 
sample (Figure 4.3).  Based on these results, the stoichiometry seen earlier is consistent 
with modulated actin-binding based on the predominance of HRA versus R42A variant 
subunits present within the total population of each tetramer set. 
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SEPARATION OF MIXED TETRAMER SPECIES 
 
Native Zone Electrophoresis of the 6-5 Aldolase Set 
Due to the presence of the His6-tag on each WT aldolase subunit and loss of 
positive charge from Arg42 on R42A subunits, it was expected that differences in net 
charge would exist between the various tetramer species in the 6-5 mixed aldolase set 
based on subunit composition.  Analytical ion-exchange chromatography further 
supported this model, however, an elution pattern showing five separate peaks was not 
observed (see Chapter 3).  Separation of a five-membered set has been readily observed 
for hybrid tetramers composed of subunits from different aldolase isozymes by native-
zone electrophoresis (Penhoet and Rutter, 1971).  To test the separation of aldolase 
species in the 6-5 set under non-denaturing conditions, native-zone electrophoresis, or 
zymography, was performed (Figure 4.4).  Purified HRA and R42A protein controls were 
subjected to electrophoresis separately and mixed together to demonstrate differential 
migration (Figure 4.4B).  Three experimental samples from the MoClo dual expression 
library were subjected to electrophoresis alongside for comparison (Figure 4.4C).   
As had been seen with chromatography, the banding pattern that resulted in the 
zymogram did not clearly indicate a five-membered set (Figure 4.4C).  Rather, a large, 
uniform smear was observed for each sample.  In contrast, the purified aldolase A 
controls showed mostly concentrated bands in the expected direction of migration for 
each variant, indicative of relatively homogeneous samples (Figure 4.4B).  Together with 
the previous ion-exchange chromatography results (see Figure 3.9) and those observed  
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Figure 4.4 Aldolase zymograms for separation of enzyme molecules differing in net charge.  
A. The general schematic for a zymogram is depicted.  Samples with active enzyme are applied to 
a cellulose acetate membrane and subjected to electrophoresis under non-denaturing conditions.  
Negative (black circled) and positively charged (red circled) ends indicate the direction of the 
electrical current and migration of applied enzyme molecules according to net charge.  Bands are 
visualized as a purple precipitate via direct activity staining of the membrane (see Chapter 2).  
The theoretical migration pattern for the 6-5 set is depicted in the leftmost lane with 
corresponding HRA (H) and R42A (R) subunit combinations for each species indicated.  (The 2:2 
species is depicted as a darker band to indicate higher predicted amounts.)  B. A zymogram 
containing purified HRA and R42A controls is shown.  The purified controls were mixed together 
and subjected to electrophoresis alongside the homotetramer samples.  C. A zymogram is shown 
containing E. coli extract samples prepared from 6-5, 7-5, 2-9, and 1-9 dual expression clones.  
For all zymogram samples, 0.01-0.06 U of enzyme was applied to the membrane.  
Abbreviations: HRA, His6-tagged rabbit aldolase A; R42A, R42A rabbit aldolase A. 
 
 
for other hybrid mixtures (Penhoet et al., 1966; Rutter et al., 1968; Gibbons, 1973; Swain 
and Lebherz, 1986), these data suggested the difference in net charge between 6-5 species 
was not sufficiently large for adequate separation using these techniques and would likely 
require further optimization or more precise approaches such as isoelectric focusing.   
  
A B C 
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Isolation of His6-tagged Species by Nickel-Chelate Chromatography 
 For preparing aldolase that would bind but not crosslink F-actin in EM studies, 
additional methods to isolate the desired 2:2 heterotetramers of aldolase from duel-
expression plasmids were pursued.  As methods of separation by charge had proven to be 
challenging with the 6-5 population of tetramers (see Chapter 3), the His6-tag was 
exploited to purify these tetramers by nickel chelate chromatography.  As the R42A 
homotetramer species would not bind to nickel resin, it was expected to result in the 
removal of R42A from the mixed set and potentially improve peak-to-peak resolution of 
the remaining aldolase hetero-oligomers.  The purified 6-5 aldolase mixture was applied 
to a nickel column and eluted with a linear imidazole gradient of varying steepness 
(Figure 4.5A-C).  The steepness of the gradient was decreased for each subsequent trial 
after collection and re-application of the same sample. 
In the first trial using a 0-500 mM gradient, the entire sample had eluted by about 
30% of the maximum gradient concentration (Figure 4.5A).  A broader peak more 
suggestive of heterogeneity was observed in the second trial, where the same sample was 
eluted using a 0-100 mM imidazole gradient (Figure 4.5B).  The heterogeneity was 
confirmed in the third nickel column trial using 0-50 mM imidazole, where the sample 
had eluted as two peaks (Figure 4.5C).  Using this method, aldolase species comprised of 
more HRA subunits were expected to elute later than those containing fewer.  A western 
blot probing for aldolase A appeared to support this notion (Figure 4.5D), though it was 
difficult to determine if a doublet band was present in earlier peak fractions that would 
indicate species containing both HRA and R42A subunits.  Although the third nickel  
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Figure 4.5 Nickel chelate chromatography improves peak resolution of 6-5 aldolase.  The 
same sample of purified 6-5 aldolase (3 mg total) was applied to a HisTrap HP column at 1 
mL/min for three separate trials, each with an adjusted linear imidazole gradient steepness for 
elution.  Protein in each fraction (blue curve) was monitored by absorbance at 280 nm (left y-
axis).  The imidazole concentration gradient is indicated on the right secondary y-axis (orange).  
A. The initial sample was eluted using a linear imidazole gradient from 0-500 mM. (The end of 
the gradient is not shown.)  B. The peak fraction from Panel A was collected and re-applied on 
the same column.  The steepness of the imidazole gradient was adjusted to 0-100 mM.  C. The 
peak fraction was collected from Panel B and applied once more on the same column, this time 
eluting with an imidazole gradient from 0-50 mM.  D. Aliquots taken from each trial of the eluate 
fraction with the highest absorbance for each peak were analyzed by western blot.  One percent 
of each fraction volume was used for the SDS-PAGE gel.  An anti-aldolase A antibody was used 
for detection of both HRA (41 kDa) and R42A (40 kDa).  Purified HRA and R42A controls were 
included in the blot, but are not shown due to faint bands.  Letters A, B, C, and C’ correspond to 
the pink, boxed letters shown above each peak from which a sample aliquot was taken.   
A 
B 
C 
D 
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column elution profile indicated additional separation was achieved, it was not fully 
discernible which tetramer species remained in each peak (Figure 4.5C-D). 
 
NEGATIVE STAINING ELECTRON MICROSCOPY OF ALDOLASE VARIANT 
INTERACTIONS WITH F-ACTIN 
 
F-actin Bundling Assays with Purified Aldolase Variants 
 
To further assess the potential for the use of aldolase variants in cryo-EM studies 
and structure determination by helical-reconstruction methods, F-actin binding of the 6-5 
aldolases was compared with that of other aldolase variants using negative staining EM 
(Figure 4.6).  Negatively-stained samples analyzed for bundling included an F-actin 
control, dimerized D128V aldolase (Beernink and Tolan, 1994), stabilized variant of WT 
aldolase referred to as gtet (Choi et al., 2001), R42A homotetramer negative control, 
HRA homotetramer, and the 6-5 mixed aldolase set.  In the D128V sample, filaments 
were fully decorated by dimeric aldolase without crosslinking (Figure 4.6B), as has been 
previously shown (Pirani, 2008).  The two control variants mimicking WT aldolase, gtet 
(Figure 4.6C) and HRA (Figure 4.6E), showed extensive bundling.  Bundling by HRA 
appeared extensive as almost no single actin filaments were observed, confirming 
pulldown data (Figure 4.3) that demonstrate the His6-tag does not impact actin-binding.  
Conversely, bundling by the R42A variant was completely absent and only single 
filaments of actin were seen along with unbound R42A molecules in the background 
(Figure 4.6D).  This result was expected as negatively-stained R42A mixed with F-actin 
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Figure 4.6 Negative staining EM of purified preparations of aldolase variants mixed with F-
actin.  Samples were stained in 0.75% uranyl formate and micrographs acquired using a JEOL 
1200EX transmission electron microscope.  F-actin was prepared at a 12 µM concentration for all 
samples.  All electron micrographs are shown at 50000× magnification.  Scale bar is 100 nm.  
Insets of boxed areas are shown at 3× larger magnification.  A. F-actin alone is shown.  B. 
D128V aldolase (3 µM) mixed with F-actin.  C. gtet aldolase (3 µM) mixed with F-actin.  D. 
Actin-binding deficient R42A aldolase (1 µM) mixed with F-actin.  E. HRA (3 µM) mixed with 
F-actin.  F. 6-5 aldolase tetramer set (3 µM) mixed with F-actin.   
 
  
A B 
C D 
E F 
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has been shown to appear identical to F-actin alone (Wang et al., 1996).   
The 6-5 aldolase set showed an effect that was intermediate to the HRA and 
R42A controls (Figure 4.6F), which coincided with the data from actin-pulldown 
experiments described earlier (Figure 4.3).  Due to presence of HRA homotetramer in the 
mixture, some crosslinking was observed, but to a lesser extent than that with WT 
aldolases.  Single filaments were present throughout and appeared to have small 
protrusions that suggested decoration of the helices by aldolase tetramers (Figure 4.7).  
Due to high saturation of background aldolase molecules, these results needed further 
optimization of aldolase:actin concentrations and viewing at higher resolution for 
confirmation. 
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Figure 4.7 Decoration of F-actin by 6-5 aldolase.  Purified F-actin was mixed with the 6-5 
aldolase set.  Samples were stained in 0.75% uranyl formate and micrographs acquired using a 
JEOL 1200EX transmission electron microscope.  F-actin was prepared at a 12 µM concentration 
for all samples.  The micrograph is shown at 30000× magnification.  Scale bar is 100 nm.  The 
inset shows a 2× close-up of the area where single, decorated filaments are indicated. 
 
 
Partial Depolymerization of F-actin For Single-Particle Analysis 
 
In addition to the samples of F-actin mixed with aldolase described above, 
samples of aldolase-bound actin were prepared for potential structural determination via 
cryo-EM single-particle analysis.  As helical reconstruction methods would require a 
sufficient number of decorated actin filaments that are straight and highly ordered to 
produce a 3-D model (Al-Khayat et al., 2005), it is generally ideal and more efficient to 
utilize single-particle analysis if possible (C. Xu, personal communications).  To assess 
whether production of particles of actin-bound aldolase is feasible, partial 
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depolymerization of F-actin was performed.  As aldolase has no appreciable binding to 
G-actin (J. Ho, unpublished studies), the purified 6-5 tetramer set was first bound to F-
actin and depolymerization of the filaments subsequently induced by removal of salts 
from the buffer solution (Pardee and Spudich, 1982).   
The samples were visualized by negative staining EM at varying time points up to 
3 d after depolymerization was initiated (Figures 4.8 and 4.9).  The majority of actin 
filaments in control (Figure 4.8A) or 6-5 aldolase-bound samples (Figures 4.8A and 4.9) 
appeared almost completely depolymerized after 3 d.  In the F-actin negative control 
(Figure 4.8A), long and relatively straight filaments remained after 1 d.  However, larger 
particles or clumps remained after 3 d, suggesting the persistence of oligomers in solution 
that would require additional dialysis time to completely dissociate into monomers.  
Oligomers composed of four or more actin monomers are significantly more stable 
structures than dimers or trimers of actin (Pollard, 2016).   
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Figure 4.8 Negative staining EM of partially-depolymerized F-actin samples.  Samples were 
stained with 0.75% uranyl formate and imaged on a Tecnai G² Spirit BioTWIN Transmission 
Electron Microscope.  All micrographs are shown at 68000× magnification.  Scale bar is 50 nm.  
A. Purified actin (12 µM) was polymerized in solution and subsequently depolymerized for up to 
3 d.  A negative control F-actin sample (not subjected to depolymerization) is shown in the top 
panel.  The center panel shows F-actin after 1 d of depolymerization.  The bottom panel shows F-
actin after 3 d of depolymerization.  B. F-actin (12 µM) mixed with the 6-5 aldolase tetramer set 
(3 µM) was depolymerized for 1 d (top), 2 d (center), and 3 d (bottom).         
A B 
0 d 
1 d 
3 d 
1 d 
2 d 
3 d 
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Figure 4.9 Negative staining EM of partially-depolymerized F-actin and 6-5 aldolases.  The 
purified 6-5 aldolase set (6 µM) was mixed with F-actin (12 µM) in vitro and depolymerized for 
2-3 d as indicated.  Each sample was stained with 0.75% uranyl formate and imaged on a Tecnai 
G² Spirit BioTWIN Transmission Electron Microscope.  Micrographs are shown at 98000× 
magnification.  Scale bar is 50 nm.   
2 d 
3 d 
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Notably, the pattern of actin-filament disassembly in the presence of aldolase 
differed from that of F-actin alone (Figure 4.8B).  The partially-depolymerized filaments 
in aldolase-containing samples appeared intact with curved stretches throughout (Figures 
4.8B and 4.9).  Large clusters were present at the 2 d time point, which were generally 
absent at 3 d.  These data suggest the likelihood of aldolase remaining bound to portions 
of F-actin, though it is difficult to discern at this resolution if individual aldolase 
tetramers are bound to actin due to sample saturation and the similarity in size of actin 
monomers (43 kDa) and subunits of aldolase (~40 kDa).  As negative staining is often 
used for prescreening cryo-EM samples, these results were used to determine appropriate 
dilutions for plunge-freezing the actin with 6-5 aldolase sample.   
 
CRYO-EM ANALYSIS OF ALDOLASE BOUND TO F-ACTIN 
 
 To assess whether helical-reconstruction could be used to model the aldolase-F-
actin structure, fully-polymerized F-actin was decorated with the 6-5 mixed aldolase set 
as done for negative staining.  The sample was applied to carbon grids and plunge-frozen 
in liquid ethane for vitrification (Thompson et al., 2016).  Cryo-EM data were collected 
and analyzed in collaboration with Dr. Chen Xu (UMass Medical School).  A 
representative image from the data set is shown in Figure 4.10.  Although single actin 
filaments and aldolase tetramers were observed, the majority of filaments in the grids 
prepared were not entirely straight.  Some crosslinking was still present, and it was 
difficult to find filaments that were uniformly decorated with aldolase during image  
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Figure 4.10 Representative cryo-EM image of the 6-5 aldolase set complexed with F-actin.   
Purified F-actin decorated with the 6-5 aldolase set was applied to a glow-discharged carbon grid 
and plunge-frozen in liquid ethane.  A micrograph from the cryo-EM data set is shown at 45000× 
magnification.  Images were acquired using a Talos Arctica transmission and scanning electron 
microscope.  A red arrowhead is shown pointing to an F-actin filament, and a blue arrowhead is 
shown pointing to an aldolase molecule. 
 
 
processing.  It was deemed that the sample concentrations needed to be troubleshot to 
obtain higher quality data if a helical-reconstruction approach was to be pursued.   
 
Partial 3-D Reconstruction of the Aldolase-F-actin Complex 
 
In order to potentially collect more high-quality images of the aldolase-F-actin 
complex for reconstruction, F-actin was decorated with 6-5 aldolase and depolymerized 
in preparation for single-particle analysis.  Based on negative stain results, the sample 
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was diluted at several different concentrations and plunge-frozen.  A cryo-EM data set 
was collected and analyzed (see Figures 2.2 and 2.3) by Dr. Kyounghwan Lee (UMass 
Medical School).   
An incomplete preliminary model based on these results is shown in Figure 4.11.  
The current resolution is at approximately 7 Å.  The recognizable structure of the 
aldolase tetramer can be seen clearly in the model.  Additional density is present around 
the aldolase molecule, which is expected to originate from actin bound to one side of the 
tetramer as predicted (C. Xu and K. Lee, personal communications).  A cryo-EM data set 
from a purified sample of aldolase alone is in the process of being collected to compare 
and further refine the current model.  Upon completion of this project, we expect to 
produce a model of the first high-resolution structure of the aldolase-F-actin complex.   
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Figure 4.11 Partial 3-D model of the aldolase-F-actin complex.  Single-particle analysis was 
used to reconstruct the aldolase-F-actin interaction from a depolymerized sample of F-actin 
decorated with 6-5 aldolase.  Four 90° rotational views of aldolase (left column) or aldolase 
complexed with actin (right column) are shown.  The preliminary model was generated by Dr. 
Kyounghwan Lee (using methods described in Chapter 2).  The resolution is approximately 7 Å.   
 134 
CHAPTER 5: INVESTIGATION OF THE FUNCTIONAL ROLE OF ALDOLASE 
IN ENDOCYTOSIS 
 
INTRODUCTION 
 
Cells inherently possess membrane elastic forces and cytosolic turgor pressure 
(Boulant et al., 2011).  As a result, the resistance must be overcome in order to fully 
execute processes such as clathrin-mediated endocytosis (CME).  Though clathrin 
stabilizes an endocytic pit during maturation, clathrin cages are not sufficient to create 
membrane curvature (McMahon and Boucrot, 2011).  Many adaptor proteins that bind to 
clathrin connect triskelia to the protein coat through flexible appendages.  For scission to 
occur, the membrane must be sufficiently deformed, constricted, and destabilized.  The 
proteins thought to perform this function are BAR domain proteins, dynamin, and actin 
machinery.  BAR domain proteins sculpt the neck of the forming vesicle via tubulation.  
Dynamin associates only after the neck has been sufficiently narrowed (Lundmark and 
Carlsson, 2010; Boulant et al., 2011).  Branched actin polymerization appears to provide 
the mechanical force for inward movement of the bud (Kaksonen et al., 2006).  How all 
of the scission module proteins are recruited and function together in late stage CME is 
not entirely clear (Rao et al., 2011).   
Aldolase has been implicated in the precise order and timing of late-stage events 
in endocytosis (Lundmark and Carlsson, 2005; 2009).  As described in Chapter 1, studies 
with two binding partners, WASP and SNX9, suggest that aldolase may be moonlighting 
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as a scaffold protein (Rangarajan et al., 2010; Lew and Tolan, 2013).  WASP is a 
nucleation-promoting factor (NPF) that activates the Arp2/3 complex, which in turn 
significantly enhances nucleation of branched actin networks (Zhang et al., 2005).  
Binding of WASP at the VCA domain induces a conformational change, although the 
exact mechanism has yet to be delineated (Rotty et al., 2013).  SNX9 is a BAR domain 
protein that appears to have a pertinent role in recruiting and activating dynamin prior to 
the scission reaction (Lundmark and Carlsson, 2003; 2004).  The binding of SNX9 to 
WASP has been reported to activate Arp2/3 through an unknown mechanism (Takenawa 
and Suetsugu, 2007; Lundmark and Carlsson, 2009).  A potential scaffolding role for 
aldolase in this process could serve at least two purposes: 1) to sequester the active 
domains of WASP and SNX9 prior to scission, and 2) to sufficiently concentrate WASP 
and SNX9 at sites of endocytosis through association of aldolase with cortical F-actin.  
This scaffolding would effectively sequester each protein until the specific function of 
each is required, enabling release at the appropriate points and in the proper sequence.  
Timing is particularly critical at the scission step and occurs on the order of seconds 
(Kaksonen et al., 2006). 
 Previous studies have linked aldolase to membrane and cytoskeletal dynamics 
during this process via interactions with SNX9, WASP, and F-actin (Buscaglia et al., 
2006; St-Jean et al., 2007; Lundmark and Carlsson, 2009; Rangarajan et al., 2010).  All 
three of the latter proteins have been shown to be enriched at sites of endocytosis 
(Takenawa and Suetsugu, 2007; Lundmark and Carlsson, 2009).  Though it has been 
suggested that aldolase may be interacting with these proteins in this pathway, there are 
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no published studies directly probing the function of aldolase during endocytosis.  This 
chapter will expand upon preliminary findings that suggest upregulation of endocytosis in 
knockdown cells (C. Ritterson Lew, unpublished studies), and further explore the modes 
of internalization relevant to this potential moonlighting role.   
Due to its ubiquitous expression and essential role in metabolism, aldolase A 
cannot be completely ablated as knockout results in lethality (Ritterson Lew and Tolan, 
2012).  Therefore, RNAi was used to knock down expression of aldolase in the present 
studies.  BSC1 cells were chosen for experimentation.  This mammalian cell line is 
derived from African green monkey kidney epithelial cells and is widely used to model 
CME (Traub, 2009) because > 95% of clathrin-coated pits observed exhibit uniform size 
and dynamics in unperturbed cells.  Two additional cell lines, COS-7 and HeLa, were 
included and have been commonly utilized in studies of endocytosis (Motley et al., 2003; 
Hansen and Nichols, 2009; Traub, 2009; Yoshida et al., 2018).  Establishing the role of 
aldolase in vesicle trafficking will open new avenues for studying non-canonical 
mechanisms that have been previously unexplored. 
 
ALDOLASE KNOCKDOWN IN CELL LINE MODELS OF ENDOCYTOSIS 
 
Testing of siRNAs Targeting Aldolase A in Monkey and Human Cell Lines 
Depletion of aldolase for moonlighting studies has been previously shown using 
siRNA-mediated gene silencing.  The siRNAs used in former studies were optimized for 
targeting mouse aldolase A, demonstrating ≥ 70-80% knockdown efficiency in various 
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mouse and rat cell lines (Ritterson Lew, 2012).  In addition, these siRNAs were designed 
to contain minimal sequence identity to rabbit aldolase A for the purpose of rescue 
experiments.  To test whether the same siRNAs could potentially be used in monkey and 
human cell lines for endocytosis studies, the sequences of three siRNAs designed by Dr. 
Carolyn Ritterson Lew were aligned to monkey and human aldolase A sequences using 
Clustal Omega (Madeira et al., 2019) (Figure 5.1).  The monkey and human aldolase A 
showed high CDS and amino acid sequence identity—82.5% and 99.5%, respectively 
(see Appendix I).  Two of the three siRNAs yielded a low number of matches: 
siRNA_287 (referred to in this thesis as siAldolase A 287 [mouse/rat]) and siRNA_1171.  
The third sequence, siRNA_1301, targets the 3' untranslated region (3' UTR) of mouse 
and rat, and showed minimal base-pair matches to monkey or human sequences.  The 
siRNA with the lowest number of mismatches, siAldolase A 287 (mouse/rat), was 
selected for initial knockdown studies in primate cell lines.   
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Figure 5.1 Alignment of siRNA and aldolase cDNA sequences.  The sequences of three 
previously-designed siRNAs targeting mouse aldolase A (Ritterson Lew, 2012), designated as 
siRNA_287 (siAldolase A 287 [mouse/rat]), siRNA_1171, and siRNA_1301, were aligned with 
complementary DNA (cDNA) sequences of mouse, rat, monkey, and human aldolase A.  Aligned 
bases for each species and siRNA are colored according to nucleotide (adenine (A) = green, 
thymine (T) = red, cytosine (C) = blue, guanine (G) = yellow).  Missing asterisks under each 
alignment denote a mismatched base with at least one species. 
 
 
 The effect of siAldolase A 287 (mouse/rat) was tested in BSC1 and COS-7 
monkey epithelial cells (Figure 5.2).  A scrambled siRNA was used as a negative control 
to rule out nonspecific changes in gene expression.  For comparison to established 
phenotypes, NIH-3T3 mouse fibroblasts were transfected in conjunction.  NIH-3T3 
knockdown cells exhibited noticeable morphological and proliferation defects, which 
have been previously observed (Ritterson Lew, 2012).  BSC1 cells appeared larger and 
were irregularly-shaped in comparison to the scrambled siRNA control cells.  
Knockdown of aldolase in COS-7 cells showed the most drastic morphological defects 
compared to the other cell lines, and had a qualitative decrease in proliferation as well. 
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Figure 5.2 Effect of aldolase knockdown on cell morphology of NIH-3T3, BSC1, and COS-7 
cells.  Knockdown of aldolase using siAldolase A 287 (mouse/rat) was performed in NIH-3T3 
(n=1), BSC1 (n=1), and COS-7 (n=2) cell lines seeded at the same density.  Negative control 
replicates for each cell line were transfected with a scrambled control, Silencer™ Negative 
Control No. 1 siRNA (Thermo Fisher Scientific, Rockford, IL).  Cells were imaged and harvested 
3 d post-transfection.  NCLs were used in aldolase specific activity assays.  For COS-7 cells, 
error is represented as SEM.  DIC images were obtained using a Zeiss Axiovert 200 M inverted 
fluorescence microscope.  Micrographs are shown at 400× magnification.  Abbreviations: DIC, 
differential interference contrast; KD, knockdown; NCL, native cell lysate. 
 
 
Aldolase activity was measured from NCLs for both treatments to assess the 
extent of knockdown.  Over 80% of aldolase activity was depleted in NIH-3T3 cells (KD: 
17%, n = 1; Figure 5.2).  The degree of knockdown was lower in BSC1 (KD: 33%, n = 1; 
Figure 5.2) and COS-7 knockdown cells (control: 100 ± 7.19; KD: 26.2 ± 10.2, n = 2; 
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Figure 5.2), which showed an approximately 70% reduction in aldolase activity.  To 
potentially improve the knockdown efficiency for additional experiments in monkey and 
human cell lines, the siAldolase A 287 (mouse/rat) sequence was subsequently modified 
to fully match the monkey aldolase A sequence.  The derived siRNA, containing no 
mismatches to the monkey sequence and one mismatch to the human sequence, is 
referred to in this work as siAldolase 287 (monkey/human).  To verify that only aldolase 
A would be targeted and not aldolases B and/or C, siAldolase 287 (monkey/human) was 
aligned to the monkey aldolases B and C gene sequences (see Appendix II). 
 
Analysis of Knockdown Efficiency in BSC1, COS-7, and HeLa cells 
 The level of aldolase knockdown by siAldolase 287 (monkey/human) was tested 
in BSC1, COS-7, and HeLa cells (Figure 5.3).  Mock-transfected controls were used for 
comparison to rule out delivery method effects.  Knockdown in BSC1 cells remained 
similar to the previous results, with about a 70% diminishment in aldolase activity 
(Figure 5.3A).  COS-7 cells showed nearly 80% knockdown (Figure 5.3B), an 
improvement from earlier findings.  HeLa cells appeared to show the highest sensitivity 
to knockdown, with slightly over 80% loss of activity.  Although the effect of modifying 
the original siRNA sequence did not significantly alter the knockdown efficiency 
observed, the extent of knockdown was sufficient for continuation of experiments in 
these cell lines. 
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Figure 5.3 Knockdown efficiency of siRNA targeting monkey and human aldolase A.  Cells 
were mock-transfected (negative control) or transfected with 50 nM of siAldolase 287 
(monkey/human).  Specific activity (U/mg) was measured in NCLs from each treatment 4 d post-
transfection and normalized to mock-transfected controls.  Error is represented as SEM.  A. KD 
in BSC1 cells (n=4).  B. KD in COS-7 cells (n=2).  C. KD in HeLa cells (n=2).   
A 
B 
C 
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Fluorescence Microscopy Studies of Internalization in Knockdown Cells 
Effect of Aldolase Knockdown on Fluid-Phase Endocytosis 
To probe the role of aldolase in fluid-phase endocytosis, otherwise known as bulk 
fluid uptake, internalization of a fluorescently-labeled dextran marker was assayed in 
BSC1 cells (Figure 5.4).  FITC-Dx uptake was quantified and compared between 
scrambled siRNA control and aldolase knockdown cells (Figure 5.4B).  An 
approximately four-fold increase in internalized Dx was observed in the knockdown cells 
(control: 38 ± 19, n = 14; KD: 143 ± 68, n = 14), indicating significant upregulation in 
endocytosis.  These findings support preliminary data from similar experiments 
performed in NIH-3T3 fibroblasts, in which three times the number of aldolase 
knockdown cells were observed to be active in fluid-phase uptake of rhodamine-labeled 
Dx compared to mock transfected and GAPDH knockdown fibroblasts (Carolyn 
Ritterson Lew, unpublished studies).  To verify that cells were indeed internalizing the 
uptake marker, FITC-Dx uptake assays were additionally performed on ice to halt 
endocytosis and rule out non-specific labeling of the cell surface or incomplete vesicle 
formation (Figure 5.5).  Punctate expression was completely absent in all control and 
knockdown cells, supporting the validity of the results described above. 
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Figure 5.4 Bulk fluid uptake following knockdown of aldolase in BSC1 cells.  A. BSC1 cells 
were transfected with scrambled siRNA or siAldolase 287 (monkey/human).  Uptake assays 
using FITC-Dx were performed 4 d after transfection.  Nuclei were DAPI-stained.  Fluorescent 
images were acquired using a Nikon Eclipse Ni-E microscope (Nikon Instruments Inc., Melville, 
NY).  Micrographs are shown at 400× magnification.  B.  For each treatment, puncta were 
quantified in individual cells.  Error is represented as standard deviation (σ) where n=14.  ****, 
P<.0001.  Abbreviations: DAPI, 4′,6-diamidino-2-phenylindole; Dx, dextran; FITC, fluorescein 
isothiocyanate. 
A 
B 
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Figure 5.5 Temperature-controlled uptake assays attenuate endocytosis.  BSC1 cells were 
transfected with scrambled siRNA or siAldolase 287 (monkey/human).  Uptake of FITC-Dx was 
performed on ice 4 d post-transfection.  Cell nuclei were stained with DAPI.  Fluorescent images 
were acquired using a Nikon Eclipse Ni-E microscope (Nikon Instruments Inc., Melville, NY).  
Micrographs are shown at 400× magnification.   
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Although the above experiments showed a correlation that is suggestive of a 
regulatory role for aldolase in endocytosis, measurement of bulk fluid uptake alone is not 
sufficient to specify a direct impact or narrow down which endocytic pathway is affected.  
Additional experiments were necessary to further investigate the function of aldolase in 
internalization pathways. 
 
Effect of Aldolase Knockdown on Clathrin-Mediated Endocytosis 
As mentioned earlier, aldolase has been implicated in regulating the scission 
module of the CME pathway (Lundmark and Carlsson, 2009).  To ascertain whether 
aldolase potentially has a regulatory role in CME, internalization of transferrin (Tf), a 
well-established marker of CME (Mayle et al., 2012), was measured.  Fluorescein-
conjugated Tf uptake assays were performed in BSC1, COS-7, and HeLa cells (Figure 
5.6-5.8).  Cells were transfected with 50 nM of siAldolase 287 (monkey/human) to knock 
down aldolase A.  Controls for each cell line were mock-transfected or treated with a 
scrambled siRNA.   
In BSC1 cells, noticeably higher levels of puncta were visible in knockdown cells 
compared to mock-transfected and scrambled siRNA controls (Figure 5.6A).  Higher 
punctate expression was observed in COS-7 (Figure 5.7A) and HeLa knockdown cells as 
well (Figure 5.8A), but were less apparent compared to the BSC1 cells.  In all three cell 
lines, a two-fold average increase in CME was observed (BSC1 mock: 147 ± 40, n  = 22; 
BSC1 scrambled: 128 ±50, n = 22; BSC1 KD: 251 ± 65, n = 22; Figure 5.6B; COS-7 
mock: 118 ± 39, n = 30; COS-7 scrambled: 140 ± 47, n = 30; COS-7 KD: 238 ± 137, n =  
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Figure 5.6 Transferrin uptake in BSC1 cells.  A. BSC1 cells were mock-transfected or 
transfected with scrambled siRNA or siAldolase 287 (monkey/human).  Following treatment (4 
d), cells were serum-starved and internalization of surface transferrin (Tf) receptors was labeled 
using fluorescein-Tf.  F-actin was phalloidin-stained and nuclei stained with DAPI.  Fluorescent 
images were acquired using a Nikon Eclipse Ni-E microscope (Nikon Instruments Inc., Melville, 
NY).  Micrographs are shown at 400× magnification.  B. Puncta were quantified and compared 
between each treatment.  Error is represented as standard deviation (σ) where n=22.  Blue bar 
indicates significance between mock and KD sample sets.  ****, P<.0001; ns, not significant. 
A 
B 
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Figure 5.7 Transferrin uptake in COS-7 cells.  A. COS-7 cells were mock-transfected or 
transfected with scrambled siRNA or siAldolase 287 (monkey/human).  Following treatment (4 
d), cells were serum-starved and internalization of surface transferrin (Tf) receptors was labeled 
using fluorescein-Tf.  F-actin was phalloidin-stained and nuclei stained with DAPI.  Fluorescent 
images were acquired using a Nikon Eclipse Ni-E microscope (Nikon Instruments Inc., Melville, 
NY).  Micrographs are shown at 400× magnification.  B. Puncta were quantified and compared 
between each treatment.  Error is represented as standard deviation (σ) where n=30.  Blue bar 
indicates significance between mock and KD sample sets.  ****, P<.0001; ns, not significant. 
A 
B 
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Figure 5.8 Transferrin uptake in HeLa cells.  A. HeLa cells were mock-transfected or 
transfected with scrambled siRNA or siAldolase 287 (monkey/human).  Following treatment (4 
d), cells were serum-starved and internalization of surface transferrin (Tf) receptors was labeled 
using fluorescein-Tf.  F-actin was phalloidin-stained and nuclei stained with DAPI.  Fluorescent 
images were acquired using a Nikon Eclipse Ni-E microscope (Nikon Instruments Inc., Melville, 
NY).  Micrographs are shown at 400× magnification.  B. Puncta were quantified and compared 
between each treatment.  Error is represented as standard deviation (σ) where n=33.  Blue bar 
indicates significance between mock and KD sample sets.  ****, P<.0001; ns, not significant.  
A 
B 
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30; Figure 5.7B; HeLa mock: 82 ± 22, n = 33; HeLa scrambled: 87 ± 31, n = 33; HeLa 
KD: 129 ± 26, n = 33; Figure 5.8B).   
As the Tf receptor (TfR) is endocytosed exclusively via CME (Sigismund et al., 
2008), these findings indicate that aldolase has an impact on the CME pathway.  These 
results could further explain the upregulation of fluid-phase endocytosis observed in the 
prior Dx uptake experiments (Figure 5.4B) as a global defect in CME can result in 
upregulation of alternative pathways as a compensatory mechanism (Mayor and Pagano, 
2007).  To further dissect the putative function of aldolase in this process, additional 
studies will be necessary to establish how actin dynamics and vesicle scission are 
regulated via interactions of aldolase with WASP and SNX9.  Preliminary experiments 
were initiated in primary rat cortical neuron cultures to explore whether aldolase 
expression could be important for vesicle endocytosis in neurons (see Appendix III).  A 
model for the proposed moonlighting function of aldolase in CME is presented in the 
next chapter.   
 The intrinsic modularity of the CME pathway enables distinct functions in 
different locations of the cell and different cell types (McMahon and Boucrot, 2011; 
Sigismund et al., 2012).  The complexity of endocytosis is believed to be an evolutionary 
consequence indicative of selective pressure for increased complexity in higher 
organisms.  Proper timing and ordered arrival of dozens of proteins is a fundamental 
aspect of CME (Conner and Schmid, 2003; Doyon et al., 2011).  Other groups have 
published evidence suggesting a possible role for aldolase in the scission step of this 
pathway (Lundmark and Carlsson, 2003; Lundmark and Carlsson, 2004; Rangarajan et 
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al., 2010).  To our knowledge, a direct assay of aldolase function in endocytosis has not 
been shown by others.   
  
 151 
CHAPTER 6: DISCUSSION 
 
PRODUCTION OF A CHIMERIC ALDOLASE A VARIANT 
 
 In order to generate an 22 tetramer of aldolase with one actin-binding dimer 
half, it was necessary to employ a newly developed co-expression approach.  
Construction of such a hybrid using conventional cloning and biochemical strategies 
(Penhoet et al., 1966; Rutter et al., 1968; Penhoet and Rutter, 1971) had posed a greater 
challenge.  For our purposes, subjecting purified HRA and R42A variant aldolases to in 
vitro hybridization did not yield appreciable levels of hybrids (see Figure 3.4).  Due to 
the unusually high strength of the subunit-interface interactions of aldolase (Deng and 
Smith, 1999; Tolan et al., 2003), it was necessary to acidify the buffer solution 
substantially during IVH in order to dissociate the subunits.  At an insufficiently low pH, 
the subunits will unfold individually, but the tetramer interfaces will remain intact, thus 
negating the purpose of the subunit-mixing procedure.  At low pH values (< 6.5), 
aldolase loses enzyme activity (Beernink, 1995).  However, reversal of activity loss from 
this method is easily achieved (see Figure 3.3A). Aldolase A-B, B-C, and A-C hybrids 
have been successfully produced this way (Penhoet et al., 1966; Rutter et al., 1968; 
Penhoet and Rutter, 1971).  In addition, chimeric tetramers composed of aldolase 
subunits from different species have been generated using this method (Heil and Lebherz, 
1978; Swain and Lebherz, 1986).  In this work, it was necessary to produce a chimeric 
aldolase containing subunit variants that were derived from the same isozyme and only 
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slightly differed in amino acid sequence (see Chapter 3).  Very little work has been 
shown demonstrating straightforward production of hybrids composed of subunits from 
the same isozyme (Meighen and Schachman, 1970).  Likewise, chimeric aldolases with 
tagged protein-variant subunits have not been reported.  Although the His6-tag generally 
did not interfere with WT aldolase function and binding interactions (Chapter 3 and 4), 
the stability of the tag has been questionable (data not shown).  It is unclear to what 
extent various protein tags withstand the harsh conditions of the IVH procedure.  
Additionally, purified enzymes by our group have shown a loss of the His6-tag over time 
(≥ approximately 30 d), even under proper storage conditions (Q. Ho, W. Gasper, S. 
Gardner, unpublished data).  Regardless of these variables, it appeared that the aldolase 
variants used in this project may have simply been more sensitive to acid denaturation 
and prone to hydrolysis, leading to the low yields that were seen.  It would be interesting 
to see whether using stabilized variants such as gtet aldolase (Choi et al., 2001) could 
lend to greater recovery of hybrids for this procedure. 
In addition to biochemical methods, attempts were made to co-express HRA and 
R42A in E. coli to facilitate in vivo hybridization for the purpose of purifying a five-
membered mixed tetramer set.  However, co-transformation of two separate vectors with 
different resistance markers failed to produce stoichiometric expression of both genes 
even though expression of each variant was equally strong when transformed individually 
(see Figure 3.1).  Although co-transformation of plasmids containing the same origin of 
replication can produce co-expression (Yang et al., 2001), it is often the case that one 
vector will outcompete the other and produce biased expression (Kim et al., 2004; 
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Romier et al., 2006).  Co-transformation of the aldolase variants in this work consistently 
resulted in biased expression of R42A (see Chapter 3).  Furthermore, the small sizes of 
pPB1-derived plasmids originally used as single expression backbone vectors for HRA 
and R42A did not appear to enhance plasmid stability to a degree sufficient for co-
expression, though this outcome has been achieved in other similar contexts (Beernink 
and Tolan, 1992; Dzivenu et al., 2004).  Commercially available Duet co-expression 
vectors (Small et al., 2010) further resulted in biased production of one subunit type over 
the other (S. Oppelt, unpublished studies).  Furthermore, noticeable differences in 
expression level for various GOIs have been observed with similar previously-developed 
polycistronic systems (Neumann et al., 2003; Kim et al., 2004; Romier et al., 2006; 
Scheich et al., 2007; Wakamori et al., 2010; Zeng et al., 2010).  Notably, these case 
studies do not include attempts to co-express slight variants in the GOI, as was the case 
here. 
For our purposes, the above co-expression methods failed to produce the HRA 
variant at sufficient levels for any purification attempts, and increasing HRA expression 
was the first step in creating dual high-level expression plasmids that expressed the 
encoded constructs equally.  Whereas this bias in expression was the main problem 
encountered using other systems, the issue was quickly resolved by the ease and 
versatility of library design afforded by the CIDAR MoClo method.  As demonstrated by 
western-blot analyses (see Figure 3.7), expression of the HRA variant was 
uncompromised across all single and dual expression constructs produced.  Furthermore, 
co-expression of both HRA and R42A variants was achieved in all twelve dual 
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expression plasmids (see Figure 3.7B).  Moreover, failure of expression of either variant 
was never observed with this method.   
 
Perspectives for Co-expression Studies 
MoClo technology has major advantages over conventional methodologies.  This 
system enables unprecedented flexibility in selecting and modifying individual control 
elements for plasmid design at the user’s discretion.  Cloning efforts are substantially 
reduced by the one-pot setup of the MoClo procedure.  Additionally, issues related to 
yield and unequal or unpredictable expression are easily circumvented.  In our 
experience, the MoClo-produced co-expression plasmids yielded on average 40 mg of 
purified protein per liter of bacterial culture.  Importantly, though some available 
techniques may offer a certain degree of control over stoichiometry (Stols et al., 2007; 
Terada et al., 2014) or flexibility in troubleshooting, expression tuning is more easily 
achieved at the plasmid construction level with the MoClo approach.  Distinct 
combinations of promoter, RBS, CDS order, and vector context can be swiftly produced 
and tested for function in parallel, thus maximizing efficiency.   
The results shown in Chapter 3 demonstrate the first successful case study of a 
biological application of the CIDAR MoClo technique.  This method provides a highly 
efficient approach for tunable co-expression of multiple proteins in a prokaryotic host.  
For this work, actin-binding heterotetramers of aldolase were successfully produced for 
use in EM studies.  Additional studies will be needed to provide insight into the 
application of MoClo for expression of toxic or hydrophobic proteins, as well as co-
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expression of more than two proteins.  However, given the success demonstrated herein, 
the use of MoClo for these applications should be easily realized. 
 
MODELING THE ALDOLASE-F-ACTIN INTERACTION 
 
There is strong evidence to suggest that the quaternary structure of aldolase may 
have evolved for moonlighting activities in the cell as monomerized Q125D/E224A 
aldolase variants (Beernink and Tolan, 1996) no longer bind to actin (Pirani, 2008; 
Ritterson Lew, 2012) or participate in F-actin polymerization in vitro (Ritterson Lew, 
2012), yet maintain normal catalytic activity comparable to WT.  The interaction of 
aldolase with F-actin remains the focal point of many aldolase moonlighting interactions 
discovered thus far.  The binding interface of aldolase and F-actin has continued to be an 
elusive and critical missing component that is infrequently addressed in studies of actin-
mediated pathways where aldolase may have a non-canonical function.  However, it is 
certainly not due to a lack of effort that the structure has not been identified.  Prior efforts 
to model this interaction were complicated by the filament-crosslinking effect produced 
by WT aldolase (Wang et al., 1996) as well as the symmetrical shape of the aldolase 
dimer variant capable of uniformly decorating F-actin (Pirani, 2008).   
Planar or paracrystalline arrays of bundled actin filaments, known as actin rafts, 
are two-dimensional analogs that have been used to generate lower-resolution (nm scale) 
models.  A recent report using cryoelectron tomography proposed an atomic model of the 
crosslinking interactions from F-actin-aldolase rafts (Hu et al., 2018).  The points of 
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contact identified support previous studies that suggest aldolase binds to actin at two sites 
on the filament (Arnold et al., 1971; Ouporov et al., 1999).  However, it is uncertain 
whether the 2-D raft interactions observed in this report accurately mimic the true 
orientations of actin-aldolase interactions in 3-D crosslinked bundles.  Additionally, the 
resolution of the structure obtained was in the nm-range at best, which is too low to 
decipher atomic details of the interactions made. 
In this thesis work, an alternative approach was explored for the purposes of 
obtaining a high-resolution model of this interaction via cryo-EM reconstruction.  To 
overcome previously observed issues caused by crosslinking and symmetry, it was 
hypothesized that an asymmetric aldolase binding unit could serve to: 1) decorate F-actin 
without crosslinking, and 2) lend to fitting of the WT aldolase crystal structure.  
 
Separation of Chimeric Aldolase Tetramers 
 Unlike mixed aldolase sets that have been produced from pairwise combinations 
of the A, B, and C isozymes (Penhoet et al., 1966; Rutter et al., 1968; Penhoet and Rutter, 
1971), the HRA-R42A chimeras did not have sufficiently large differences in charge to 
allow clean separation (see Figures 3.9 and 4.4).  It was originally predicted that the 
addition of a His6-tag to each WT variant subunit as well as the loss of Arg from the 
R42A substitution would help to create differences in charge between species great 
enough to allow separation.  However, it was evident that various charged-molecule 
separation techniques as well as those exploiting the His6-tag (see Figure 4.5) still could 
not clearly resolve individual chimeric species.   
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 If the predicted net charge is compared for each species within the mixed aldolase 
set produced from HRA and R42A subunits (Figure 6.1A), stark differences can be seen 
for a comparable theoretical mixed set created from HRA and WT aldolase C subunits 
(Figure 6.1B).  Clearly, such differences are necessary if the resulting species are to be 
visualized by native zone electrophoresis or separated by ion-exchange chromatography.  
This consideration is especially relevant for hybrids produced from subunit variants of 
the same isozyme.  Previous work has demonstrated that chemical modifications such as 
succinylation of Lys side chains may be necessary to create derivatives of the same 
enzyme that are distinct enough to separate (Meighen and Schachman, 1970).   
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Figure 6.1 Predicted net charges of hybridized aldolase species.  The net charge of various 
aldolase homotetramer and chimeric species was predicted using Protein Calculator v3.4 
(protocalc.sourceforge.net).  Protein sequences from rabbit aldolase A for HRA, R42A, and WT 
aldolase C were input to predict the net charge of each subunit type.  A. Combinations of tetramer 
species resulting from the hybridization of R42A (white) and HRA (purple) subunits are 
diagrammed.  The net charge at pH values between 6.0-7.5 is shown below each species.  B. For 
comparison and hypothetical purposes, a mixed tetramer set composed of aldolase C (orange) and 
HRA (purple) subunits with corresponding predicted net charges is depicted.  
A 
B 
- 
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 Ultimately, it did not appear necessary to completely separate the different species 
in the mixed HRA:R42A aldolase set.  The only problematic species was the HRA 
homotetramer, which was the sole crosslinking species in the set.  As 2:2 
heterotetrameric aldolases were expected to be the predominant species, it was expected 
that a sufficient pool of hybridized species would decorate F-actin in EM studies. 
 
Decorating Actin Filaments with Asymmetric Aldolase 
 
 Actin is a dynamic polymer capable of adopting a variety of higher-order 
structures that include bundles and mesh networks based on interactions with specific 
actin-binding proteins (Dos Remedios et al., 2003; Pollard, 2016).  As discussed above, 
aldolase bound to F-actin in vitro induces filament bundling or raft formation, which is 
not amenable to high-resolution modeling.  Though dimeric aldolase has been found to 
uniformly decorate the F-actin helix and lend to EM reconstruction, the D128V aldolase 
crystal structure could not previously be definitively fitted to initial 3-D density 
envelopes for determination of the binding interface (Pirani, 2008).  It has since been 
hypothesized that in order to reconstruct an accurate model of an actin filament decorated 
with aldolase, sufficient density would be required for docking of the WT aldolase crystal 
structure.  The chimeric 2:2 aldolase was predicted to serve as an appropriate asymmetric 
binding unit for this purpose.  Negative staining of this sample mixed with F-actin 
showed a large population of single filaments that appeared to be decorated with 
asymmetric aldolase tetramers (see Figure 4.7).  However, the cryo-EM data set showed 
that at higher resolution, there was still a fair proportion of crosslinked filaments present 
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(see Figure 4.10).  Better separation of single, decorated filaments is desired if helical 
reconstruction is to be pursued (C. Xu, personal communication).   
 
Partial Depolymerization of F-actin in the Presence of an Actin-Binding Protein  
 
Complete disassembly of F-actin with toxins, such as cytochalasin D (Casella et 
al., 1981), would likely release bound aldolase (Pagliaro and Taylor, 1992).  Thus, partial 
depolymerization of F-actin was pursued for single-particle analysis of the aldolase-F-
actin complex.  Early sedimentation experiments have suggested the possible binding of 
aldolase to G-actin in vitro (Arnold et al., 1971), though this interaction is unlikely to be 
physiologically relevant as the Kd was later measured to be > 50 µM (J. Ho, unpublished 
studies).  Therefore, polymerization of actin was required prior to binding of aldolase in 
vitro and incomplete depolymerization attempted.   
The mechanisms of actin depolymerization are not well-understood in the context 
of the cell (Brieher, 2013).  Although it may have been possible to explore actin 
disassembly in the presence of filament-severing proteins, manipulation of the rate and 
extent of depolymerization by these proteins in vitro is not trivial.  In addition, nothing is 
known about how or if this might work with aldolase bound to the filament.  Severin, a 
protein found in Dictyostelium discoideum, is able to sever actin filaments, but remains 
bound to G-actin, filament fragments, and other oligomers of actin (Giffard et al., 1984).  
Other severing proteins, such as cofilin and gelsolin, have been shown to alter the F-actin 
structure (McGough et al., 1997; Dawson et al., 2003) and could potentially compete 
with aldolase-binding or alter the binding mode of aldolase.  In addition, fragmentation of 
actin has been achieved via mechanical means such as sonication to break filaments 
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(Kawamura and Maruyama, 1970; Oosawa and Maruyama, 1987).  However, this 
technique was expected to be too disruptive to enzyme stability (Özbek and Ülgen, 
2000).  To increase the likelihood of retaining aldolase-bound particles of actin for EM 
reconstruction, depolymerization was instead gradually induced by salt removal.  This 
method has been shown to depolymerize bare F-actin alone (Pardee and Spudich, 1982) 
as well as in the presence of another actin-binding protein in solution, such as gelsolin 
(Bryan and Coluccio, 1985).   
The TEM data from the partially-depolymerized F-actin samples mixed with 6-5 
aldolase appeared to confirm incomplete actin disassembly as particles of various sizes 
were observed (see Figures 4.8 and 4.9).  It was hypothesized that 2-D class averages of 
F-actin fragments with aldolase still bound could then be used to reconstruct a 3-D model 
of the decorated actin filament.  After cryo-EM data collection and particle selection from 
this sample (see Figures 2.2 and 2.3), a preliminary 3-D reconstruction (see Figure 4.11) 
was produced by Dr. Kyounghwan Lee (UMass Medical School).  Completion of this 
model is currently in progress with the goal of a high-resolution structure. 
 
Future Directions for a High Resolution 3-D Model of the Aldolase-F-actin Complex 
 
 In order to further refine our current model, cryo-EM data for aldolase tetramers 
alone are needed to confirm that the extra density seen originated from actin.  These data 
are currently in the process of being collected.  Though we predicted that the aldolase-
actin interaction would be properly preserved, it remains to be seen whether such 
depolymerized actin fragments retain aldolase bound and in the correct orientation.  
Should the single-particle approach not yield the desired structure, a helical 
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reconstruction method will be revisited.  In this case, it may become necessary to further 
improve the sample quality for cryo-EM raw data collection.  To that end, the HRA 
homotetramer could be removed from the mixed tetramer set to eliminate the crosslinking 
effect entirely.  This level of purity can most likely be achieved via methods such as 
isoelectric focusing.  Ultimately, a high-resolution model needs to be solved from data 
that lend to fitting of the aldolase and actin crystal structures.  Knowledge of this 
complex will lead to clearer models of aldolase functional compartmentation in the cell 
and moonlighting mechanisms that are related to this interaction.   
 
THE MOONLIGHTING FUNCTION OF ALDOLASE IN ENDOCYTOSIS 
 
In addition to controlling biomass, endocytosis controls the flow of information 
inside cells by enabling various internalization pathways to coordinate specific cellular 
responses to environmental cues.  Targeting of ligand molecules and the cognate 
receptors to specialized membrane compartments is critical to the regulation of signal 
transduction (Andersson, 2012).  Receptor turnover at the cell surface plays a direct role 
in determining the very nature of intracellular signaling cascades from activation to 
magnitude, duration, and termination.   
Many other key cellular functions rely on proper endocytosis as well, such as 
nutrient acquisition, homeostasis, migration, differentiation, and neurotransmission 
(McMahon and Boucrot, 2011).  Defects in proteins involved in CME are associated with 
human diseases, including a wide array of metabolic and genetic syndromes, cancer 
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types, and neurological disorders.  In particular, most of the core scission machinery 
proteins that are known overlap multiple disease states.  Ironically, the scission module of 
CME is the least understood step of this pathway.   
Because of the importance in many cellular functions, alternative routes have also 
evolved to accomplish separate tasks (Sigismund, 2012).  Increased complexity in higher 
organisms naturally demands greater plasticity in cellular responses to rapidly changing 
environmental conditions and internal needs.  To precisely fine-tune cellular physiology, 
this level of flexibility is partially acquired through diverse cargo sorting signals in 
addition to adaptors and accessory molecules that can vary between pathway and cell 
types (Robinson, 2004; Lakadamyali et al., 2006).  Studies comparing each pathway, 
however, have shown that a number of components are reused to achieve different goals 
in different contexts (Kumari et al., 2010).  As a clearly multifunctional protein, it will be 
interesting to see if aldolase is among the expanding list of accessory proteins connecting 
endocytosis to actin machinery.   
Ultimately, a complete knowledge of the mechanisms that pertain to endocytic 
systems necessitates detailed understanding of key molecules and where each one acts to 
modulate vesicle formation and trafficking.  Future studies need to further address the 
question of how endocytosis is upregulated and downregulated to better decipher the 
relationship with disease states such as cancer, infections from machinery hijacking by 
bacteria and viruses for gaining entry into the body, and aggregation disorders like 
Huntington’s and Alzheimer’s Disease (McMahon and Boucrot, 2011).  Continued 
research on accessory proteins will likely contribute to filling in gaps where key 
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questions remain in the field.  Defining the role of aldolase in this process will be one 
important piece to this puzzle. 
 
Proposed Model for the Scaffolding Role of Aldolase in Clathrin-Mediated Endocytosis 
 In the experiments presented in Chapter 5, the impact of aldolase knockdown on 
endocytosis was observed to be the same in three cell lines.  Endocytosis was found to be 
markedly increased in uptake assays using two different markers: dextran, to measure 
fluid-phase uptake (see Figure 5.4), and transferrin, to measure CME (see Figures 5.6-
5.8).  Based on these findings, at least two interpretations can be applied.  It is important 
to note that bulk fluid uptake does not account for CME and is considered to better act as 
a broad range marker for CIE (Oliver et al., 1984; Le Roux et al., 2012; Basquin et al., 
2013).  Fluid-phase endocytosis does not involve receptor-mediated trafficking and, in 
fact, encompasses multiple CIE pathways (Kumari et al., 2010).  Therefore, one 
possibility is that aldolase directly regulates a CIE pathway and the removal produces a 
gain-of-function effect, permitting upregulation.  However, which CIE pathway and the 
underlying cause of aberrant endocytic phenotypes observed cannot be deduced from this 
general assay.  Previous work has suggested that aldolase may localize to caveolae-
enriched lipid rafts, and targeting of aldolase to the PM has been shown to increase with 
caveolin-1 overexpression (Raikar et al., 2006).  Furthermore, all three putative 
interaction partners of aldolase during endocytosis—actin, WASP, and SNX9, have 
functions in both CME and CIE (Yarar et al., 2007; Lundmark and Carlsson, 2009; 
McMahon and Boucrot, 2011).   
 165 
Another possibility, which is proposed in this work, posits that aldolase depletion 
produces a global CME defect, and the phenotype observed for fluid-phase uptake is due 
to the effect of compensatory mechanisms perhaps upregulating CIE pathways (Mayor 
and Pagano, 2007).  The data from the Tf uptake assays further support this possibility as 
the TfR is known to be constitutively endocytosed via CME (Sigismund et al., 2008; 
McMahon and Boucrot, 2011).  As CME is the major endocytic pathway in eukaryotic 
organisms, it is unlikely that these effects from aldolase knockdown would be seen if 
CME was not directly impacted.  To further decipher the exact role of aldolase, future 
studies dissecting aldolase interactions during endocytosis via live-cell imaging studies 
will be necessary. 
A possible model for CME proposes that the aldolase tetramer localizes to the cell 
periphery at sites of endocytosis via association with cortical actin (Figure 6.2A-B), and 
serves as a temporary depot for SNX9 and WASP (Figure 6.2B-E).  As described in 
Chapter 1, the quaternary structure of aldolase is not relevant for catalysis, and its 
extraordinary interface strength has been predicted to have evolved for moonlighting 
functions (Beernink and Tolan, 1996; Ritterson Lew, 2012).  Therefore, with two 
subunits occupied from binding F-actin, additional binding of SNX9 and WASP could 
take place simultaneously in the individual hydrophobic pockets (Figure 6.3) of the 
remaining two subunits of the tetramer.  Binding would result in sequestration of the 
active domains of these proteins that are necessary for clathrin and actin machinery.  As 
previously discussed, this scaffolding effect could serve to sequester and concentrate 
SNX9 and WASP just prior to vesicle scission, ensuring precise timing and efficiency for 
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Figure 6.2 Working model of the aldolase scaffolding function in CME.  A. An enlarged 
model of predicted bidentate binding of aldolase (blue) to a cortical actin filament (green) is 
shown.  Schematic adapted from Pollard, 2016.  B. In a complex with aldolase, the binding 
domains of WASP and SNX9 for Arp2/3 and AP-2/clathrin interactions, respectively, are 
sequestered prior to vesicle scission.  C. Release of SNX9, likely by a kinase (Lundmark and 
Carlsson, 2004; Bendris and Schmid, 2017), enables recruitment of dynamin and oligomerization 
at the scission site.  D. A second (undetermined) phosphorylation event releases WASP, which 
gets recruited to the bud neck by SNX9 and activates Arp2/3 to trigger actin polymerization.  
E. Shown as the last two steps, constriction of the membrane and inward force from actin 
polymerization sever the vesicle shortly after.  (Cortical F-actin and Arp2/3 are not shown.)   
A B 
C 
D 
E 
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Figure 6.3 Crystal structure of the aldolase hydrophobic pocket.  One subunit of the rabbit 
aldolase A tetramer is shown in violet (PDB: 1ADO).  Residues within the hydrophobic pocket in 
which SNX9 (Rangarajan et al., 2010) or WASP (St-Jean et al., 2007) can bind and become 
sequestered by aldolase are highlighted in yellow (left).  Residues in the active site of aldolase 
involved in catalysis (Choi et al., 1999) are shown for comparison and highlighted in pale cyan 
(right). 
 
 
coordination of actin dynamics and scission machinery.  Release from aldolase would 
then trigger the events facilitating vesicle release.   
The plausibility of this model is partly due to the fact that aldolase has been found 
to exist in excess in the cell (Ottaway and Mowbray, 1977; Orosz et al., 1988; Lundmark 
and Carlsson, 2003), making it possible to distribute various pools of aldolase to alternate 
moonlighting functions.  Supporting this notion, it has further been shown that 
knockdown of aldolase to as low as 5-10% of normal levels does not disrupt the 
glycolytic flux or ATP concentration in cells (Ritterson Lew and Tolan, 2012).  
Moreover, it is known that there are far fewer genes than previously predicted to account 
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for vertebrate complexity (Venter et al., 2001; Touchman, 2010), and many proteins 
appear to have instead evolved to switch between different functions (Jeffery, 1999).  The 
binding pocket of aldolase contains residues important for moonlighting interactions that 
reside very closely to active site residues used in substrate binding (Figure 6.3).  SNX9- 
and WASP-binding to aldolase have been shown to compete with binding of active site 
ligands (St-Jean et al., 2007; Rangarajan et al., 2010), further suggesting 
multifunctionality that may involve alternating between transient complexes for roles 
specific to the needs of the cell.  Aldolase has been demonstrated to possess multiple 
functions in the cell, and evidence for fractions of cellular aldolase localized to the actin 
cytoskeleton has been observed in quiescent and actively motile cells (Wang et al., 1997).  
Continued studies of these diverse activities will provide a better understanding of how 
cellular complexity is accomplished and improve future approaches to therapeutics. 
 
ALDOLASE AS A POTENTIAL DRUG THERAPEUTIC TARGET 
 
Aldolase participates in a variety of protein-protein interactions, many of which 
have not been delineated.  Binding partners outside of glycolysis fall into three main 
categories: signal transduction, cell motility, and vesicle trafficking.  All these processes 
require actin dynamics and affect both the normal and disease states of eukaryotic 
organisms (Mayor and Pagano, 2007; McMahon and Boucrot, 2011).  Basic processes 
like endocytosis have emerged as interconnected pathways far more significant and 
complex than previously expected.  Investigating the numerous regulatory components 
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that serve to ensure ordered progression from clathrin-coated pit initiation to vesicle 
release will be crucial to understanding how endocytosis is coordinated with cell 
physiology.   
It has recently been shown that the rate of endocytosis can be exploited to 
enhance the delivery of anticancer drugs to cancer cells (Ali et al., 2014).  By increasing 
the rate of internalization, drug-carrying gold nanoparticles were found to be more 
effectively targeted.  In using this method, the concentration of nanoparticles required for 
plasmonic chemotherapy was reduced, which in turn alleviated the level of 
chemotherapeutic toxicity.   
As first described by the Warburg effect (Warburg et al., 1927), glycolysis is 
upregulated in cancer tissues.  Not surprisingly, overexpression of aldolase A is found in 
several cancers including lung, kidney, and liver (Pfleiderer et al., 1975; Chaerkady et 
al., 2008; Poschmann et al., 2009; Rho et al., 2009; Dang, 2012).  More recently, 
aldolase A has been shown to be a marker of lung squamous cell carcinoma (Du et al., 
2014).  In this study, high expression of aldolase A was found to correlate with tumor 
formation and metastasis.  Additionally, knockdown of aldolase A in NCI-H520 lung 
squamous carcinoma cells resulted in decreased tumorigenesis and cell motility.  As 
mentioned in Chapter 1, previous work from our group has demonstrated that targeting 
aldolase A using RNAi results in decreased cancer-cell proliferation, and that this effect 
can be rescued (Ritterson Lew and Tolan, 2012).  This inhibition was attributed to loss of 
interaction with F-actin that affected cytokinesis. 
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 Future studies should investigate the potential therapeutic value of aldolase as a 
drug target and address how targeting aldolase affects processes downstream of 
endocytosis and other actin-driven pathways.  Aldolase has been found in ternary 
complex with SNX9 and dynamin in multiple cell types, and has been demonstrated to 
inhibit SNX9 membrane association (Lundmark and Carlsson, 2004).  Aldolase has been 
shown to have an inhibitory effect on WASP-stimulated actin polymerization as well 
(Ritterson Lew and Tolan, 2013).  It will be important to assess how altering levels of 
SNX9 and WASP will impact processes such as cell migration, division, and invasion, 
and how these activities relate to cancer and metastasis.  Although, any pharmaceutical 
targeting of aldolase needs to consider many unintended side-effects due to the multiple 
cellular functions in which aldolase has a role.  
 
CONCLUSIONS 
 
In this thesis, the first application of CIDAR MoClo for a biological problem was 
presented.  These results showed that MoClo can be applied to tune the expression of any 
multi-subunit protein complex for ideal protein stoichiometry.  The results further 
illustrate that difficulties in control of expression levels are not necessarily restricted to 
physiologically toxic, hydrophobic, or membrane proteins, and more readily adaptable 
DNA assembly methods can be exploited to influence protein stoichiometry as well as 
unique molecular properties.  MoClo technology has great potential to become an 
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extremely useful and widely-adopted tool for generating multi-protein complexes of 
interest for protein-protein interaction and structural studies. 
 A heterotetrameric aldolase was purified and utilized as an asymmetric binding 
unit to decorate F-actin.  From TEM and subsequent cryo-EM studies of this interaction, 
a partial 3-D reconstruction of the aldolase-F-actin complex has been produced at a 
resolution of approximately 7 Å.  It is expected that aldolase is bound to actin in a 
physiologically relevant orientation, and that aldolase and actin crystal structures can be 
fitted to this model to determine the aldolase-actin binding interface.  Further refinement 
of the model is necessary and will lead to the first high-resolution structure of this 
complex in the 50 years since it was first discovered. 
 Aldolase is found in excess in the cell and likely has numerous roles in addition to 
sugar metabolism.  In the context of endocytosis, it was shown that depletion of aldolase 
A in several cell lines by RNAi results in significantly increased internalization of CIE 
and CME markers.  It is predicted that aldolase may regulate the coordination of actin 
dynamics and scission machinery in late-stage CME.  Rescue studies are required in the 
future using aldolase variants that contain mutations disrupting the binding of putative 
interaction partners, including actin, WASP, and SNX9.  In addition, mutations that 
destabilize the aldolase tetramer must be further characterized to determine the possible 
significance of quaternary structure in functioning as a tight scaffold during endocytosis.  
Deeper investigation of aldolase kinetics during endocytosis and morphological analysis 
of clathrin-coated pits will be important as well.  Continued work in this area of research 
will serve to further demonstrate the relevance of aldolase moonlighting and provide 
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more pieces of evidence to challenge the notion that aldolase may simply have a 
propensity for promiscuous binding interactions. 
  
 173 
APPENDIX I: ALIGNMENT OF DNA AND PROTEIN SEQUENCES OF 
MONKEY AND HUMAN ALDOLASE A 
 
Alignment of predicted Macaca fascicularis (XM_015442238.1 → 
XP_015297724.1) and Homo sapiens (NM_001243177.3 → NP_001230106.1) coding 
and amino acid sequences was performed using Clustal Omega (Madeira et al., 2019).  
Sequence identity was calculated from the start codon of the human sequence.   
 
 
(DNA) 
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APPENDIX II: ALIGNMENT OF ALDOLASES B AND C WITH siRNA 
TARGETING MONKEY ALDOLASE A 
 
Macaca fascicularis full ALDO B gene (XM_005581166.1):  
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Macaca fascicularis full ALDO C gene (XM_005583239.2):  
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 181 
APPENDIX III: ALDOLASE EXPRESSION AND KNOCKDOWN STUDIES IN 
PRIMARY RAT CORTICAL NEURONS 
  
 Preliminary studies were performed using primary neuronal cultures.  To observe 
expression of aldolase A, neurons were antibody-stained (Figure A3.1).  RNAi was used 
to knock down aldolase A.  Neurons were co-transfected with a cytoplasmic EGFP 
marker as a transfection efficiency control.  Following transfection (2-4 d), cells were 
probed with an antibody against post-synaptic density protein 95 (PSD-95) (Figure A3.2), 
synaptophysin (Figure A3.3), or actin (Figure A3.4).   
 
 
 
Figure A3.1 Aldolase A expression in cortical neurons.  ICC was used to antibody stain 
aldolase A in untreated primary rat cortical neurons (DIV15).  Aldolase A antibody (Santa Cruz 
Biotechnology, Santa Cruz, CA) was detected with an Alexa Fluor 488-conjugated secondary 
antibody (Thermo Fisher Scientific, Rockford, IL).  Nuclei were DAPI-stained.  Micrograph is 
shown at 630× magnification.  Fluorescent images were acquired using a Zeiss Axiovert 200 M 
inverted fluorescence microscope (Carl Zeiss Microscopy, LLC, Thornwood, NY).  
Abbreviations: DAPI, 4′,6-diamidino-2-phenylindole; DIV, days in vitro; ICC, 
immunocytochemistry. 
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Figure A3.2 PSD-95 expression in aldolase knockdown cells.  Primary rat cortical neurons 
(DIV15) were mock-transfected or transfected with scrambled siRNA or siAldolase A 287 
(mouse/rat).  All cell samples were co-transfected with pEGFP-C1 plasmid (0.3 ng/µL).  ICC was 
used to antibody stain PSD-95.  An Alexa Fluor 555-conjugated secondary antibody (Thermo 
Fisher Scientific, Rockford, IL) was used for detection.  Nuclei were DAPI-stained.  EGFP-
positive cells were imaged using a Zeiss Axiovert 200 M inverted fluorescence microscope (Carl 
Zeiss Microscopy, LLC, Thornwood, NY).  Micrographs are shown at 630× magnification.   
 
  
 183 
 
 
 
 
Figure A3.3 Synaptophysin expression in aldolase knockdown cells.  Primary rat cortical 
neurons (DIV15) were mock-transfected or transfected with scrambled siRNA or siAldolase A 
287 (mouse/rat).  All cell samples were co-transfected with pEGFP-C1 plasmid (0.3 ng/µL).  ICC 
was used to antibody stain synaptophysin (Santa Cruz Biotechnology, Santa Cruz, CA).  An 
Alexa Fluor 555-conjugated secondary antibody (Thermo Fisher Scientific, Rockford, IL) was 
used for detection.  Nuclei were DAPI-stained.  EGFP-positive cells were imaged using a Zeiss 
Axiovert 200 M inverted fluorescence microscope (Carl Zeiss Microscopy, LLC, Thornwood, 
NY).  Micrographs are shown at 630× magnification.   
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Figure A3.4 Actin-stained aldolase knockdown neurons.  Primary rat cortical neurons (DIV15) 
were mock-transfected or transfected with siAldolase A 287 (mouse/rat).  Knockdown samples 
were co-transfected with pEGFP-C1 plasmid (0.3 ng/µL).  ICC was used to antibody stain actin 
(Santa Cruz Biotechnology, Santa Cruz, CA).  An Alexa Fluor 555-conjugated secondary 
antibody (Thermo Fisher Scientific, Rockford, IL) was used for detection.  Nuclei were DAPI-
stained.  Images were acquired using a Zeiss Axiovert 200 M inverted fluorescence microscope 
(Carl Zeiss Microscopy, LLC, Thornwood, NY).  Micrographs are shown at 630× magnification.   
 
 
 Staining of dendritic spines was analyzed using Fiji (Schindelin et al., 2012).  The 
mean fluorescence intensity (a.u.) was measured for individual cells.  A two-fold 
decrease in intensity was observed for actin in knockdown cells compared to mock-
transfected cells (Figure A3.4).  No difference in average fluorescence intensity was 
observed for PSD-95 (Figure A3.2), a synaptic protein that is associated with receptors 
and the cytoskeleton and is important for endocytosis of α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid receptors (AMPARs) (Bhattacharyya et al., 2008).  CME is 
essential for AMPAR turnover (Hanley, 2018), however PSD-95 may be spatially-
segregated from clathrin machinery (Blanpied et al., 2002; Lu et al., 2007).  Additionally, 
no difference was observed for synaptophysin (Figure A3.3), a protein that regulates 
vesicle endocytosis in neurons in a clathrin-independent manner (Daly et al., 2000).   
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